0000950170-24-086879.txt : 20240726 0000950170-24-086879.hdr.sgml : 20240726 20240726160519 ACCESSION NUMBER: 0000950170-24-086879 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240726 DATE AS OF CHANGE: 20240726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGILYSYS INC CENTRAL INDEX KEY: 0000078749 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373] ORGANIZATION NAME: 06 Technology IRS NUMBER: 340907152 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-05734 FILM NUMBER: 241146805 BUSINESS ADDRESS: STREET 1: 3655 BROOKSIDE PARKWAY STREET 2: SUITE 300 CITY: ALPHARETTA STATE: GA ZIP: 30022 BUSINESS PHONE: 7708107800 MAIL ADDRESS: STREET 1: 3655 BROOKSIDE PARKWAY STREET 2: SUITE 300 CITY: ALPHARETTA STATE: GA ZIP: 30022 FORMER COMPANY: FORMER CONFORMED NAME: PIONEER STANDARD ELECTRONICS INC DATE OF NAME CHANGE: 19920703 10-Q 1 agys-20240630.htm 10-Q 10-Q
false0000078749Q1--03-3120240000078749agys:ProfessionalServicesMember2024-04-012024-06-300000078749us-gaap:StockAppreciationRightsSARSMember2024-04-012024-06-300000078749us-gaap:CommonStockMembersrt:MaximumMemberagys:TwoThousandAndTwentyEquityIncentivePlanMember2024-06-300000078749us-gaap:RetainedEarningsMember2024-03-3100000787492023-04-012023-06-300000078749us-gaap:PerformanceSharesMembersrt:ChiefExecutiveOfficerMember2024-04-012024-06-300000078749us-gaap:RestrictedStockUnitsRSUMember2024-04-012024-06-300000078749us-gaap:CommonStockMembersrt:MaximumMemberagys:TwoThousandAndTwentyEquityIncentivePlanMember2024-04-012024-06-300000078749us-gaap:AdditionalPaidInCapitalMember2024-06-300000078749us-gaap:SellingAndMarketingExpenseMember2023-04-012023-06-3000000787492023-06-300000078749us-gaap:RestrictedStockMember2024-04-012024-06-300000078749us-gaap:RestrictedStockUnitsRSUMember2024-03-310000078749us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-3000000787492024-06-300000078749us-gaap:SellingAndMarketingExpenseMember2024-04-012024-06-3000000787492024-04-012024-06-300000078749us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000078749us-gaap:CommonStockMember2023-03-310000078749us-gaap:RetainedEarningsMember2023-04-012023-06-3000000787492023-04-012023-12-310000078749us-gaap:EmployeeStockMember2024-04-012024-06-300000078749us-gaap:ProductMember2024-04-012024-06-300000078749us-gaap:RestrictedStockUnitsRSUMember2024-06-300000078749us-gaap:AdditionalPaidInCapitalMember2024-03-310000078749us-gaap:SeriesAPreferredStockMember2024-06-300000078749us-gaap:GeneralAndAdministrativeExpenseMember2023-04-012023-06-300000078749us-gaap:GeneralAndAdministrativeExpenseMember2024-04-012024-06-300000078749us-gaap:TreasuryStockCommonMember2023-04-012023-06-300000078749agys:TwoThousandAndTwentyEquityIncentivePlanMember2024-06-300000078749us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300000078749us-gaap:AdditionalPaidInCapitalMember2023-03-310000078749us-gaap:CommonStockMember2023-06-300000078749us-gaap:PerformanceSharesMembersrt:ChiefExecutiveOfficerMember2024-06-300000078749agys:ProductDevelopmentMember2023-04-012023-06-300000078749us-gaap:RetainedEarningsMember2023-06-300000078749us-gaap:CommonStockMember2024-06-300000078749us-gaap:TreasuryStockCommonMember2024-03-310000078749us-gaap:RetainedEarningsMember2023-03-310000078749us-gaap:TreasuryStockCommonMember2023-03-310000078749us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300000078749us-gaap:RestrictedStockMember2024-06-300000078749us-gaap:RestrictedStockMember2024-03-310000078749us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000078749us-gaap:CommonStockMember2024-03-310000078749agys:SupportMaintenanceSubscriptionServicesAndProfessionalServicesMember2024-04-012024-06-300000078749agys:ProductDevelopmentMember2024-04-012024-06-300000078749us-gaap:RetainedEarningsMember2024-06-300000078749us-gaap:StockAppreciationRightsSARSMember2024-06-300000078749us-gaap:ConvertiblePreferredStockMemberus-gaap:MajorityShareholderMember2020-05-222020-05-220000078749us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-3000000787492024-03-310000078749us-gaap:RetainedEarningsMember2024-04-012024-06-300000078749us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300000078749us-gaap:StockAppreciationRightsSARSMember2024-03-310000078749us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-3000000787492023-03-310000078749us-gaap:CommonStockMemberagys:TwoThousandAndSixteenStockIncentivePlanMember2024-06-300000078749agys:SubscriptionAndMaintenanceMember2023-04-012023-06-300000078749agys:ProfessionalServicesMember2023-04-012023-06-300000078749us-gaap:TreasuryStockCommonMember2023-06-3000000787492024-07-190000078749us-gaap:AdditionalPaidInCapitalMember2023-06-300000078749us-gaap:TreasuryStockCommonMember2024-04-012024-06-300000078749us-gaap:EmployeeStockMember2024-06-300000078749us-gaap:EmployeeStockMember2024-06-302024-06-300000078749agys:SubscriptionAndMaintenanceMember2024-04-012024-06-300000078749us-gaap:ProductMember2023-04-012023-06-300000078749agys:SupportMaintenanceSubscriptionServicesAndProfessionalServicesMember2023-04-012023-06-300000078749us-gaap:TreasuryStockCommonMember2024-06-30xbrli:pureiso4217:USDxbrli:sharesxbrli:sharesiso4217:USD

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2024

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission File Number: 000-5734

 

AGILYSYS, INC.

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

34-0907152

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer
Identification No.)

3655 Brookside Parkway, Suite 300

Alpharetta, Georgia

30022

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (770) 810-7800

 

Securities registered pursuant to Section 12(b) of the Act:

 


Title of each class

 

Trading

Symbol(s)

 


Name of each exchange on which registered

Common Stock, without par value

 

AGYS

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated filer

 

 

Accelerated filer

 

Non-Accelerated filer

 

 

Smaller reporting company

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of July 19, 2024, the registrant had 27,881,838 shares of common stock outstanding.

 

 

1


 

AGILYSYS, INC.

TABLE OF CONTENTS

 

 

 

 

 

Part I. Financial Information

 

 

Item 1

Financial Statements (Unaudited)

3

 

 

 

 

 

 

Condensed Consolidated Balance Sheets – June 30, 2024 (Unaudited) and March 31, 2024

3

 

 

 

 

 

 

Condensed Consolidated Statements of Operations (Unaudited) – Three Months Ended June 30, 2024 and June 30, 2023

4

 

 

 

 

 

 

Condensed Consolidated Statements of Comprehensive Income (Unaudited) – Three Months Ended June 30, 2024 and June 30, 2023

5

 

 

 

 

 

 

Condensed Consolidated Statements of Cash Flows (Unaudited) – Three Months Ended June 30, 2024 and June 30, 2024

6

 

 

 

 

 

 

Condensed Consolidated Statements of Shareholders' Equity (Unaudited) – Three Months Ended June 30, 2024 and June 30, 2023

7

 

 

 

 

 

 

Notes to Condensed Consolidated Financial Statements (Unaudited)

8

 

 

 

 

 

Item 2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

17

 

 

 

 

 

Item 3

Quantitative and Qualitative Disclosures About Market Risk

23

 

 

 

 

 

Item 4

Controls and Procedures

23

 

 

 

 

Part II. Other Information

 

 

 

 

 

 

Item 1

Legal Proceedings

24

 

 

 

 

 

Item 1A

Risk Factors

24

 

 

 

 

 

Item 2

Unregistered Sales of Equity Securities and Use of Proceeds

24

 

 

 

 

 

Item 3

Defaults Upon Senior Securities

24

 

 

 

 

 

Item 4

Mine Safety Disclosures

24

 

 

 

 

 

Item 5

Other Information

24

 

 

 

 

 

Item 6

Exhibits

25

 

 

 

 

Signatures

 

 

26

 

2


 

AGILYSYS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

 

June 30, 2024 (Unaudited)

 

 

March 31,
2024

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

144,111

 

 

$

144,891

 

Accounts receivable, net of allowance for expected credit losses
   of $
944 and $974, respectively

 

 

27,308

 

 

 

29,441

 

Contract assets

 

 

3,523

 

 

 

2,287

 

Inventories

 

 

5,300

 

 

 

4,587

 

Prepaid expenses and other current assets

 

 

6,523

 

 

 

7,731

 

Total current assets

 

 

186,765

 

 

 

188,937

 

Property and equipment, net

 

 

17,663

 

 

 

17,930

 

Operating lease right-of-use assets

 

 

17,843

 

 

 

18,384

 

Goodwill

 

 

32,659

 

 

 

32,791

 

Intangible assets, net

 

 

16,706

 

 

 

16,952

 

Deferred income taxes, non-current

 

 

76,237

 

 

 

67,373

 

Other non-current assets

 

 

7,825

 

 

 

8,063

 

Total assets

 

$

355,698

 

 

$

350,430

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

10,085

 

 

$

9,422

 

Contract liabilities

 

 

49,200

 

 

 

56,148

 

Accrued liabilities

 

 

13,127

 

 

 

19,522

 

Operating lease liabilities, current

 

 

4,992

 

 

 

4,279

 

Total current liabilities

 

 

77,404

 

 

 

89,371

 

Deferred income taxes, non-current

 

 

549

 

 

 

554

 

Operating lease liabilities, non-current

 

 

18,903

 

 

 

19,613

 

Other non-current liabilities

 

 

4,671

 

 

 

4,415

 

Commitments and contingencies

 

 

 

 

 

 

Shareholders' equity:

 

 

 

 

 

 

Common shares, without par value, at $0.30 stated value; 80,000,000
   shares authorized;
33,342,288 shares issued; and 27,872,345
   and
27,376,862 shares outstanding at June 30, 2024
   and March 31, 2024, respectively

 

 

10,003

 

 

 

10,003

 

Treasury shares, 5,469,903 and 5,965,426 at June 30, 2024
   and March 31, 2024, respectively

 

 

(1,642

)

 

 

(1,791

)

Capital in excess of stated value

 

 

98,277

 

 

 

94,680

 

Retained earnings

 

 

151,861

 

 

 

137,755

 

Accumulated other comprehensive loss

 

 

(4,328

)

 

 

(4,170

)

Total shareholders' equity

 

 

254,171

 

 

 

236,477

 

Total liabilities and shareholders' equity

 

$

355,698

 

 

$

350,430

 

See accompanying notes to unaudited condensed consolidated financial statements.

3


 

AGILYSYS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

 

Three months ended
June 30,

 

(In thousands, except per share data)

 

2024

 

 

2023

 

Net revenue:

 

 

 

 

 

 

Products

 

$

9,874

 

 

$

12,781

 

Subscription and maintenance

 

 

38,043

 

 

 

32,125

 

Professional services

 

 

15,595

 

 

 

11,153

 

Total net revenue

 

 

63,512

 

 

 

56,059

 

Cost of goods sold:

 

 

 

 

 

 

Products

 

 

5,226

 

 

 

6,565

 

Subscription and maintenance

 

 

8,108

 

 

 

7,637

 

Professional services

 

 

10,310

 

 

 

8,800

 

Total cost of goods sold

 

 

23,644

 

 

 

23,002

 

Gross profit

 

 

39,868

 

 

 

33,057

 

Gross profit margin

 

 

62.8

%

 

 

59.0

%

Operating expenses:

 

 

 

 

 

 

Product development

 

 

14,720

 

 

 

13,321

 

Sales and marketing

 

 

7,014

 

 

 

7,301

 

General and administrative

 

 

10,483

 

 

 

9,365

 

Depreciation of fixed assets

 

 

838

 

 

 

923

 

Amortization of internal-use software and intangibles

 

 

251

 

 

 

430

 

Other charges, net

 

 

550

 

 

 

759

 

Legal settlements

 

 

265

 

 

 

 

Total operating expense

 

 

34,121

 

 

 

32,099

 

Operating income

 

 

5,747

 

 

 

958

 

Other income (expense):

 

 

 

 

 

 

Interest income

 

 

1,782

 

 

 

1,101

 

Other (expense), net

 

 

(157

)

 

 

(159

)

Income before taxes

 

 

7,372

 

 

 

1,900

 

Income tax (benefit) provision

 

 

(6,734

)

 

 

352

 

Net income

 

$

14,106

 

 

$

1,548

 

Series A convertible preferred stock dividends

 

 

 

 

 

(459

)

Net income attributable to common shareholders

 

$

14,106

 

 

$

1,089

 

 

 

 

 

 

 

 

Weighted average shares outstanding - basic

 

 

27,134

 

 

 

24,936

 

 

 

 

 

 

 

 

Net income per share - basic:

 

$

0.52

 

 

$

0.04

 

 

 

 

 

 

 

 

Weighted average shares outstanding - diluted

 

 

28,127

 

 

 

26,177

 

 

 

 

 

 

 

 

Net income per share - diluted:

 

$

0.50

 

 

$

0.04

 

See accompanying notes to unaudited condensed consolidated financial statements.

4


 

AGILYSYS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(Unaudited)

 

 

Three months ended
June 30,

 

(In thousands)

 

2024

 

 

2023

 

Net income

 

 

14,106

 

 

$

1,548

 

Other comprehensive income (loss):

 

 

 

 

 

 

Unrealized foreign currency translation adjustments

 

 

(158

)

 

 

523

 

Total comprehensive income

 

$

13,948

 

 

$

2,071

 

See accompanying notes to unaudited condensed consolidated financial statements.

5


 

AGILYSYS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

Three Months Ended

 

 

 

June 30,

 

(In thousands)

 

2024

 

 

2023

 

 

 

 

 

 

 

 

Operating activities

 

 

 

 

 

 

Net income

 

$

14,106

 

 

$

1,548

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation of fixed assets

 

 

838

 

 

 

923

 

Amortization of internal-use software and intangibles

 

 

251

 

 

 

430

 

Deferred income taxes

 

 

(8,861

)

 

 

(129

)

Share-based compensation

 

 

4,429

 

 

 

3,167

 

Changes in operating assets and liabilities

 

 

(9,665

)

 

 

(5,917

)

Net cash provided by operating activities

 

 

1,098

 

 

 

22

 

Investing activities

 

 

 

 

 

 

Capital expenditures

 

 

(869

)

 

 

(3,065

)

Additional investments in corporate-owned life insurance policies

 

 

 

 

 

(2

)

Net cash used in investing activities

 

 

(869

)

 

 

(3,067

)

Financing activities

 

 

 

 

 

 

Payment of preferred stock dividends

 

 

 

 

 

(918

)

Repurchase of common shares to satisfy employee tax withholding

 

 

(925

)

 

 

(1,783

)

Principal payments under long-term obligations

 

 

 

 

 

(1

)

Net cash used in financing activities

 

 

(925

)

 

 

(2,702

)

Effect of exchange rate changes on cash

 

 

(84

)

 

 

(2

)

Net decrease in cash and cash equivalents

 

 

(780

)

 

 

(5,749

)

Cash and cash equivalents at beginning of period

 

 

144,891

 

 

 

112,842

 

Cash and cash equivalents at end of period

 

$

144,111

 

 

$

107,093

 

See accompanying notes to unaudited condensed consolidated financial statements.

6


 

AGILYSYS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(Unaudited)

 

 

Three Months Ended June 30, 2024

 

 

 

Common Shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issued

 

 

In Treasury

 

 

Capital in
excess of

 

 

 

 

 

Accumulated
other

 

 

 

 

(In thousands, except share data)

 

Shares

 

 

Stated
value

 

 

Shares

 

 

Stated
value

 

 

Stated
value

 

 

Retained
earnings

 

 

comprehensive
income (loss)

 

 

Total

 

Balance at March 31, 2024

 

 

33,342

 

 

$

10,003

 

 

 

(5,965

)

 

$

(1,791

)

 

$

94,680

 

 

$

137,755

 

 

$

(4,170

)

 

$

236,477

 

Share-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4,850

 

 

 

 

 

 

 

 

 

4,850

 

Restricted shares issued, net

 

 

 

 

 

 

 

 

11

 

 

 

3

 

 

 

(3

)

 

 

 

 

 

 

 

 

 

Shares issued upon exercise of SSARs

 

 

 

 

 

 

 

 

498

 

 

 

150

 

 

 

(150

)

 

 

 

 

 

 

 

 

 

Shares withheld for taxes upon
   exercise of SSARs or vesting
   of restricted shares

 

 

 

 

 

 

 

 

(14

)

 

 

(4

)

 

 

(1,100

)

 

 

 

 

 

 

 

 

(1,104

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

14,106

 

 

 

 

 

 

14,106

 

Unrealized translation adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(158

)

 

 

(158

)

Balance at June 30, 2024

 

 

33,342

 

 

$

10,003

 

 

 

(5,470

)

 

$

(1,642

)

 

$

98,277

 

 

$

151,861

 

 

$

(4,328

)

 

$

254,171

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30, 2023

 

 

 

Common Shares

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Issued

 

 

In Treasury

 

 

Capital in
excess of

 

 

 

 

 

Accumulated
other

 

 

 

 

(In thousands, except share data)

 

Shares

 

 

Stated
value

 

 

Shares

 

 

Stated
value

 

 

Stated
value

 

 

Retained
earnings

 

 

comprehensive
income (loss)

 

 

Total

 

Balance at March 31, 2023

 

 

31,607

 

 

$

9,482

 

 

 

(6,280

)

 

$

(1,884

)

 

$

52,978

 

 

$

52,764

 

 

$

(4,030

)

 

$

109,310

 

Share-based compensation

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3,377

 

 

 

 

 

 

 

 

 

3,377

 

Restricted shares issued, net

 

 

 

 

 

 

 

 

12

 

 

 

3

 

 

 

(3

)

 

 

 

 

 

 

 

 

 

Shares issued upon exercise of SSARs

 

 

 

 

 

 

 

 

50

 

 

 

15

 

 

 

(15

)

 

 

 

 

 

 

 

 

 

Shares withheld for taxes upon
   exercise of SSARs or vesting
   of restricted shares

 

 

 

 

 

 

 

 

(37

)

 

 

(11

)

 

 

(2,602

)

 

 

 

 

 

 

 

 

(2,613

)

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,548

 

 

 

 

 

 

1,548

 

Series A convertible preferred stock dividends

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(459

)

 

 

 

 

 

(459

)

Unrealized translation adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

523

 

 

 

523

 

Balance at June 30, 2023

 

 

31,607

 

 

$

9,482

 

 

 

(6,255

)

 

$

(1,877

)

 

$

53,735

 

 

$

53,853

 

 

$

(3,507

)

 

$

111,686

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to unaudited condensed consolidated financial statements.

7


 

AGILYSYS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

1. Nature of Operations and Financial Statement Presentation

Nature of Operations

Agilysys has been a leader in hospitality software for more than 45 years, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare. The Company’s software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service. Many of the top hospitality companies around the world use Agilysys solutions to improve guest loyalty, drive revenue growth, and increase operational efficiencies. Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India, with headquarters in Alpharetta, GA.

The Company has just one reportable segment serving the global hospitality industry.

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements include our accounts consolidated with our wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Our fiscal year ends on March 31st. References to a particular year refer to the fiscal year ending in March of that year. For example, fiscal 2025 refers to the fiscal year ending March 31, 2025.

Our unaudited interim financial statements are prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information, the instructions to the Quarterly Report on Form 10-Q (Quarterly Report) under the Securities Exchange Act of 1934, as amended (the Exchange Act), and Rule 10-01 of Regulation S-X under the Exchange Act. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations relating to interim financial statements.

The Condensed Consolidated Balance Sheet as of June 30, 2024, as well as the Condensed Consolidated Statements of Operations, Condensed Consolidated Statements of Comprehensive Income, Condensed Consolidated Statements of Cash Flows, and Condensed Consolidated Statements of Shareholders’ Equity for the three months ended June 30, 2024 and 2023, are unaudited. However, these financial statements have been prepared on the same basis as those in the audited annual financial statements. In the opinion of management, all adjustments of a recurring nature necessary to fairly state the results of operations, financial position, and cash flows have been made.

These unaudited interim financial statements should be read together with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended March 31, 2024, filed with the Securities and Exchange Commission (SEC) on May 22, 2024.

Use of estimates

Preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates.

2. Summary of Significant Accounting Policies

A detailed description of our significant accounting policies can be found in the audited financial statements for the fiscal year ended March 31, 2024, included in our Annual Report on Form 10-K. There have been no material changes to our significant accounting policies from those disclosed therein.

Recently Issued Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”) to update income tax

8


 

disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments in the ASU also remove disclosures related to certain unrecognized tax benefits and deferred taxes. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, or our fiscal 2026. The amendments may be applied prospectively or retrospectively with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.

In November 2023, the FASB issued ASU No. 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”) to expand reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 applies to entities with a single reportable segment. Annual disclosures are required for fiscal years beginning after December 15, 2023 or our fiscal 2025. Interim disclosures are required for periods within fiscal years beginning after December 15, 2024, or our fiscal 2026. Retrospective application is required for all prior periods presented with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.

3. Revenue Recognition

Our customary business practice is to enter into legally enforceable written contracts with our customers. The majority of our contracts are governed by a master service agreement between us and the customer, which sets forth the general terms and conditions of any individual contract between the parties, which is then supplemented by a customer order to specify the different goods and services, the associated prices, and any additional terms for an individual contract. Performance obligations specific to each individual contract are defined within the terms of each order. Each performance obligation is identified based on the goods and services that will be transferred to our customer that are both capable of being distinct and are distinct within the context of the contract. The transaction price is determined based on the consideration to which we will be entitled and expect to receive in exchange for transferring goods or services to the customer. Typically, our contracts do not provide our customer with any right of return or refund; we do not constrain the contract price as it is probable that there will not be a significant revenue reversal due to a return or refund.

Typically, our customer contracts contain one or more of the following goods or services which constitute performance obligations.

Our proprietary software licenses typically provide for a perpetual right to use our software. Generally, our contracts do not provide significant services of integration and customization and installation services are not required to be purchased directly from us. The software is delivered before related services are provided and is functional without professional services, updates and technical support. We have concluded that the software license is distinct as the customer can benefit from the software on its own. Software revenue is typically recognized when the software is delivered or made available for download to the customer.

We recognize revenue for hardware sales when the product is shipped to the customer and when obligations that affect the customer’s final acceptance of the arrangement have been fulfilled. Hardware is purchased from suppliers and provided to the end-user customers via drop-ship or from inventory. We are responsible for negotiating price both with the supplier and the customer, payment to the supplier, establishing payment terms and product returns with the customer, and we bear the credit risk if the customer does not pay for the goods. As the principal contact with the customer, we recognize revenue and cost of goods sold when we ship or are notified by the supplier that the product has been shipped. In certain limited instances, as shipping terms dictate, revenue is recognized upon receipt at the point of destination or upon installation at the customer site.

Our subscription service revenue is comprised of fees for contracts that provide customers a right to access our software for a subscribed period. We do not provide the customer the contractual right to license the software at any time outside of the subscription period under these contracts. Our subscription service revenue is primarily based on rates per location, including rates per points of sale and per room. We recognize certain subscription service revenue on a per-transaction basis. The customer can only benefit from the software and software maintenance when provided the right to access the software. Accordingly, each of the rights to access the software, the maintenance services, any hosting services, and any transaction-based services is not considered a distinct performance obligation in the context of the contract and should be combined into a single performance obligation to be recognized over the contract period. The Company recognizes subscription revenue over a one-month period based on the typical monthly invoicing and renewal cycle in accordance with our customer agreement terms.

We derive maintenance service revenue from providing unspecified updates, upgrades, bug fixes, and technical support services for our proprietary software. These services represent a stand-ready obligation that is concurrently delivered and

9


 

has the same pattern of transfer to the customer; we account for these maintenance services as a single performance obligation. Maintenance revenue includes the same services provided by third-parties for remarketed software. We recognize substantially all maintenance revenue over the contract period of the maintenance agreement. We also recognize certain maintenance service revenue based on the volume of payment transactions processed by third parties through access to our software.

Professional services revenues primarily consist of fees for consulting, implementation, installation, integration, development and training and are generally recognized over time as the customer simultaneously receives and consumes the benefits of the professional services as the services are being performed. Certain professional development services are recognized upon delivery of the developed solutions to the customer. At the end of each reporting period, we recognize the most likely amount of variable consideration on any contract holdbacks we expect to bill for development services delivered. Professional services can be provided by internal or external providers, do not significantly affect the customer’s ability to access or use other provided goods or services, and provide a measure of benefit beyond that of other promised goods or services in the contract. As a result, professional services are considered distinct in the context of the contract and represent a separate performance obligation. Professional services that are billed on a time and materials basis are recognized over time as the services are performed. For contracts billed on a fixed price basis, revenue is recognized over time using an input method based on labor hours expended to date relative to the total labor hours expected to be required to satisfy the related performance obligation.

We use the market approach to derive standalone selling price (“SSP”) by maximizing observable data points (in the form of recently executed customer contracts) to determine the price customers are willing to pay for the goods and services transferred. If the contract contains a single performance obligation, the entire transaction price is allocated to that performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative SSP basis.

Shipping and handling fees billed to customers are recognized as revenue and the related costs are recognized in cost of goods sold. Revenue is recorded net of any applicable taxes collected and remitted to governmental agencies.

Disaggregation of Revenue

We derive and report our revenue from the sale of products (proprietary software licenses, third party hardware and operating systems), subscription and maintenance, and professional services. Products revenue recognized at a point in time totaled $9.9 million and $12.8 million for the three months ended June 30, 2024 and 2023, respectively. Subscription, maintenance, and substantially all professional services revenue recognized over time totaled $53.6 million and $43.3 million for the three months ended June 30, 2024 and 2023, respectively.

Contract Balances

Contract assets are rights to consideration in exchange for goods or services that we have transferred to a customer when that right is conditional on something other than the passage of time. The majority of our contract assets represent unbilled amounts related to products and professional services. We expect billing and collection of our contract assets to occur within the next twelve months. We receive payments from customers based upon contractual billing schedules and accounts receivable are recorded when the right to consideration becomes unconditional. Contract liabilities represent consideration received or consideration which is unconditionally due from customers prior to transferring goods or services to the customer under the terms of the contract.

Revenue recognized from amounts included in contract liabilities at the beginning of the period was $26.8 million and $22.1 million for the three months ended June 30, 2024 and 2023, respectively. Because the right to the transaction became unconditional, we transferred to accounts receivable from contract assets at the beginning of the period, $1.9 million and $1.6 million for the three months ended June 30, 2024 and 2023, respectively.

Our arrangements are for a period of one year or less. As a result, unsatisfied performance obligations as of June 30, 2024 are expected to be satisfied and the allocated transaction price recognized in revenue within a period of 12 months or less.

Assets Recognized from Costs to Obtain a Contract

Sales commission expenses that would not have occurred absent the customer contracts are considered incremental costs to obtain a contract. We expense the incremental costs to obtain a contract as incurred when the expected benefit and amortization period is one year or less. For subscription contracts that are renewed monthly based on an agreement term, we capitalize commission expenses and amortize as we satisfy the underlying performance obligations, generally based on the contract terms and anticipated renewals. Other sales commission expenses have a period of benefit of one year or less and are therefore expensed as incurred in line with the practical expedient elected.

10


 

We had $4.8 million and $4.0 million of capitalized sales incentive costs as of June 30, 2024 and 2023, respectively. These balances are included in other non-current assets on our condensed consolidated balance sheets. During the three months ended June 30, 2024 and 2023, we expensed $0.9 million and $0.9 million, respectively, of sales commissions, which included amortization of capitalized amounts of $0.4 million and $0.4 million, respectively. These expenses are included in operating expenses – sales and marketing in our condensed consolidated statement of operations. All other costs to obtain a contract are not considered incremental and therefore are expensed as incurred.

4. Additional Balance Sheet Information

Additional information related to the condensed consolidated balance sheets is as follows:

 

(In thousands)

 

June 30, 2024

 

 

March 31, 2024

 

Accrued liabilities:

 

 

 

 

 

 

Salaries, wages, employee benefits, and payroll taxes

 

$

7,744

 

 

$

16,264

 

Income and indirect taxes payable

 

 

4,264

 

 

 

1,684

 

Other

 

 

1,119

 

 

 

1,574

 

Total

 

$

13,127

 

 

$

19,522

 

Other non-current liabilities:

 

 

 

 

 

 

Employee benefit obligations

 

 

4,571

 

 

 

4,315

 

Other

 

 

100

 

 

 

100

 

Total

 

$

4,671

 

 

$

4,415

 

 

5. Supplemental Disclosures of Cash Flow Information

 

Additional information related to the condensed consolidated statements of cash flows is as follows:

 

 

 

Three months ended
June 30,

 

(In thousands)

 

 

2024

 

 

 

2023

 

Cash receipts for interest, net

 

$

1,424

 

 

$

893

 

Cash payments for income tax, net

 

 

578

 

 

 

376

 

Cash payments for operating leases

 

 

912

 

 

 

1,425

 

Cash payments for finance leases

 

 

 

 

 

2

 

Accrued capital expenditures

 

 

181

 

 

 

320

 

 

6. Income Taxes

The following table compares our income tax provision and effective tax rates for the three months ended June 30, 2024 and 2023:

 

 

 

Three months ended
June 30,

 

(Dollars in thousands)

 

2024

 

 

2023

 

Income tax (benefit) provision

 

$

(6,734

)

 

$

352

 

Effective tax rate

 

nm

 

 

 

18.5

%

nm - not meaningful

For the three months ended June 30, 2023, income tax provision and the effective tax rate were primarily driven by activity within the foreign jurisdictions in which the company operates as valuation allowances were recorded against deferred tax assets in the U.S. and Canada. We released valuation allowances recorded against Canadian, U.S. Federal and certain state deferred tax assets in the period ending December 31, 2023.

For the three months ended June 30, 2024, income tax (benefit) and the effective tax rate were primarily driven by the impact of discrete excess tax benefits associated with Share-Based Compensation.

11


 

Our India subsidiary operates in a “Special Economic Zone (“SEZ”)”. One of the benefits associated with the SEZ is that the India subsidiary is not subject to regular India income taxes during its first five years of operations, which included fiscal 2018 through fiscal 2022. The India subsidiary is subject to 50% of regular India income taxes during its second five years of operations, which includes fiscal 2023 through fiscal 2027.

We have recorded and maintain valuation allowances offsetting the Company’s deferred tax assets in certain U.S. States and foreign jurisdictions. The ultimate realization of deferred tax assets depends on various factors including the generation of future taxable income in the periods in which the underlying temporary differences are deductible. We maintain valuation allowances for deferred tax assets until we have sufficient evidence to support the reversal of all or some portion of the allowances.

7. Commitments and Contingencies

We are involved in legal actions that arise in the ordinary course of business. It is the opinion of management that the resolution of any current pending litigation will not have a material adverse effect on our financial position or results of operations.

8. Earnings per Share

The following data shows the amounts used in computing earnings per share and the effect on earnings and the weighted average number of shares of dilutive potential common shares.

 

 

Three months ended
June 30,

 

(In thousands, except per share data)

2024

 

 

2023

 

Numerator:

 

 

 

 

 

Net income

$

14,106

 

 

$

1,548

 

Series A convertible preferred stock dividends

 

 

 

 

(459

)

Net income attributable to common shareholders

$

14,106

 

 

$

1,089

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

Weighted average shares outstanding - basic

 

27,134

 

 

 

24,936

 

Dilutive SSARs

 

710

 

 

 

1,008

 

Dilutive unvested restricted shares

 

270

 

 

 

231

 

Dilutive unvested restricted stock units

 

13

 

 

 

2

 

Weighted average shares outstanding - diluted

 

28,127

 

 

 

26,177

 

 

 

 

 

 

 

Income per share - basic:

$

0.52

 

 

$

0.04

 

Income per share - diluted:

$

0.50

 

 

$

0.04

 

 

 

 

 

 

 

Anti-dilutive SSARs, restricted shares,
   performance shares and preferred shares

 

7

 

 

 

1,735

 

Basic income per share is computed as net income attributable to common shareholders divided by the weighted average basic shares outstanding. The outstanding shares used to calculate the weighted average basic shares excludes 367,271 and 339,956 of restricted shares at June 30, 2024 and 2023, respectively, as these shares were issued but were not vested and therefore, not considered outstanding for purposes of computing basic income per share at the balance sheet dates.

Diluted income per share includes the impact of all potentially dilutive securities on earnings per share. We have stock-settled appreciation rights (SSARs), restricted shares, restricted stock units, and preferred shares that are potentially dilutive securities.

9. Share-based Compensation

We may grant incentive stock options, non-qualified stock options, SSARs, restricted shares, restricted stock units, and performance shares under our shareholder-approved 2020 Stock Incentive Plan (the 2020 Plan) for up to 2.25 million common shares, plus 868,864 common shares, the number of shares that were remaining for grant under the 2016 Stock

12


 

Incentive Plan (the 2016 Plan) as of the effective date of the 2020 Plan, plus the number of shares remaining for grant under the 2016 Plan that are forfeited, settled in cash, canceled or expired. The maximum aggregate number of restricted shares or restricted stock units that may be granted under the 2020 Plan is 3.1 million. We may also grant shares under our shareholder-approved Employee Stock Purchase Plan (the ESPP) for up to 500,000 common shares.

We may distribute authorized but unissued shares or treasury shares to satisfy share option and SSAR exercises or grants of restricted shares, restricted stock units, performance shares, or ESPP shares.

For SSARs, the exercise price must be set at least equal to the closing market price of our common shares on the date of grant. The maximum term of SSARs is seven years from the date of grant. The Compensation Committee of the Board of Directors establishes the period over which SSARs subject to a service condition vest and the vesting criteria for SSARs subject to a market condition.

Restricted shares and restricted stock units, whether time-vested or performance-based, may be issued at no cost or at a purchase price that may be below their fair market value, but are subject to forfeiture and restrictions on their sale or other transfer. Performance-based grants may be conditioned upon the attainment of specified performance objectives and other conditions, restrictions, and contingencies. Restricted shares have the right to receive dividends, if any, upon vesting, subject to the same forfeiture provisions that apply to the underlying grants.

We record compensation expense related to SSARs, restricted shares, restricted stock units, performance shares, and ESPP shares granted to certain employees and non-employee directors based on the fair value of the awards on the grant date. The fair value of restricted stock unit and restricted share grants subject only to a service condition is based on the closing price of our common shares on the grant date. For stock option and SSAR grants subject only to a service condition, we estimate the fair value on the grant date using the Black-Scholes-Merton option pricing model with inputs including the closing market price at grant date, exercise price and assumptions regarding the risk-free interest rate, expected volatility of our common shares based on historical volatility, and expected term as estimated using the simplified method. We use the simplified method for SSAR grants because we believe historical exercise data does not provide a reasonable basis upon which to estimate the expected term. For restricted stock unit, restricted share, and SSAR grants subject to a market condition, we estimate the fair value on the grant date through a lattice option pricing model that utilizes a Monte Carlo analysis with inputs including the closing market price at grant date, share price threshold, performance period term and assumptions regarding the risk-free interest rate and expected volatility of our common shares based on historical volatility. Inputs for SSAR grants subject to a market condition also include exercise price, remaining contractual term, and suboptimal exercise factor.

We record compensation expense for restricted stock units, restricted shares, and SSAR grants subject to a service condition using the graded vesting method. We record compensation expense for ESPP shares on a straight-line basis over the applicable offering period. We record compensation expense for SSAR grants subject only to a market condition over the derived service period, which is an output of the lattice option pricing model. Under the 2020 Plan, the fair value of performance shares is based on the closing price of our common shares on the settlement date of the performance award, for which we record compensation expense over the service period consistent with our annual bonus incentive plan as approved by the Compensation Committee of the Board of Directors.

The following table summarizes the share-based compensation expense for restricted and performance grants included in the condensed consolidated statements of operations:

 

Three months ended
June 30,

 

(In thousands)

2024

 

 

2023

 

Product development

 

2,636

 

 

 

1,625

 

Sales and marketing

 

331

 

 

 

166

 

General and administrative

 

1,462

 

 

 

1,376

 

Total share-based compensation expense

 

4,429

 

 

 

3,167

 

Stock-Settled Appreciation Rights

SSARs are rights granted to an employee to receive value equal to the difference between the price of our common shares on the date of exercise and the exercise price. The value is settled in common shares of Agilysys, Inc.

13


 

We use a Black-Scholes-Merton option pricing model to estimate the fair value of service condition SSARs and a lattice option pricing model to estimate the fair value of market condition SSARs. There were no SSARs granted during the three months ended June 30, 2024 and 2023.

The following table summarizes the activity during the three months ended June 30, 2024 for SSARs awarded under the 2020 and 2016 Plans:

(In thousands, except share and per share data)

 

Number of
Rights

 

 

Weighted-Average Exercise Price

 

 

Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

(per right)

 

 

(in years)

 

 

 

 

Outstanding at April 1, 2024

 

 

1,297,339

 

 

$

27.63

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(737,136

)

 

 

33.48

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2024

 

 

560,203

 

 

$

19.94

 

 

 

3.3

 

 

$

47,169

 

Exercisable at June 30, 2024

 

 

560,203

 

 

$

19.94

 

 

 

3.3

 

 

$

47,169

 

Vested and expected to vest at June 30, 2024

 

 

560,203

 

 

$

19.94

 

 

 

3.3

 

 

$

47,169

 

 

As of June 30, 2024, there was no unrecognized share-based compensation expense related to SSARs.

Restricted Shares

We granted shares to certain of our Directors, executives and key employees, the vesting of which is service-based. Certain restricted shares are also subject to a market condition. The following table summarizes the activity during the three months ended June 30, 2024 for restricted shares awarded under the 2020 Plan:

 

 

Number of Shares

 

 

Weighted-Average
Grant-Date
Fair Value

 

 

 

 

 

 

(per share)

 

Outstanding at April 1, 2024

 

 

436,177

 

 

$

65.52

 

Granted

 

 

13,149

 

 

 

103.30

 

Vested

 

 

(79,792

)

 

 

53.51

 

Forfeited

 

 

(2,263

)

 

 

70.58

 

Outstanding at June 30, 2024

 

 

367,271

 

 

$

68.05

 

 

The weighted-average grant date fair value of the restricted shares includes grants subject only to a service condition and certain grants subject to both a service condition and a market condition. As of June 30, 2024, total unrecognized share-based compensation expense related to unvested restricted shares was $12.9 million, which is expected to be recognized over a weighted-average vesting period of 2.0 years.

Restricted Stock Units

We granted restricted stock units to our Chief Executive Officer, the vesting of which is service-based. Certain restricted stock units are also subject to a market condition. The following table summarizes the activity during three months ended June 30, 2024 for restricted stock units awarded under the 2020 Plan:

 

 

 

Number of Shares

 

 

Weighted-Average Grant-Date Fair Value

 

 

 

 

 

 

(per share)

 

Outstanding at April 1, 2024

 

 

56,547

 

 

$

70.03

 

Granted

 

 

 

 

 

Vested

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Outstanding at June 30, 2024

 

 

56,547

 

 

$

70.03

 

As of June 30, 2024, total unrecognized share-based compensation expense related to non-vested restricted stock units was $2.0 million, which is expected to be recognized over the weighted-average vesting period of 1.8 years.

14


 

Performance Shares

Upon approval of the Compensation Committee of our Board of Directors, after achieving the performance conditions associated with our annual bonus plan, we granted 6,098 common shares to our Chief Executive Officer in May 2024 that vested immediately for a total value of $0.6 million.

Employee Stock Purchase Plan Shares

The ESPP permits participants to purchase common stock through regular payroll deductions, up to a specified percentage of their eligible compensation. The ESPP is compensatory because, among other provisions, it currently allows participants to purchase stock at up to a 15% discount from the lower of the closing price of a share of our common stock on the first or last trading day of the ESPP offering period. We measure share-based compensation expense for the ESPP based on the fair value of the ESPP grant at the beginning of the offering period. The fair value includes the value of the discount and the value associated with the call and put options that take advantage of the variability in the common stock price during the offering period. We estimate the value of the call and put options using the Black-Scholes-Merton option pricing model with inputs including the closing market price of our common stock on the first date of the offering period and assumptions regarding the risk-free interest rate, expected term, and expected volatility of our common shares over the offering period based on historical volatility.

 

 

Offering Period Ended

 

 

 

June 30, 2024

 

Grant date fair value

 

$

81.60

 

Risk-free interest rate over contractual term

 

 

5.36

%

Expected term (in years)

 

 

0.41

 

Expected volatility

 

 

47.41

%

The risk-free interest rate is based on the yield of a zero coupon U.S. Treasury bond whose maturity period approximates the expected term of the ESPP shares. The expected term is the offering period, which is typically six months.

We record amounts withheld from participants during each offering period in accrued salaries, wages and related benefits in the consolidated balance sheets until such shares are purchased. Amounts withheld from participants for the offering period ended June 30, 2024 totaled $0.5 million as of June 30, 2024.

As of June 30, 2024, there was no unrecognized share-based compensation expense related of the offering period ending June 30, 2024.

10. Preferred Stock

Series A Convertible Preferred Stock

On May 22, 2020, we completed the sale of 1,735,457 shares of our preferred stock, without par value, designated as “Series A Convertible Preferred Stock” (the “Convertible Preferred Stock”) to MAK Capital Fund L.P. and MAK Capital Distressed Debt Fund I, LP (the “Holders”) each, in its capacity as a designee of MAK Capital One LLC (the “Purchaser”), pursuant to the terms of the Investment Agreement, dated as of May 11, 2020, between the Company and the Purchaser, for an aggregate purchase price of $35 million. We incurred issuance costs of $1.0 million. We added all issuance costs that were netted against the proceeds upon issuance of the Convertible Preferred Stock to its redemption value. As disclosed in our Annual Report for the fiscal year ended March 31, 2021, Michael Kaufman, the Chairman of the Company’s Board of Directors, is the Chief Executive Officer of MAK Capital One LLC.

Conversion

On November 24, 2023, at our option, we required conversion of all the outstanding shares of Convertible Preferred Stock to common stock. On November 27, 2023, we filed a Certificate of Elimination with the Secretary of State of the State of Delaware with respect to the Convertible Preferred Stock pursuant to which the Convertible Preferred Stock was eliminated and returned to the status of authorized and unissued preferred shares of the Company. Following the mandatory conversion of the outstanding shares of the Convertible Preferred Stock on November 24, 2023, there were no outstanding shares of the Convertible Preferred Stock. Accordingly, we removed the Series A convertible preferred stock, no par value from temporary equity on our consolidated balance sheet and recorded the associated increase of common shares at

15


 

$0.30 stated value and capital in excess of stated value further reflected in our consolidated statement of shareholders' equity.

Dividends

Prior to the conversion on November 24, 2023, the Holders were entitled to dividends on the Liquidation Preference at the rate of 5.25% per annum, payable semi-annually either (i) 50% in cash and 50% in kind as an increase in the then-current Liquidation Preference or (ii) 100% in cash, at the option of the Company. We paid dividends in the same period as declared by the Company’s Board of Directors.

Accounting Policy

Prior to the conversion on November 24, 2023, we classified convertible preferred stock as temporary equity in the consolidated balance sheets due to certain contingent redemption clauses that were at the election of the Holders. We increased the carrying value of the convertible preferred stock to its redemption value for all undeclared dividends using the interest method.
 

16


 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

In “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”), management explains the general financial condition and results of operations for Agilysys and subsidiaries including:

— what factors affect our business;

— what our earnings and costs were;

— why those earnings and costs were different from the year before;

— where the earnings came from;

— how our financial condition was affected; and

— where the cash will come from to fund future operations.

The MD&A analyzes changes in specific line items in the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Cash Flows and provides information that management believes is important to assessing and understanding our consolidated financial condition and results of operations. This Quarterly Report on Form 10-Q updates information included in our Annual Report on Form 10-K for the fiscal year ended March 31, 2024, filed with the Securities and Exchange Commission (SEC). This discussion should be read in conjunction with the Condensed Consolidated Financial Statements and related Notes that appear in Item 1 of this Quarterly Report as well as our Annual Report for the year ended March 31, 2024. Information provided in the MD&A may include forward-looking statements that involve risks and uncertainties. Many factors could cause actual results to be materially different from those contained in the forward-looking statements. See “Forward-Looking Information” on page 23 of this Quarterly Report, Item 1A "Risk Factors" in Part II of this Quarterly Report, and Item 1A “Risk Factors” in Part I of our Annual Report for the fiscal year ended March 31, 2024 for additional information concerning these items. Management believes that this information, discussion, and disclosure is important in making decisions about investing in Agilysys.

Overview

Recent Developments

Macroeconomic Conditions

During the three months ended June 30, 2024, global macroeconomic conditions were, and continue to be, influenced by a number of factors, including, but not limited to, political unrest, armed conflicts, labor shortages and natural disasters. We believe such conditions are impacting customer spending and provider pricing decisions resulting in decreased demand, increased costs, and reduced margins particularly in areas outside of the United States.

Our Business

Agilysys has been a leader in hospitality software for more than 45 years, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare. The Company’s software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service. Many of the top hospitality companies around the world use Agilysys solutions to improve guest loyalty, drive revenue growth, and increase operational efficiencies.

The Company has just one reportable segment serving the global hospitality industry. Agilysys operates across North America, Europe, the Middle East, Asia-Pacific and India with headquarters located in Alpharetta, Georgia.

Our top priority is increasing shareholder value by improving operating and financial performance and profitably growing the business through superior products and services. To that end, we expect to invest a certain portion of our cash on hand to fund enhancements to existing software products, to develop and market new software products, and to expand our customer breadth, both vertically and geographically.


 

 

17


 

Our strategic plan specifically focuses on:

Putting the customer first
Focusing on product innovation and development
Improving our liquidity
Increasing organizational efficiency and teamwork
Developing our employees and leaders
Growing revenue by improving the breadth and depth of our product set across both point-of-sale and property management applications
Growing revenue through international expansion

The primary objective of our ongoing strategic planning process is to create shareholder value by capitalizing on growth opportunities, increasing profitability and strengthening our competitive position within the specific technology solutions and end markets we serve. Profitability and industry-leading growth will be achieved through tighter management of operating expenses and sharpening the focus of our investments to concentrate on growth opportunities that offer the highest returns.

Revenue - Defined

As required by the SEC, we separately present revenue earned as products revenue, subscription and maintenance revenue or professional services revenue in our condensed consolidated statements of operations. In addition to the SEC requirements, we may, at times, also refer to revenue as defined below. The terminology, definitions, and applications of terms we use to describe our revenue may be different from those used by other companies and caution should be used when comparing these financial measures to those of other companies. We use the following terms to describe revenue:

Revenue – We present revenue net of sales returns and allowances.
Products revenue – Revenue earned from the sales of software licenses, third party hardware and operating systems.
Subscription and maintenance revenue – Revenue earned from the ongoing delivery of software updates, upgrades, bug fixes, technical support, and transaction-based fees over the period covered by subscription or maintenance agreements with our customers for both proprietary and remarketed solutions.
Professional services revenue – Revenue earned from the delivery of implementation, integration, development and installation services for proprietary and remarketed products.

18


 

Results of Operations

First Fiscal Quarter 2025 Compared to First Fiscal Quarter 2024

Net Revenue and Operating Income

The following table presents our consolidated revenue and operating results for the three months ended June 30, 2024 and 2023:

 

 

 

Three months ended
June 30,

 

 

Increase (decrease)

 

(Dollars in thousands)

 

 

2024

 

 

 

2023

 

 

$

 

 

%

 

Net revenue:

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

$

9,874

 

 

$

12,781

 

 

$

(2,907

)

 

 

(22.7

)%

Subscription and maintenance

 

 

38,043

 

 

 

32,125

 

 

 

5,918

 

 

 

18.4

%

Professional services

 

 

15,595

 

 

 

11,153

 

 

 

4,442

 

 

 

39.8

%

Total net revenue

 

 

63,512

 

 

 

56,059

 

 

 

7,453

 

 

 

13.3

%

Cost of goods sold:

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

 

5,226

 

 

 

6,565

 

 

 

(1,339

)

 

 

(20.4

)%

Subscription and maintenance

 

 

8,108

 

 

 

7,637

 

 

 

471

 

 

 

6.2

%

Professional services

 

 

10,310

 

 

 

8,800

 

 

 

1,510

 

 

 

17.2

%

Total cost of goods sold

 

 

23,644

 

 

 

23,002

 

 

 

642

 

 

 

2.8

%

Gross profit

 

$

39,868

 

 

$

33,057

 

 

$

6,811

 

 

 

20.6

%

Gross profit margin

 

 

62.8

%

 

 

59.0

%

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Product development

 

$

14,720

 

 

$

13,321

 

 

$

1,399

 

 

 

10.5

%

Sales and marketing

 

 

7,014

 

 

 

7,301

 

 

 

(287

)

 

 

(3.9

)%

General and administrative

 

 

10,483

 

 

 

9,365

 

 

 

1,118

 

 

 

11.9

%

Depreciation of fixed assets

 

 

838

 

 

 

923

 

 

 

(85

)

 

nm

 

Amortization of internal-use software and intangibles

 

 

251

 

 

 

430

 

 

 

(179

)

 

 

(41.6

)%

Other charges, net

 

 

550

 

 

 

759

 

 

 

(209

)

 

nm

 

Legal settlements

 

 

265

 

 

 

 

 

 

265

 

 

nm

 

Operating income

 

$

5,747

 

 

$

958

 

 

$

4,789

 

 

 

499.9

%

Operating income percentage

 

 

9.0

%

 

 

1.7

%

 

 

 

 

 

 

nm - not meaningful

 

19


 

The following table presents the percentage relationship of our condensed consolidated statement of operations line items to our consolidated net revenues for the periods presented:

 

 

 

Three months ended
June 30,

 

 

 

 

2024

 

 

 

2023

 

Net revenue:

 

 

 

 

 

 

Products

 

 

15.5

%

 

 

22.8

%

Subscription and maintenance

 

 

59.9

 

 

 

57.3

 

Professional services

 

 

24.6

 

 

 

19.9

 

Total net revenue

 

 

100.0

%

 

 

100.0

%

Cost of goods sold:

 

 

 

 

 

 

Products

 

 

8.2

%

 

 

11.7

%

Subscription and maintenance

 

 

12.8

 

 

 

13.6

 

Professional services

 

 

16.2

 

 

 

15.7

 

Total net cost of goods sold

 

 

37.2

%

 

 

41.0

%

Gross profit

 

 

62.8

%

 

 

59.0

%

Operating expenses:

 

 

 

 

 

 

Product development

 

 

23.2

%

 

 

23.8

%

Sales and marketing

 

 

11.0

 

 

 

13.0

 

General and administrative

 

 

16.6

 

 

 

16.7

 

Depreciation of fixed assets

 

 

1.3

 

 

 

1.6

 

Amortization of internal-use software and intangibles

 

 

0.4

 

 

 

0.8

 

Other charges, net

 

 

0.9

 

 

 

1.4

 

Legal settlements

 

 

0.4

 

 

 

 

Operating income

 

 

9.0

%

 

 

1.7

%

 

Net revenue. Total net revenue increased $7.5 million, or 13.3%, during the first quarter of fiscal 2025 compared to the first quarter of fiscal 2024. Products revenue decreased $2.9 million, or 22.7%, due to increasing customer preference for subscription-based software licenses instead of perpetual software licenses and to their decreasing need for hardware due to improvements we have made to our technology enabling more support for consumer grade devices our customers can source elsewhere. Subscription and maintenance revenue increased $5.9 million, or 18.4%, compared to the first quarter of fiscal 2024 driven by continued growth in subscription-based service revenue, which increased 32.0% during the first quarter of fiscal 2025 compared to the first quarter of fiscal 2024. Professional services revenue increased $4.4 million, or 39.8%, due to higher sales and service activity as our new and existing customers continue implementing technology to improve their operations.

Gross profit and gross profit margin. Our total gross profit increased $6.8 million, or 20.6%, during the first quarter of fiscal 2025 and total gross profit margin increased from 59.0% to 62.8% compared to the first quarter of fiscal 2024 driven by changes in the composition of revenue by category. Products gross profit decreased $1.6 million, or 25.2%, and products gross profit margin decreased from 48.6% to 47.1% due to the composition of hardware and proprietary software products delivered. Subscription and maintenance gross profit increased $5.4 million, or 22.2%, and gross profit margin increased from 76.2% to 78.7% as revenue increases outpaced variable costs as a result of certain cost control initiatives. Professional services gross profit increased $2.9 million, or 124.6%, and gross profit margin increased from 21.1% to 33.9% reflecting improved utilization rates from efficiency gains on multi-solution implementations and revenue associated with a large development service contract.

 

Operating Expenses

Operating expenses, excluding other charges, net and legal settlements, increased $2.0 million, or 6.3%, during the first quarter of fiscal 2025 compared with the first quarter of fiscal 2024.

Product development. Product development increased $1.4 million, or 10.5%, in the first quarter of fiscal 2025 compared with the first quarter of fiscal 2024 due to hiring and increased salary, incentive and employee benefits rates across our development teams.

Sales and marketing. Sales and marketing decreased $0.3 million, or 3.9%, in the first quarter of fiscal 2025 compared with the first quarter of fiscal 2024 due to timing of marketing event and trade show activity.

20


 

General and administrative. General and administrative increased $1.1 million, or 11.9%, in the first quarter of fiscal 2025 compared with the first quarter of fiscal 2024 due to increased compensation rates across our administrative teams and payroll taxes associated with certain exercises of stock-settled appreciation rights during the quarter.

Depreciation of fixed assets. Depreciation of fixed assets decreased $0.1 million, or 9.2%, in the first quarter of fiscal 2025 compared with the first quarter of fiscal 2024 due to the timing of assets reaching their useful life.

Amortization of internal-use software and intangibles. Amortization of internal-use software and intangibles decreased $0.2 million, or 41.6%, in the first quarter of fiscal 2025 compared with the first quarter of fiscal 2024 due to the full amortization of certain intangible assets.

Other charges, net. Other charges, net consist of losses on asset disposals, severance costs and acquisition costs related to business combinations.

Legal settlements. Legal settlements consist of settlements of employment and other business-related matters.

Other income (expense)

 

 

 

Three months ended
June 30,

 

 

Favorable (unfavorable)

 

(Dollars in thousands)

 

 

2024

 

 

 

2023

 

 

$

 

 

%

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

$

1,782

 

 

$

1,101

 

 

$

681

 

 

 

61.9

%

Other (expense), net

 

 

(157

)

 

 

(159

)

 

 

2

 

 

nm

 

Total other income, net

 

$

1,625

 

 

$

942

 

 

$

683

 

 

 

72.5

%

nm - not meaningful

Interest income. Interest income consists of interest earned on cash equivalents including short-term investments in commercial paper, treasury bills and money market funds.

Other (expense), net. Other (expense), net mainly consists of movement of foreign currencies against the US dollar.

Income Taxes

 

 

 

Three months ended
June 30,

 

 

Favorable (unfavorable)

(Dollars in thousands)

 

 

2024

 

 

 

2023

 

 

$

 

 

%

Income tax (benefit) provision

 

$

(6,734

)

 

$

352

 

 

$

7,086

 

 

nm

Effective tax rate

 

nm

 

 

 

18.5

%

 

 

 

 

 

nm - not meaningful

For the three months ended June 30, 2023, income tax provision and the effective tax rate were primarily driven by activity within the foreign jurisdictions in which the company operates as valuation allowances were recorded against deferred tax assets in the U.S. and Canada. We released valuation allowances recorded against Canadian, U.S. Federal and certain state deferred tax assets in the period ending December 31, 2023.

For the three months ended June 30, 2024, income tax (benefit) and the effective tax rate were primarily driven by the impact of discrete excess tax benefits associated with Share-Based Compensation.

We are consistently subject to tax audits. Due to the nature of examinations in multiple jurisdictions, changes could occur in the amount of gross unrecognized tax benefits during the next 12 months that we cannot anticipate.

We have recorded and maintain valuation allowances offsetting the Company’s deferred tax assets in certain U.S. States and foreign jurisdictions. The ultimate realization of deferred tax assets depends on various factors including the generation of future taxable income in the periods in which the underlying temporary differences are deductible. We maintain valuation allowances for deferred tax assets until we have sufficient evidence to support the reversal of all or some portion of the allowances.

21


 

Liquidity and Capital Resources

Overview

Our cash requirements consist primarily of working capital needs, capital expenditures, and payments of contractual obligations. Our contractual obligations consist primarily of operating leases for office space.

At June 30, 2024, 100% of our cash and cash equivalents, of which 96% were located in the United States, were deposited in bank accounts or invested in highly liquid investments including commercial paper and treasury bills with original maturity from the date of acquisition of three months or less and money market funds. We determine the fair value of commercial paper using significant other observable inputs based on pricing from independent sources that use quoted prices in active markets for identical assets or other observable inputs including benchmark yields and interest rates. We believe credit risk is limited with respect to our cash and cash equivalents.

We believe that cash flow from operating activities, cash on hand of $144.1 million as of June 30, 2024, and access to capital markets will provide adequate funds to meet our short- and long-term liquidity requirements.

Cash Flow

 

 

 

Three months ended
June 30,

 

(In thousands)

 

 

2024

 

 

 

2023

 

Net cash provided by (used in):

 

 

 

 

 

 

Operating activities

 

$

1,098

 

 

$

22

 

Investing activities

 

 

(869

)

 

 

(3,067

)

Financing activities

 

 

(925

)

 

 

(2,702

)

Effect of exchange rate changes on cash

 

 

(84

)

 

 

(2

)

Decrease in cash

 

$

(780

)

 

$

(5,749

)

 

Cash flow provided by operating activities. Cash flow provided by operating activities was $1.1 million in the first three months of fiscal 2025. The provision of cash was due to cash-based earnings of $10.8 million and a decrease of $9.7 million due to changes in net operating assets and liabilities. Cash-based earnings is net income of $14.1 million and $3.3 million of non-cash adjustments.

Cash flow used in investing activities. Consists primarily of property and equipment purchases, which decreased during the three months ended June 30, 2024 compared to the three months ended June 30, 2023 due to leasehold improvements and equipment purchases for our new office lease in Las Vegas, Nevada during the three months ended June 30, 2023.

Cash flow used in financing activities. Cash flow used in financing activities decreased during the three months ended June 30, 2024 compared to the three months ended June 30, 2023 due to a reduction from $1.8 million to $0.9 million in the repurchase of shares to satisfy employee tax withholding on share-based compensation and a reduction from $0.9 million to zero in preferred stock dividend payments during the respective periods.

Contractual Obligations

As of June 30, 2024, there were no significant changes to our contractual obligations as presented in our Annual Report for the year ended March 31, 2024.

Off-Balance Sheet Arrangements

We have not entered into any off-balance sheet arrangements that have had or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources.

Critical Accounting Policies

A detailed description of our significant accounting policies is included in our Annual Report for the year ended March 31, 2024. There have been no material changes in our significant accounting policies and estimates since March 31, 2024.

22


 

Forward-Looking Information

This Quarterly Report and other publicly available documents, including the documents incorporated herein and therein by reference, contain, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "will" and similar references to future periods. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. These statements are based on management’s current expectations, intentions, or beliefs and are subject to a number of factors, assumptions, and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause or contribute to such differences or that might otherwise impact the business include the risk factors set forth in Item 1A in Part II of this Quarterly Report and Item IA of our Annual Report for the fiscal year ended March 31, 2023. We undertake no obligation to update any such factor or to publicly announce the results of any revisions to any forward-looking statements contained herein whether as a result of new information, future events, or otherwise.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

For quantitative and qualitative disclosures about market risk affecting us, see Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” contained in our Annual Report for the fiscal year ended March 31, 2024. There have been no material changes in our market risk exposures since March 31, 2024.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision of and with the participation of our Chief Executive Officer (“CEO”), Chief Financial Officer (“CFO”) and Corporate Controller and Treasurer, as Principal Accounting Officer (“PAO”), management evaluated the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Quarterly Report. Based on that evaluation, the CEO, CFO and PAO concluded that, as of the end of the period covered by this Quarterly Report, our disclosure controls and procedures were effective.

Changes in Internal Control over Financial Reporting

No changes in our internal control over financial reporting occurred during the three months ended June 30, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

Our management, including our CEO, CFO and PAO, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system will be achieved. Further, the design of a control system must reflect the impact of resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the possibility that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors. Additionally, controls can be circumvented by individual acts, by collusion of two or more people, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all possible future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

23


 

PART II. OTHER INFORMATION

None.

Item 1A. Risk Factors

There have been no material changes in the risk factors included in our Annual Report for the fiscal year ended March 31, 2024 that may materially affect our business, results of operations, or financial condition.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

24


 

Item 6. Exhibits

 

10.1

 

Second Amendment to Agilysys, Inc. Employee Stock Purchase Plan.

 

 

 

 31.1

 

Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.

 

 

 

 31.2

 

Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.

 

 

 

 31.3

 

Rule 13a-14(a)/15d-14(a) Certification of Corporate Controller and Treasurer.

 

 

 

 32

 

Certification of Chief Executive Officer, Chief Financial Officer and Corporate Controller and Treasurer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of Sarbanes-Oxley Act of 2002.

 

 

 

101.INS

 

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

 

 

 

101.SCH

 

Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

 

 

 

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

*

 

Denotes a management contract or compensatory plan or arrangement.

 

25


 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned thereunto duly authorized.

AGILYSYS, INC.

 

Date:

July 26, 2024

/s/ William David Wood III

William David Wood III

Chief Financial Officer

(Principal Financial Officer and Duly Authorized Officer)

 

26


EX-10.1 2 agys-ex10_1.htm EX-10.1 EX-10.1

Exhibit 10.1

SECOND AMENDMENT TO AGILYSYS, INC.

EMPLOYEE STOCK PURCHASE PLAN

This SECOND AMENDMENT to the AGILYSYS, INC. EMPLOYEE STOCK

PURCHASE PLAN is made by AGILYSYS, INC., a Delaware corporation (the “Company”), and is effective as of January 31, 2024.

WHEREAS, the Company originally established the Agilysys, Inc. Employee Stock Purchase Plan, as amended (the “Plan”);

WHEREAS, pursuant to Section 19.9 of the Plan, the Compensation Committee of the Board of Directors of the Company (the “Committee”), has the right to amend the Plan;

WHEREAS, the Committee wishes to amend the Plan to reflect that the Committee will have the authority to designate separate offerings under the Plan pursuant to the adoption by it of an offering document for each separate offering, the terms of which are not required to be identical, provided the terms satisfy Treasury Regulation Sections 1.423-2(a)(2) and (a)(3);

WHEREAS, the Committee wishes to amend the Plan to clarify that certain employees of the Company or certain of its subsidiaries may not be eligible to participate in the Plan or certain offerings under the Plan; and

WHEREAS, the Committee wishes to amend the Plan to provide the Committee with the discretion to determine the minimum percentage of a participant’s compensation that must be elected to use to purchase shares of the Company’s common stock under the Plan during an offering period.

NOW, THEREFORE, the Plan is hereby amended, effective January 31, 2023, as follows:

1.
The definition of “Employee” included in Section 2 of the Plan is hereby amended and restated in its entirety to read as follows:

““Employee” means any person who is rendering services to the Company or a Participating Subsidiary as an employee pursuant to an employment relationship with such employer. For purposes of the Plan, the employment relationship shall be treated as continuing intact while the individual is on military leave, sick leave or other leave of absence approved by the Company or a Participating Subsidiary that meets the requirements of Treasury Regulation Section 1.421-1(h)(2). Where the period of leave exceeds three (3) months, or such other period of time specified in Treasury Regulation Section 1.421-1(h)(2), and the individual’s right to re-employment is not guaranteed by statute or contract, the employment relationship shall be deemed to have terminated on the first day immediately following such three-month period, or such other period specified in Treasury Regulation Section 1.421-1(h)(2). Notwithstanding the foregoing, the definition of Employee will not include any person who is a citizen or resident of a foreign jurisdiction if granting them an option under the Plan would violate the law of such jurisdiction, or if compliance with the laws of the jurisdiction would cause the Plan to violate Section 423 of the Code.”

 

 


 

2.
The definition of “Eligible Employee” included in Section 2 of the Plan is hereby amended and restated in its entirety to read as follows:

““Eligible Employee” means an Employee who (i) has been employed by the Company or a Participating Subsidiary for at least two (2) years and (ii) is customarily employed for at least twenty (20) hours per week. Notwithstanding the foregoing, the Committee, in its discretion, from time to time may provide in an Offering Document prior to an Offering Date (on a uniform and nondiscriminatory basis or as otherwise permitted by Treasury Regulation Section 1.423-2) that the definition of Eligible Employeewill or will not include an individual if he or she: (i) has not completed at least two (2) years of service since his or her last hire date (or such lesser period of time as may be determined by the Committee in its discretion), (ii) customarily works not more than twenty (20) hours per week (or such lesser period of time as may be determined by the Administrator in its discretion), (iii) is a highly compensated employee within the meaning of Section 414(q) of the Code, or (iv) is a highly compensated employee within the meaning of Section 414(q) of the Code with compensation above a certain level or is an officer or subject to the disclosure requirements of Section 16(a) of the Exchange Act, provided the exclusion is applied with respect to each Offering in an identical manner to all highly compensated individuals of the Employer whose Eligible Employees are participating in that Offering. Each exclusion will be applied with respect to an Offering in a manner complying with U.S. Treasury Regulation Section 1.423-2(e)(2)(ii).”

3.
The definition of “Offering” is added to Section 2 of the Plan based on alphabetical order to read as follows:

““Offering” means an offer under the Plan of an option that may be exercised during an Offering Period as further described in Section 5. For purposes of the Plan, the Committee may designate separate Offerings under the Plan (the terms of which need not be identical) in which Eligible Employees of the Company and/ or one or more Participating Subsidiaries will participate, even if the dates of the applicable Offering Periods of each such Offering are identical and the provisions of the Plan will separately apply to each Offering. To the extent permitted by Treasury Regulation Section 1.423- 2(a)(1), the terms of each Offering need not be identical provided that the terms of the Plan and an Offering together satisfy Treasury Regulation Sections 1.423-2(a)(2) and (a)(3).”

4.
The definition of “Offering Document” is added to Section 2 of the Plan based on alphabetical order to read as follows:

““Offering Document” means the offering document as described in Section 5 below.”

5.
The definition of “Offering or Offering Period” included in Section 2 of the Plan is hereby amended and restated in its entirety to read as follows:

““Offering Period” means the periods established by the Committee (not to exceed 27 months) in the applicable Offering Document during which an option granted pursuant to the Plan may be exercised. The duration and timing of Offering Periods may be changed pursuant to Sections 5, 18 and 19.”

6.
The definition of “Plan ” included in Section 2 of the Plan is amended by adding in “, Inc.” after Agilysys.
7.
The definition of “Purchase Date” included in Section 2 of the Plan is hereby amended and restated in its entirety to read as follows:

 


 

““Purchase Date” means the last Trading Day of an Offering Period.”

8.
The definition of “Purchase Price”included in Section2 of the Plan is hereby amended and restated in its entirety to read as follows:

““Purchase Price” means an amount per Common Share designated by the Committee from time to time in the applicable Offering Document; provided that the Purchase Price shall not be less than the lesser of (i) eighty-five percent (85%) (or such greater percentage as designated by the Committee) of the Fair Market Value of a Common Share on the Offering Date or (ii) eighty-five percent (85%) (or such greater percentage as designated by the Committee) of the Fair Market Value of a Common Share on the Purchase Date; provided further, that, the Purchase Price per Common Share will in no event be less than the par value of the Common Share.”

9.
The first paragraph of Section 4 of the Plan is hereby amended and restated in its entirety to read as follows:

“4. Eligibility. Unless otherwise determined by the Committee in a manner that is consistent with Section 423 of the Code and as may be specified in an Offering Document, any individual who is an Eligible Employee as of the first day of the enrollment period designated by the Committee for a particular Offering during an Offering Period shall be eligible to participate in such Offering Period, subject to the requirements of Section 423 of the Code.”

10.
Section 5 of the Plan is hereby amended and restated in its entirety to read as follows:

“5. Offering Periods. The Committee may from time to time grant or provide for the grant of rights to purchase Common Shares under the Plan during one or more periods (each, an “Offering Period”) selected by the Committee commencing on such dates as selected by the Committee. The terms and conditions applicable to each Offering shall be set forth in an “Offering Document” adopted by the Committee, which Offering Document shall be in such form and shall contain such terms and conditions as the Committee shall deem appropriate and shall be incorporated by reference into and made part of the Plan, including (a) the length of the Offering Period, which period shall not exceed twenty-seven months, (b) the Purchase Date(s) on which rights granted under the Plan shall be exercised and purchases of Common Shares carried out during such Offering Period, and (c) the maximum number of Common Shares that may be purchased by an Eligible Employee during such Offering Period. The provisions of separate Offering Periods under the Plan need not be identical.”

11.
Section 6 of the Plan is hereby amended and restated in its entirety to read as follows:

“6. Participation.

a.
Enrollment; Payroll Deductions. Except as otherwise set forth in an Offering Document or determined by the Committee, an Eligible Employee may elect to participate in the Plan by properly completing an Enrollment Form, which may be electronic, and submitting it to the Company, in accordance with the enrollment procedures established by the Committee or set forth in the Offering Document. Participation in the Plan is entirely voluntary. By submitting an Enrollment Form, the Eligible Employee authorizes payroll deductions from his or her paycheck in an amount equal to at least 1%, but not more than 10% of his or her Compensation on each pay day occurring during the Offering Period for which the authorization is applicable (or such other percentages as the Committee may specify in the applicable Offering Document). Payroll deductions shall commence on the first payroll date following the applicable Offering Date and end on the last payroll date

 


 

on or before the corresponding Offering Period Purchase Date. The Company shall maintain records of all payroll deductions but shall have no obligation to pay interest on payroll deductions or to hold such amounts in a trust or in any segregated account.
b.
Election Changes. During an Offering Period, a Participant may decrease his or her rate of payroll deductions applicable to such Offering Period only once. To make such a change, the Participant must submit a new Enrollment Form authorizing the new rate of payroll deductions at least fifteen days before the applicable Purchase Date for such Offering Period. During an Offering Period, a Participant may not increase his or her rate of payroll deductions for such applicable Offering Period. A Participant may increase or decrease his or her rate of payroll deductions for future Offering Periods by submitting a new Enrollment Form authorizing the new rate of payroll deductions at least fifteen days before the start of the next Offering Period in which the Participant will participate.
c.
Automatic Re-enrollment. The deduction rate selected in the Enrollment Form shall remain in effect for subsequent applicable Offering Periods unless the Participant (a) submits a new Enrollment Form authorizing a new level of payroll deductions in accordance with Section 6.2, (b) withdraws from the Plan in accordance with Section 10, or (c) terminates employment or otherwise becomes ineligible to participate in the Plan.”
12.
Section 7 of the Plan is hereby amended and restated in its entirety to read as follows:

“7. Grant of Option. With respect to each Offering, on each Offering Date, each Participant in the applicable Offering Period shall be granted an option to purchase, on the applicable Purchase Date, a number of Common Shares determined by dividing the Participant's accumulated payroll deductions by the applicable Purchase Price (subject to adjustment in accordance with Section 18 and the limitations set forth in Section 13 of the Plan).”

13.
Section 8 of the Plan is hereby amended and restated in its entirety to read as follows:

“8. Exercise of Option/Purchase of Shares. With respect to each Offering Period, a Participant’s option to purchase Common Shares will be exercised automatically on the Purchase Date of the applicable Offering Period. The Participant’s accumulated payroll deductions will be used to purchase the maximum number of shares (including fractional shares) that can be purchased with the amounts in the Participant’s notional account. The minimum number of Common Shares that must be purchased on a Purchase Date is one (1). In the event the Participant’s accumulated payroll deductions used to purchase shares on the Purchase Date is less than the amount required to purchase one (1) whole Common Share, the accumulated payroll deductions will be paid to the Participant promptly following the Purchase Date.”

14.
The first sentence of Section 9 of the Plan is amended and restated to read as follows:

“As soon as reasonably practicable after each Purchase Date for an applicable Offering, the Company will arrange for the delivery to each Participant of the Common Shares purchased upon exercise of his or her option.”

 

 


 

15.
The first sentence of Section 10.1 of the Plan is amended and restated to read as follows:

“A Participant may withdraw from an Offering Period by submitting to the Company a revised Enrollment Form indicating his or her election to withdraw at least fifteen days before the Purchase Date.”

16.
Section 11 of the Plan is hereby amended and restated in its entirety to read as follows:

“11. Termination of Employment; Change in Employment Status. Upon termination of a Participant's employment for any reason, including death, disability or retirement, or a change in the Participant's employment status following which the Participant is no longer an Eligible Employee with respect to an Offering, which in either case occurs on or prior to the applicable Purchase Date, the Participant will be deemed to have withdrawn from the Plan and the payroll deductions in the Participant's notional account (that have not been used to purchase Common Shares) shall be returned to the Participant, or in the case of the Participant's death, to the person(s)entitled to such amounts under Section 17, and the Participant's option shall be automatically terminated. The Company will have sole discretion to determine whether a Participant has terminated employment and the effective date on which the Participant terminated employment, regardless of any notice period or garden leave required under local law.”

17.
Section 13.2 of the Plan is hereby amended and restated in its entirety to read as follows:

“13.2 Over-subscribed Offerings. The number of Common Shares which a Participant may purchase in an Offering under the Plan may be reduced if an Offering is over-subscribed. No option granted under the Plan shall permit a Participant to purchase Common Shares which, if added together with the total number of Common Shares purchased by all other Participants in such Offering Period, would exceed the total number of Common Shares remaining available under the Plan. If the Committee determines that, on a particular Purchase Date, the number of Common Shares with respect to which options are to be exercised exceeds the number of Common Shares then available under the Plan, the Company shall make a pro rata allocation of the Common Shares remaining available for purchase in as uniform a manner as practicable and as the Committee determines to be equitable.”

18.
Section 19.1 of the Plan is hereby amended and restated in its entirety to read as follows:

“19.1 Equal Rights and Privileges. Notwithstanding any provision of the Plan to the contrary and in accordance with Section 423 of the Code, all Eligible Employees who are granted options under an Offering under the Plan shall have the same rights and privileges under the Offering so that the Offering and this Plan qualifies as an “employee stock purchase plan” within the meaning of Section 423 of the Code.”

19.
The first sentence of Section 19.3 of the Plan is hereby amended and restated in its entirety to read as follows:

“A Participant will become a shareholder with respect to the Common Shares that are purchased pursuant to options granted under an Offering under the Plan when the shares are transferred to the Participant’s ESPP Share Account.”

 

 


 

20.
Section 19.12 of the Plan is hereby amended and restated in its entirety to read as follows:

“19.12 Section 423. The Plan is intended to qualify as an “employee stock purchase plan” under Section 423 of the Code.Any provision of the Plan or an Offering under the Plan that is inconsistent with Section 423 of the Code shall be reformed to comply with Section 423 of the Code.”

21.
Except as provided in this Second Amendment, no other changes or amendments shall be made to the Plan as previously stated (including all prior amendments) and the remainder thereof shall remain in full force and effect.

 

IN WITNESS WHEREOF, the Committee has executed this Amendment on this 31 day of January, 2024.

 

COMMITTEE

 

By: /s/ Dana Jones

Dana Jones, Chair

 


EX-31.1 3 agys-ex31_1.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

I, Ramesh Srinivasan, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Agilysys, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 26, 2024

 

By:

/s/ Ramesh Srinivasan

 

Ramesh Srinivasan

 

President and Chief Executive Officer

 

(Principal Executive Officer)

 


EX-31.2 4 agys-ex31_2.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

I, William David Wood III, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Agilysys, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 26, 2024

 

By:

/s/ William David Wood III

 

William David Wood III

 

Chief Financial Officer

 

(Principal Financial Officer)

 


EX-31.3 5 agys-ex31_3.htm EX-31.3 EX-31.3

Exhibit 31.3

CERTIFICATION OF THE CORPORATE CONTROLLER AND TREASURER

I, Chris J. Robertson, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Agilysys, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: July 26, 2024

 

By:

/s/ Chris J. Robertson

 

Chris J. Robertson

 

Corporate Controller and Treasurer

 

(Principal Accounting Officer)

 


EX-32 6 agys-ex32.htm EX-32 EX-32

Exhibit 32

CERTIFICATION

Certification Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Ramesh Srinivasan, the Chief Executive Officer, William David Wood III, the Chief Financial Officer, and Chris J. Robertson, the Corporate Controller and Treasurer, of Agilysys, Inc. (the “Company”), hereby certify, that, to their knowledge:

1. The Quarterly Report on Form 10-Q of the Company for the period ended June 30, 2024 (the “ Report ”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: July 26, 2024

 

By:

/s/ Ramesh Srinivasan

Ramesh Srinivasan

President and Chief Executive Officer

(Principal Executive Officer)

/s/ William David Wood III

William David Wood III

Chief Financial Officer

(Principal Financial Officer)

/s/ Chris J. Robertson

Chris J. Robertson

Corporate Controller and Treasurer

(Principal Accounting Officer)

 


EX-101.SCH 7 agys-20240630.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100020 - Disclosure - Earnings Per Share (Details) 2 link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Condensed Consolidated Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 100080 - Disclosure - Nature of Operations and Financial Statement Presentation link:presentationLink link:calculationLink link:definitionLink 100090 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 100100 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 100110 - Disclosure - Additional Balance Sheet Information link:presentationLink link:calculationLink link:definitionLink 100120 - Disclosure - Supplemental Disclosures of Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 100130 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 100140 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 100150 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 100160 - Disclosure - Share-based Compensation link:presentationLink link:calculationLink link:definitionLink 100170 - Disclosure - Preferred Stock link:presentationLink link:calculationLink link:definitionLink 100180 - Disclosure - Business Combination link:presentationLink link:calculationLink link:definitionLink 100190 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 100200 - Disclosure - Additional Balance Sheet Information (Tables) link:presentationLink link:calculationLink link:definitionLink 100210 - Disclosure - Supplemental Disclosures of Cash Flow Information (Tables) link:presentationLink link:calculationLink link:definitionLink 100220 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 100230 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 100240 - Disclosure - Share-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 100250 - Disclosure - Business Combination (Tables) link:presentationLink link:calculationLink link:definitionLink 100260 - Disclosure - Revenue Recognition - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 100270 - Disclosure - Additional Balance Sheet Information - Schedule of Additional Information Related to the Condensed Consolidated Balance Sheets (Details) link:presentationLink link:calculationLink link:definitionLink 100280 - Disclosure - Supplemental Disclosures of Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 100290 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 100300 - Disclosure - Income Taxes (Details Textual) link:presentationLink link:calculationLink link:definitionLink 100310 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 100320 - Disclosure - Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 100330 - Disclosure - Earnings Per Share (Details Textual) link:presentationLink link:calculationLink link:definitionLink 100340 - Disclosure - Share-based Compensation (Details Textual) link:presentationLink link:calculationLink link:definitionLink 100350 - Disclosure - Share-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 100360 - Disclosure - Share-based Compensation (Details 2) link:presentationLink link:calculationLink link:definitionLink 100370 - Disclosure - Share-based Compensation - Restricted Shares Rollforward (Details) link:presentationLink link:calculationLink link:definitionLink 100380 - Disclosure - Share-based Compensation - Schedule of Principal Assumptions Utilized in Valuing Service Condition SARs (Details) link:presentationLink link:calculationLink link:definitionLink 100390 - Disclosure - Preferred Stock - (Details Textual) link:presentationLink link:calculationLink link:definitionLink Statement [Line Items] Statement [Line Items] Dilutive unvested restricted stock units Dilutive Unvested Restricted Stock Units Dilutive unvested restricted stock units. Plan Name Plan Name [Domain] Gross profit margin Gross Profit Ratio Gross profit ratio. Regular corporate income tax rate in India Regular Corporate Income Tax Rate India Regular corporate income tax rate in India. Entity Address, Postal Zip Code Entity Address, Postal Zip Code Numerator: Numerator [Abstract] Numerator. Weighted Average Number Diluted Shares Outstanding Adjustment, Total Dilutive unvested restricted shares Weighted Average Number of Shares Outstanding, Diluted, Adjustment Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Net revenue: Revenues [Abstract] Unrecognized stock based compensation expense related to unvested restricted stock Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Business Combination Business Combination Disclosure [Text Block] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Dilutive SSARs Dilutive S S A Rs Dilutive SSARs. Preferred Stock Preferred Stock [Text Block] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Shares issued upon exercise of SSARs Shares Issued Upon Exercise of SSARs Shares issued upon exercise of SSARs Shares issued upon exercise of SSARs Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures, Total Restricted shares issued, net Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Schedule Of Stock By Class [Table] Stock, Class of Stock [Table] Product and Service Product and Service [Axis] Deferred Income Tax Liabilities, Net, Total Deferred income taxes, non-current Deferred Income Tax Liabilities, Net Share-Based Payment Arrangement, Noncash Expense [Abstract] Payments to Acquire Productive Assets, Total Capital expenditures Payments to Acquire Productive Assets Employee Stock [Member] Title of Individual Title and Position [Axis] Revenue Recognition Revenue from Contract with Customer [Text Block] Sale of Stock [Domain] Unrealized foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Entity Central Index Key Entity Central Index Key Cash receipts for interest, net Interest Paid Receipts Interest Paid Receipts Common Stock, Shares, Issued, Total Common stock, shares issued Common Stock, Shares, Issued Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Income Statement [Abstract] Entity Address, State or Province Entity Address, State or Province Other charges, net Other Expenses Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income before taxes Capitalized Contract Cost, Net, Total Capitalized contract cost, net Capitalized Contract Cost, Net Revenue recognized Contract with Customer, Liability, Revenue Recognized Number Of Shares Withheld For Taxes Upon Exercise Of Stock Options Ssars Or Vesting Of Restricted Shares Number of Shares Withheld For Taxes Upon Exercise of Stock Options, SSARs or Vesting of Restricted Shares Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (in shares) Treasury shares Treasury Stock, Common, Shares Cover Cover [Abstract] Net income per share - basic: Income per share - basic: Earnings Per Share, Basic, Total Earnings Per Share, Basic Weighted Average Exercise Price, Outstanding at Beginning of Period Weighted Average Exercise Price, Outstanding at End of Period Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price. Operating expenses: Operating Expenses [Abstract] Cash payments for finance leases Finance Lease, Principal Payments Weighted Average Exercise Price, Exercised Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price Sales and marketing [Member] Selling and Marketing Expense [Member] Summary of share-based compensation expense Share-Based Payment Arrangement, Expense Number of Rights, Outstanding at Beginning of Period Number of Rights, Outstanding at End of Period Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Amounts withheld from participants Share Based Compensation Amounts Withheld from Participants Share based compensation amounts withheld from participants. Retained Earnings (Accumulated Deficit), Ending Balance Retained Earnings (Accumulated Deficit), Beginning Balance Retained Earnings (Accumulated Deficit), Total Retained earnings Retained Earnings (Accumulated Deficit) Plan Name Plan Name [Axis] Payments for (Proceeds from) Life Insurance Policies, Total Additional investments in corporate-owned life insurance policies Payments for (Proceeds from) Life Insurance Policies Other Other Accrued Liabilities, Noncurrent Supplemental Cash Flow Elements [Abstract] Current assets: Assets, Current [Abstract] Subscription and maintenance. Subscription And Maintenance Member Subscription and maintenance [Member] Net Cash Provided by (Used in) Operating Activities Net cash provided by operating activities Weighted Average Grant Date Fair Value, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Product and Service Product and Service [Domain] Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Remaining Contractual Term, Outstanding at End of Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Property, Plant and Equipment, Net, Ending Balance Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Total Property and equipment, net Property, Plant and Equipment, Net Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Common stock, stated value Common Stock, Par or Stated Value Per Share Contract with Customer, Liability, Total Contract liabilities Contract with Customer, Liability Income and indirect taxes payable Taxes Payable, Current, Total Taxes Payable, Current Statement of Cash Flows [Abstract] Preferred stock, par value Preferred Stock, No Par Value Restricted Stock [Member] Restricted Stock [Member] Balance Sheet Related Disclosures [Abstract] Equity Components Equity Components [Axis] Entity Address, Address Line One Entity Address, Address Line One Schedule of amounts used in computing earnings per share and the effect on earnings and the weighted average number of shares of dilutive potential common shares Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Salaries, wages, employee benefits, and payroll taxes Employee-related Liabilities, Current, Total Employee-related Liabilities, Current Number of Shares, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Risk-free interest rate over contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Legal settlements Legal settlements Gain (Loss) from Litigation Settlement Number of Shares, Outstanding at beginning of period Number of Shares, Outstanding at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Amendment Flag Amendment Flag Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Operating lease liabilities, non-current Operating Lease, Liability, Noncurrent Schedule of Share-based Payment Award, Stock Appreciation Rights, Valuation Assumptions [Table Text Block] Schedule Of Share Based Payment Award Stock Appreciation Rights Valuation Assumptions Table [Text Block] Schedule of principal assumptions utilized in valuing service condition SARs Series A convertible preferred stock dividends Series A convertible preferred stock dividends Accretion Of Convertible Preferred Stock Dividends Accretion of convertible preferred stock dividends. Net income Net Income (Loss) Net income Professional services [Member] Professional Services [Member] Professional Services [Member] Equity Component Equity Component [Domain] Statistical Measurement Statistical Measurement [Domain] General and Administrative Expense, Total General and administrative General and Administrative Expense Additional Balance Sheet Information Supplemental Balance Sheet Disclosures [Text Block] Capitalized contract cost, amortization Capitalized Contract Cost, Amortization Employee stock purchase plan discount on shares Employee Stock Purchase Plan Discount On Shares Employee Stock Purchase Plan Discount On Shares Other income (expense), net Other income (expense), net Other Nonoperating Income (Expense), Total Other Nonoperating Income (Expense) Treasury stock [Member] Treasury Stock, Common [Member] Disaggregation Of Revenue [Table] Disaggregation of Revenue [Table] Weighted Average Exercise Price, Vested and expected to vest at End of Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageExerciseNumber Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Weighted Average Exercise Number Cash payments for operating leases Operating Lease, Payments Common Shares Issued under Employee Stock Purchase Plan Stock Issued During Period, Shares, Employee Stock Purchase Plans Sales commissions and fees Sales Commissions and Fees Award Type All Award Types Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Class of Stock Class of Stock [Domain] Comprehensive Income (Loss), Net of Tax, Attributable to Parent Total comprehensive income Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding, Beginning Balance Common stock, shares outstanding Common Stock, Shares, Outstanding Unusual Risk or Uncertainty, Nature Unusual Risk or Uncertainty, Nature [Axis] Activity related to restricted shares awarded by the Company Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Entity Interactive Data Current Entity Interactive Data Current Products [Member] Product [Member] Document Quarterly Report Document Quarterly Report Weighted Average Exercise Price, Forfeited Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures In Period Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures In Period Weighted Average Exercise Price Weighted Average Grant Date Fair Value, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Remaining Contractual Term, Exercisable at End of Period Share Based Compensation Arrangement By Share Based Payment Award Vested And Expected To Vest Outstanding Remaining Contractual Term Share-based Compensation Arrangement by Share-based Payment Award, Vested and Expected to Vest, Outstanding, Remaining Contractual Term Statistical Measurement Statistical Measurement [Axis] Cost of Goods and Services Sold, Total Total cost of goods sold Cost of Goods and Services Sold Related Party Related and Nonrelated Parties [Domain] Selling and Marketing Expense, Total Sales and marketing Selling and Marketing Expense Product development [Member] Product Development [Member] Product development. Shares available for grant Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Weighted Average Grant Date Fair Value, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average vesting period Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Effect of exchange rate changes on cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Income Statement Location Statement of Income Location, Balance [Axis] Total assets Assets Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Percentage of deferral of the employer-paid portion of social security taxes due in December 31, 2022 Percentage Of Deferral Of Employer Paid Portion Of Social Security Taxes Due In Year Two Percentage of deferral of the employer-paid portion of social security taxes due in year two. Number of Shares, Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Recently Issued Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Entity Address, City or Town Entity Address, City or Town Accumulated other comprehensive income (loss) [Member] AOCI Attributable to Parent [Member] Equity [Abstract] Payments of stock issuance costs Payments of Stock Issuance Costs Number of Shares, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Transfers to accounts receivable Contract with Customer, Asset, Reclassified to Receivable Liability, Defined Benefit Plan, Noncurrent, Total Employee benefit obligations Liability, Defined Benefit Plan, Noncurrent Depreciation, Total Depreciation of fixed assets Depreciation Depreciation of fixed assets Shares issued upon exercise of SSARs ( in shares) Share Issued Upon Exercise of SSARs Share issued upon exercise of SSARs Share-based compensation, grant date fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Share-based Compensation Share-Based Payment Arrangement [Text Block] Shares authorized under 2020 Equity incentive plan Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Series A Preferred Stock [Member] Series A Convertible Preferred Stock [Member] Series A Preferred Stock [Member] CARES Act [Member] C A R E S Act [Member] CARES Act [Member]. Chief Executive Officer [Member] Chief Executive Officer [Member] Current liabilities: Liabilities, Current [Abstract] Total Accrued Liabilities Income Taxes Paid, Net, Total Income Taxes Paid, Net Cash payments for income tax, net Document Type Document Type Document Type Title of 12(b) Security Title of 12(b) Security Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Statement of Stockholders' Equity [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Research and Development Expense, Total Product development Research and Development Expense Repurchase of common shares to satisfy employee tax withholding Payment, Tax Withholding, Share-Based Payment Arrangement Preferred Stock Dividend Rate Percentage Preferred Stock, Dividend Rate, Percentage Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent, Total Unrealized translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Sale of Stock [Axis] Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] MAK Capital One, LLC [Member] Majority Shareholder [Member] Two Thousand and Twenty Equity Incentive Plan [Member] Two Thousand and Twenty Equity Incentive Plan [Member] Two thousand and twenty equity incentive plan member. Revenue from Contract with Customer, Excluding Assessed Tax, Total Total net revenue Revenue from Contract with Customer, Excluding Assessed Tax Weighted Average Exercise Price, Exercisable at End of Period Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price. Statement of Comprehensive Income [Abstract] Income Taxes Income Tax Disclosure [Text Block] Effective tax rates from continuing operations Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Supplemental Disclosures of Cash Flow Information Cash Flow, Supplemental Disclosures [Text Block] Stock Based Compensation (Textual) [Abstract] Stock Based Compensation Textual [Abstract] Stock based compensation. Total operating expense Selling, General and Administrative Expense Other Other Accrued Liabilities, Current Entity Address, Address Line Two Entity Address, Address Line Two LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities and Equity [Abstract] Period End Date Document Period End Date Document Period End Date Net Cash Provided by (Used in) Financing Activities Net cash used in financing activities Effective Income Tax Rate Reconciliation, Percent, Total Effective tax rate Effective Income Tax Rate Reconciliation, Percent Other non-current liabilities: Liabilities, Noncurrent [Abstract] Support, Maintenance, Subscription Services, and Professional Services [Member] Support Maintenance Subscription Services And Professional Services [Member] Support, Maintenance, Subscription Services, And Professional Services [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Anti-dilutive SSARs, restricted shares, performance shares and preferred shares APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total Share-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Accrued Liabilities, Current, Total Accrued liabilities Accrued Liabilities, Current Income tax (benefit) provision Income tax (benefit) expense Income Tax Expense (Benefit), Total Income Tax Expense (Benefit) Trading Symbol Trading Symbol Business Combinations [Abstract] Total shareholders' equity Beginning balance Ending balance Equity, Attributable to Parent Total Other non-current liabilities Other Liabilities, Noncurrent Activity Related to Restricted Shares Awarded by the Company Activity Related To Restricted Shares Awarded By Company [Abstract] Activity related to restricted shares awarded by the Company. Restricted Stock Units [Member] Restricted Stock Units (RSUs) [Member] Goodwill, Ending Balance Goodwill, Beginning Balance Goodwill, Total Goodwill Goodwill Summary of share-based compensation expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Number of Rights, Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted Deferred income tax expense Deferred Income Tax Expense (Benefit), Total Deferred income taxes Deferred Income Tax Expense (Benefit) Activity related SSARs award Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block] Conversion of preferred stock Preferred stock issued, value Stock Issued During Period, Value, Conversion of Convertible Securities Class Of Stock [Line Items] Class of Stock [Line Items] Scenario [Axis] Security Exchange Name Security Exchange Name Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Class of Stock Class of Stock [Axis] Maximum [Member] Maximum [Member] Total liabilities and shareholders' equity Liabilities and Equity Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Net income per share - diluted: Income per share - diluted: Earnings Per Share, Diluted, Total Earnings Per Share, Diluted Aggregate Intrinsic Value, Exercisable at End of Period Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Aggregate Intrinsic Value. Two Thousand and Sixteen Stock Incentive Plan [Member] Two Thousand and Sixteen Stock Incentive Plan [Member] Two Thousand And Sixteen Stock Incentive Plan [Member] Two Thousand and Sixteen Stock Incentive Plan US State Statutes of Limitations [Member] US State Statutes of Limitations [Member] US state statutes of limitations member Total current assets Assets, Current Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Forcast [Member] Forecast [Member] Entity Filer Category Entity Filer Category Number of Rights, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Nature of Operations and Financial Statement Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Other income (expense): Nonoperating Income (Expense) [Abstract] Current Fiscal Year End Date Current Fiscal Year End Date Award Type Award Type [Axis] Share-based Payment Arrangement, Noncash Expense, Total Share-based Payment Arrangement, Noncash Expense Share-based compensation Share-Based Payment Arrangement, Noncash Expense Related Party Related and Nonrelated Parties [Axis] Entity Registrant Name Entity Registrant Name Gross profit Gross Profit Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Earnings per Share Earnings Per Share [Text Block] Entity Emerging Growth Company Entity Emerging Growth Company Weighted Average Number of Shares Outstanding, Basic, Total Weighted average shares outstanding - basic Weighted Average Number of Shares Outstanding, Basic Common stock, shares authorized Common Stock, Shares Authorized Amortization of Intangible Assets, Total Amortization of Intangible Assets Amortization of internal-use software and intangibles General and administrative [Member] General and Administrative Expense [Member] Accounting Policies [Abstract] Income Tax Disclosure [Abstract] Shareholders' equity: Equity, Attributable to Parent [Abstract] Statement [Table] Statement [Table] Share Based Compensation Arrangement By Share Based Payment Award Vested And Expected To Vest Outstanding Remaining Contractual Term Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Earnings Per Share, Diluted [Abstract] Earnings Per Share, Diluted [Abstract] Denominator: Denominator [Abstract] Denominator. Entity File Number Securities Act File Number Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Revenue from Contract with Customer [Abstract] Earnings Per Share [Abstract] Contract with Customer, Asset, after Allowance for Credit Loss, Current, Total Contract assets Contract with Customer, Asset, after Allowance for Credit Loss, Current Statement of Financial Position [Abstract] Interest Expense, Total Interest expense Interest Expense, Operating and Nonoperating Operating Income (Loss) Operating income Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Entity Shell Company Entity Shell Company Entity Tax Identification Number Entity Tax Identification Number ASSETS Assets [Abstract] Entity Current Reporting Status Entity Current Reporting Status Net Income (Loss) Available to Common Stockholders, Basic Net income attributable to common shareholders Document Fiscal Year Focus Document Fiscal Year Focus Series A convertible preferred stock, par value Preferred Stock, Value, Issued, Ending Balance Preferred Stock, Value, Issued, Beginning Balance Preferred Stock, Value, Issued, Total Series A convertible preferred stock, no par value Preferred Stock, Value, Issued Repayments of Long-term Debt, Total Principal payments under long-term obligations Repayments of Long-Term Debt Number of Rights, Forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures Accrued capital expenditures Capital Expenditures Incurred but Not yet Paid City Area Code City Area Code Schedule of supplemental cash flow information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Total current liabilities Liabilities, Current Cost of goods sold: Cost of Revenue [Abstract] Inventory, Net, Total Inventories Inventory, Net Conversion of Series A preferred stock (in shares) Preferred stock issued Stock Issued During Period, Shares, Conversion of Convertible Securities Incremental common shares attributable to restricted shares (in shares) Incremental Common Shares Attributable To Restricted Shares Incremental Common Shares Attributable to Restricted Shares Number of Rights, Exercisable at End of Period Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Share based compensation arrangement by share based payment award non option equity instruments exercisable. Organization, Consolidation and Presentation of Financial Statements [Abstract] Local Phone Number Local Phone Number Aggregate Intrinsic Value, Outstanding at End of Period Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value. Additional Paid in Capital, Ending Balance Additional Paid in Capital, Beginning Balance Additional Paid in Capital, Total Capital in excess of stated value Additional Paid in Capital Income Tax Jurisdiction [Axis] Commitments and Contingencies Disclosure [Abstract] Treasury shares, 5,469,903 and 5,965,426 at June 30, 2024 and March 31, 2024, respectively Treasury Stock, Value, Ending Balance Treasury Stock, Value, Beginning Balance Treasury Stock, Value, Total Treasury Stock, Value Convertible Preferred Stock [Member] Convertible Preferred Stock [Member] Operating lease liabilities, current Operating Lease, Liability, Current Income Tax Jurisdiction [Domain] Retained earnings [Member] Retained Earnings [Member] Document Transition Report Document Transition Report Deferred Income Tax Assets, Net, Total Deferred income taxes, non-current Deferred Income Tax Assets, Net Minimum [Member] Minimum [Member] Number of Rights, Expired Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations Common stock [Member] Common Stock [Member] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Aggregate Intrinsic Value, Vested and expected to vest at End of Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Weighted average grant date fair value (in dollars per share) Weighted Average Grant-Date Fair Value, Outstanding at beginning of period Weighted Average Grant-Date Fair Value, Outstanding at end of period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Capital in excess of Stated value [Member] Additional Paid-in Capital [Member] Weighted Average Exercise Price, Expired Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations In Period Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations In Period Weighted Average Exercise Price Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Income Statement Location Statement of Income Location, Balance [Domain] Other Assets, Noncurrent, Total Other non-current assets Other Assets, Noncurrent Performance Share [Member] Performance Shares [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Scenario [Domain] Title of Individual Title and Position [Domain] Weighted Average Exercise Price, Granted Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price Common shares, without par value, at $0.30 stated value; 80,000,000 shares authorized; 33,342,288 shares issued; and 27,872,345 and 27,376,862 shares outstanding at June 30, 2024 and March 31, 2024, respectively Common Stock, Value, Issued, Ending Balance Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Total Common Stock, Value, Issued Interest income Interest income Investment Income, Interest Stock Settled Appreciation Rights (SSARs) [Member] Stock Settled Appreciation Rights (SSARs) [Member] Stock Appreciation Rights (SARs) [Member] Schedule of Additional Information Related to the Condensed Consolidated Balance Sheets Schedule of Accrued Liabilities [Table Text Block] Commitments and contingencies Commitments and Contingencies Unusual Risk or Uncertainty, Nature Unusual Risk or Uncertainty, Nature [Domain] Weighted average shares outstanding - diluted Weighted average shares outstanding - diluted Weighted Average Number of Shares Outstanding, Diluted Recently Issued Accounting Pronouncements Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Accounts receivable, net of allowance for expected credit losses of $944 and $974, respectively Accounts Receivable, after Allowance for Credit Loss, Current, Total Accounts Receivable, after Allowance for Credit Loss, Current Number of Rights, Vested and expected to vest at June 30, 2024 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Payment of preferred stock dividends Payments of Ordinary Dividends, Preferred Stock and Preference Stock Dividends declaration and payment terms Dividend Payment Restrictions Schedule, Description Entity Small Business Entity Small Business Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total Restricted shares issued, net (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Restricted shares issued, net (in shares) Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Internal Revenue Service (IRS) [Member] Internal Revenue Service (IRS) [Member] Repurchases Of Shares To Satisfy Employee Tax Withholding Repurchases of shares to satisfy employee tax withholding. Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares Changes in operating assets and liabilities Increase Decrease In Operating Assets And Liabilties Changes in operating assets and liabilties. Intangible Assets, Net (Excluding Goodwill), Total Intangible assets, net Intangible Assets, Net (Excluding Goodwill) State and Local Jurisdiction [Member] State and Local Jurisdiction [Member] Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent, Total Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Net income Accounts Payable, Current, Total Accounts payable Accounts Payable, Current Accounts Receivable, Allowance for Credit Loss, Ending Balance Accounts Receivable, Allowance for Credit Loss, Beginning Balance Allowance for expected credit losses Accounts Receivable, Allowance for Credit Loss XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.2
Document and Entity Information - shares
3 Months Ended
Jun. 30, 2024
Jul. 19, 2024
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2024  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Entity Registrant Name AGILYSYS, INC.  
Entity Central Index Key 0000078749  
Entity Current Reporting Status Yes  
Current Fiscal Year End Date --03-31  
Entity Filer Category Large Accelerated Filer  
Entity Common Stock, Shares Outstanding   27,881,838
Entity Shell Company false  
Entity Small Business false  
Entity Emerging Growth Company false  
Trading Symbol AGYS  
Title of 12(b) Security Common Stock, without par value  
Security Exchange Name NASDAQ  
Document Quarterly Report true  
Document Transition Report false  
Entity Interactive Data Current Yes  
Entity File Number 000-5734  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 34-0907152  
Entity Address, Address Line One 3655 Brookside Parkway  
Entity Address, Address Line Two Suite 300  
Entity Address, City or Town Alpharetta  
Entity Address, State or Province GA  
Entity Address, Postal Zip Code 30022  
City Area Code 770  
Local Phone Number 810-7800  
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Mar. 31, 2024
Current assets:    
Cash and cash equivalents $ 144,111,000 $ 144,891,000
Accounts receivable, net of allowance for expected credit losses of $944 and $974, respectively 27,308,000 29,441,000
Contract assets 3,523,000 2,287,000
Inventories 5,300,000 4,587,000
Prepaid expenses and other current assets 6,523,000 7,731,000
Total current assets 186,765,000 188,937,000
Property and equipment, net 17,663,000 17,930,000
Operating lease right-of-use assets 17,843,000 18,384,000
Goodwill 32,659,000 32,791,000
Intangible assets, net 16,706,000 16,952,000
Deferred income taxes, non-current 76,237,000 67,373,000
Other non-current assets 7,825,000 8,063,000
Total assets 355,698,000 350,430,000
Current liabilities:    
Accounts payable 10,085,000 9,422,000
Contract liabilities 49,200,000 56,148,000
Accrued liabilities 13,127,000 19,522,000
Operating lease liabilities, current 4,992,000 4,279,000
Total current liabilities 77,404,000 89,371,000
Deferred income taxes, non-current 549,000 554,000
Operating lease liabilities, non-current 18,903,000 19,613,000
Other non-current liabilities 4,671,000 4,415,000
Commitments and contingencies
Shareholders' equity:    
Common shares, without par value, at $0.30 stated value; 80,000,000 shares authorized; 33,342,288 shares issued; and 27,872,345 and 27,376,862 shares outstanding at June 30, 2024 and March 31, 2024, respectively 10,003,000 10,003,000
Treasury shares, 5,469,903 and 5,965,426 at June 30, 2024 and March 31, 2024, respectively (1,642,000) (1,791,000)
Capital in excess of stated value 98,277,000 94,680,000
Retained earnings 151,861,000 137,755,000
Accumulated other comprehensive loss (4,328,000) (4,170,000)
Total shareholders' equity 254,171,000 236,477,000
Total liabilities and shareholders' equity $ 355,698,000 $ 350,430,000
XML 11 R3.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Jun. 30, 2024
Mar. 31, 2024
Allowance for expected credit losses $ 944 $ 974
Common stock, stated value $ 0.3 $ 0.3
Common stock, shares authorized 80,000,000 80,000,000
Common stock, shares issued 33,342,288 33,342,288
Common stock, shares outstanding 27,872,345 27,376,862
Treasury shares 5,469,903 5,965,426
XML 12 R4.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Net revenue:    
Total net revenue $ 63,512 $ 56,059
Cost of goods sold:    
Total cost of goods sold 23,644 23,002
Gross profit $ 39,868 $ 33,057
Gross profit margin 62.80% 59.00%
Operating expenses:    
Product development $ 14,720 $ 13,321
Sales and marketing 7,014 7,301
General and administrative 10,483 9,365
Depreciation of fixed assets 838 923
Amortization of internal-use software and intangibles 251 430
Other charges, net 550 759
Legal settlements 265 0
Total operating expense 34,121 32,099
Operating income 5,747 958
Other income (expense):    
Interest income 1,782 1,101
Other income (expense), net (157) (159)
Income before taxes 7,372 1,900
Income tax (benefit) provision (6,734) 352
Net income 14,106 1,548
Series A convertible preferred stock dividends 0 (459)
Net income attributable to common shareholders $ 14,106 $ 1,089
Weighted average shares outstanding - basic 27,134 24,936
Net income per share - basic: $ 0.52 $ 0.04
Weighted average shares outstanding - diluted 28,127 26,177
Net income per share - diluted: $ 0.5 $ 0.04
Products [Member]    
Net revenue:    
Total net revenue $ 9,874 $ 12,781
Cost of goods sold:    
Total cost of goods sold 5,226 6,565
Subscription and maintenance [Member]    
Net revenue:    
Total net revenue 38,043 32,125
Cost of goods sold:    
Total cost of goods sold 8,108 7,637
Professional services [Member]    
Net revenue:    
Total net revenue 15,595 11,153
Cost of goods sold:    
Total cost of goods sold $ 10,310 $ 8,800
XML 13 R5.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Statement of Comprehensive Income [Abstract]    
Net income $ 14,106 $ 1,548
Other comprehensive income (loss):    
Unrealized foreign currency translation adjustments (158) 523
Total comprehensive income $ 13,948 $ 2,071
XML 14 R6.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities    
Net income $ 14,106 $ 1,548
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation of fixed assets 838 923
Amortization of internal-use software and intangibles 251 430
Deferred income taxes (8,861) (129)
Share-based compensation 4,429 3,167
Changes in operating assets and liabilities (9,665) (5,917)
Net cash provided by operating activities 1,098 22
Investing activities    
Capital expenditures (869) (3,065)
Additional investments in corporate-owned life insurance policies 0 (2)
Net cash used in investing activities (869) (3,067)
Financing activities    
Payment of preferred stock dividends 0 (918)
Repurchase of common shares to satisfy employee tax withholding (925) (1,783)
Principal payments under long-term obligations 0 (1)
Net cash used in financing activities (925) (2,702)
Effect of exchange rate changes on cash (84) (2)
Net decrease in cash and cash equivalents (780) (5,749)
Cash and cash equivalents at beginning of period 144,891 112,842
Cash and cash equivalents at end of period $ 144,111 $ 107,093
XML 15 R7.htm IDEA: XBRL DOCUMENT v3.24.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock [Member]
Treasury stock [Member]
Capital in excess of Stated value [Member]
Retained earnings [Member]
Accumulated other comprehensive income (loss) [Member]
Beginning balance at Mar. 31, 2023 $ 109,310 $ 9,482 $ (1,884) $ 52,978 $ 52,764 $ (4,030)
Beginning balance (in shares) at Mar. 31, 2023   31,607 (6,280)      
Share-based compensation 3,377     3,377    
Restricted shares issued, net     $ 3 (3)    
Restricted shares issued, net (in shares)     12      
Shares issued upon exercise of SSARs     $ 15 (15)    
Shares issued upon exercise of SSARs ( in shares)     50      
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (2,613)   $ (11) (2,602)    
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (in shares)     (37)      
Net income 1,548       1,548  
Series A convertible preferred stock dividends (459)       (459)  
Unrealized translation adjustments 523         523
Ending balance at Jun. 30, 2023 111,686 $ 9,482 $ (1,877) 53,735 53,853 (3,507)
Ending balance (in shares) at Jun. 30, 2023   31,607 (6,255)      
Beginning balance at Mar. 31, 2024 236,477 $ 10,003 $ (1,791) 94,680 137,755 (4,170)
Beginning balance (in shares) at Mar. 31, 2024   33,342 (5,965)      
Share-based compensation 4,850     4,850    
Restricted shares issued, net     $ 3 (3)    
Restricted shares issued, net (in shares)     11      
Shares issued upon exercise of SSARs     $ 150 (150)    
Shares issued upon exercise of SSARs ( in shares)     498      
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (1,104)   $ (4) (1,100)    
Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (in shares)     (14)      
Net income 14,106       14,106  
Series A convertible preferred stock dividends 0          
Unrealized translation adjustments (158)         (158)
Ending balance at Jun. 30, 2024 $ 254,171 $ 10,003 $ (1,642) $ 98,277 $ 151,861 $ (4,328)
Ending balance (in shares) at Jun. 30, 2024   33,342 (5,470)      
XML 16 R8.htm IDEA: XBRL DOCUMENT v3.24.2
Nature of Operations and Financial Statement Presentation
3 Months Ended
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Operations and Financial Statement Presentation

1. Nature of Operations and Financial Statement Presentation

Nature of Operations

Agilysys has been a leader in hospitality software for more than 45 years, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare. The Company’s software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service. Many of the top hospitality companies around the world use Agilysys solutions to improve guest loyalty, drive revenue growth, and increase operational efficiencies. Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India, with headquarters in Alpharetta, GA.

The Company has just one reportable segment serving the global hospitality industry.

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements include our accounts consolidated with our wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Our fiscal year ends on March 31st. References to a particular year refer to the fiscal year ending in March of that year. For example, fiscal 2025 refers to the fiscal year ending March 31, 2025.

Our unaudited interim financial statements are prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information, the instructions to the Quarterly Report on Form 10-Q (Quarterly Report) under the Securities Exchange Act of 1934, as amended (the Exchange Act), and Rule 10-01 of Regulation S-X under the Exchange Act. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations relating to interim financial statements.

The Condensed Consolidated Balance Sheet as of June 30, 2024, as well as the Condensed Consolidated Statements of Operations, Condensed Consolidated Statements of Comprehensive Income, Condensed Consolidated Statements of Cash Flows, and Condensed Consolidated Statements of Shareholders’ Equity for the three months ended June 30, 2024 and 2023, are unaudited. However, these financial statements have been prepared on the same basis as those in the audited annual financial statements. In the opinion of management, all adjustments of a recurring nature necessary to fairly state the results of operations, financial position, and cash flows have been made.

These unaudited interim financial statements should be read together with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended March 31, 2024, filed with the Securities and Exchange Commission (SEC) on May 22, 2024.

Use of estimates

Preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates.

XML 17 R9.htm IDEA: XBRL DOCUMENT v3.24.2
Summary of Significant Accounting Policies
3 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

A detailed description of our significant accounting policies can be found in the audited financial statements for the fiscal year ended March 31, 2024, included in our Annual Report on Form 10-K. There have been no material changes to our significant accounting policies from those disclosed therein.

Recently Issued Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”) to update income tax

disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments in the ASU also remove disclosures related to certain unrecognized tax benefits and deferred taxes. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, or our fiscal 2026. The amendments may be applied prospectively or retrospectively with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.

In November 2023, the FASB issued ASU No. 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”) to expand reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 applies to entities with a single reportable segment. Annual disclosures are required for fiscal years beginning after December 15, 2023 or our fiscal 2025. Interim disclosures are required for periods within fiscal years beginning after December 15, 2024, or our fiscal 2026. Retrospective application is required for all prior periods presented with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.

XML 18 R10.htm IDEA: XBRL DOCUMENT v3.24.2
Revenue Recognition
3 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue Recognition

3. Revenue Recognition

Our customary business practice is to enter into legally enforceable written contracts with our customers. The majority of our contracts are governed by a master service agreement between us and the customer, which sets forth the general terms and conditions of any individual contract between the parties, which is then supplemented by a customer order to specify the different goods and services, the associated prices, and any additional terms for an individual contract. Performance obligations specific to each individual contract are defined within the terms of each order. Each performance obligation is identified based on the goods and services that will be transferred to our customer that are both capable of being distinct and are distinct within the context of the contract. The transaction price is determined based on the consideration to which we will be entitled and expect to receive in exchange for transferring goods or services to the customer. Typically, our contracts do not provide our customer with any right of return or refund; we do not constrain the contract price as it is probable that there will not be a significant revenue reversal due to a return or refund.

Typically, our customer contracts contain one or more of the following goods or services which constitute performance obligations.

Our proprietary software licenses typically provide for a perpetual right to use our software. Generally, our contracts do not provide significant services of integration and customization and installation services are not required to be purchased directly from us. The software is delivered before related services are provided and is functional without professional services, updates and technical support. We have concluded that the software license is distinct as the customer can benefit from the software on its own. Software revenue is typically recognized when the software is delivered or made available for download to the customer.

We recognize revenue for hardware sales when the product is shipped to the customer and when obligations that affect the customer’s final acceptance of the arrangement have been fulfilled. Hardware is purchased from suppliers and provided to the end-user customers via drop-ship or from inventory. We are responsible for negotiating price both with the supplier and the customer, payment to the supplier, establishing payment terms and product returns with the customer, and we bear the credit risk if the customer does not pay for the goods. As the principal contact with the customer, we recognize revenue and cost of goods sold when we ship or are notified by the supplier that the product has been shipped. In certain limited instances, as shipping terms dictate, revenue is recognized upon receipt at the point of destination or upon installation at the customer site.

Our subscription service revenue is comprised of fees for contracts that provide customers a right to access our software for a subscribed period. We do not provide the customer the contractual right to license the software at any time outside of the subscription period under these contracts. Our subscription service revenue is primarily based on rates per location, including rates per points of sale and per room. We recognize certain subscription service revenue on a per-transaction basis. The customer can only benefit from the software and software maintenance when provided the right to access the software. Accordingly, each of the rights to access the software, the maintenance services, any hosting services, and any transaction-based services is not considered a distinct performance obligation in the context of the contract and should be combined into a single performance obligation to be recognized over the contract period. The Company recognizes subscription revenue over a one-month period based on the typical monthly invoicing and renewal cycle in accordance with our customer agreement terms.

We derive maintenance service revenue from providing unspecified updates, upgrades, bug fixes, and technical support services for our proprietary software. These services represent a stand-ready obligation that is concurrently delivered and

has the same pattern of transfer to the customer; we account for these maintenance services as a single performance obligation. Maintenance revenue includes the same services provided by third-parties for remarketed software. We recognize substantially all maintenance revenue over the contract period of the maintenance agreement. We also recognize certain maintenance service revenue based on the volume of payment transactions processed by third parties through access to our software.

Professional services revenues primarily consist of fees for consulting, implementation, installation, integration, development and training and are generally recognized over time as the customer simultaneously receives and consumes the benefits of the professional services as the services are being performed. Certain professional development services are recognized upon delivery of the developed solutions to the customer. At the end of each reporting period, we recognize the most likely amount of variable consideration on any contract holdbacks we expect to bill for development services delivered. Professional services can be provided by internal or external providers, do not significantly affect the customer’s ability to access or use other provided goods or services, and provide a measure of benefit beyond that of other promised goods or services in the contract. As a result, professional services are considered distinct in the context of the contract and represent a separate performance obligation. Professional services that are billed on a time and materials basis are recognized over time as the services are performed. For contracts billed on a fixed price basis, revenue is recognized over time using an input method based on labor hours expended to date relative to the total labor hours expected to be required to satisfy the related performance obligation.

We use the market approach to derive standalone selling price (“SSP”) by maximizing observable data points (in the form of recently executed customer contracts) to determine the price customers are willing to pay for the goods and services transferred. If the contract contains a single performance obligation, the entire transaction price is allocated to that performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative SSP basis.

Shipping and handling fees billed to customers are recognized as revenue and the related costs are recognized in cost of goods sold. Revenue is recorded net of any applicable taxes collected and remitted to governmental agencies.

Disaggregation of Revenue

We derive and report our revenue from the sale of products (proprietary software licenses, third party hardware and operating systems), subscription and maintenance, and professional services. Products revenue recognized at a point in time totaled $9.9 million and $12.8 million for the three months ended June 30, 2024 and 2023, respectively. Subscription, maintenance, and substantially all professional services revenue recognized over time totaled $53.6 million and $43.3 million for the three months ended June 30, 2024 and 2023, respectively.

Contract Balances

Contract assets are rights to consideration in exchange for goods or services that we have transferred to a customer when that right is conditional on something other than the passage of time. The majority of our contract assets represent unbilled amounts related to products and professional services. We expect billing and collection of our contract assets to occur within the next twelve months. We receive payments from customers based upon contractual billing schedules and accounts receivable are recorded when the right to consideration becomes unconditional. Contract liabilities represent consideration received or consideration which is unconditionally due from customers prior to transferring goods or services to the customer under the terms of the contract.

Revenue recognized from amounts included in contract liabilities at the beginning of the period was $26.8 million and $22.1 million for the three months ended June 30, 2024 and 2023, respectively. Because the right to the transaction became unconditional, we transferred to accounts receivable from contract assets at the beginning of the period, $1.9 million and $1.6 million for the three months ended June 30, 2024 and 2023, respectively.

Our arrangements are for a period of one year or less. As a result, unsatisfied performance obligations as of June 30, 2024 are expected to be satisfied and the allocated transaction price recognized in revenue within a period of 12 months or less.

Assets Recognized from Costs to Obtain a Contract

Sales commission expenses that would not have occurred absent the customer contracts are considered incremental costs to obtain a contract. We expense the incremental costs to obtain a contract as incurred when the expected benefit and amortization period is one year or less. For subscription contracts that are renewed monthly based on an agreement term, we capitalize commission expenses and amortize as we satisfy the underlying performance obligations, generally based on the contract terms and anticipated renewals. Other sales commission expenses have a period of benefit of one year or less and are therefore expensed as incurred in line with the practical expedient elected.

We had $4.8 million and $4.0 million of capitalized sales incentive costs as of June 30, 2024 and 2023, respectively. These balances are included in other non-current assets on our condensed consolidated balance sheets. During the three months ended June 30, 2024 and 2023, we expensed $0.9 million and $0.9 million, respectively, of sales commissions, which included amortization of capitalized amounts of $0.4 million and $0.4 million, respectively. These expenses are included in operating expenses – sales and marketing in our condensed consolidated statement of operations. All other costs to obtain a contract are not considered incremental and therefore are expensed as incurred.

XML 19 R11.htm IDEA: XBRL DOCUMENT v3.24.2
Additional Balance Sheet Information
3 Months Ended
Jun. 30, 2024
Balance Sheet Related Disclosures [Abstract]  
Additional Balance Sheet Information

4. Additional Balance Sheet Information

Additional information related to the condensed consolidated balance sheets is as follows:

 

(In thousands)

 

June 30, 2024

 

 

March 31, 2024

 

Accrued liabilities:

 

 

 

 

 

 

Salaries, wages, employee benefits, and payroll taxes

 

$

7,744

 

 

$

16,264

 

Income and indirect taxes payable

 

 

4,264

 

 

 

1,684

 

Other

 

 

1,119

 

 

 

1,574

 

Total

 

$

13,127

 

 

$

19,522

 

Other non-current liabilities:

 

 

 

 

 

 

Employee benefit obligations

 

 

4,571

 

 

 

4,315

 

Other

 

 

100

 

 

 

100

 

Total

 

$

4,671

 

 

$

4,415

 

XML 20 R12.htm IDEA: XBRL DOCUMENT v3.24.2
Supplemental Disclosures of Cash Flow Information
3 Months Ended
Jun. 30, 2024
Supplemental Cash Flow Elements [Abstract]  
Supplemental Disclosures of Cash Flow Information

5. Supplemental Disclosures of Cash Flow Information

 

Additional information related to the condensed consolidated statements of cash flows is as follows:

 

 

 

Three months ended
June 30,

 

(In thousands)

 

 

2024

 

 

 

2023

 

Cash receipts for interest, net

 

$

1,424

 

 

$

893

 

Cash payments for income tax, net

 

 

578

 

 

 

376

 

Cash payments for operating leases

 

 

912

 

 

 

1,425

 

Cash payments for finance leases

 

 

 

 

 

2

 

Accrued capital expenditures

 

 

181

 

 

 

320

 

XML 21 R13.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes
3 Months Ended
Jun. 30, 2024
Income Tax Disclosure [Abstract]  
Income Taxes

6. Income Taxes

The following table compares our income tax provision and effective tax rates for the three months ended June 30, 2024 and 2023:

 

 

 

Three months ended
June 30,

 

(Dollars in thousands)

 

2024

 

 

2023

 

Income tax (benefit) provision

 

$

(6,734

)

 

$

352

 

Effective tax rate

 

nm

 

 

 

18.5

%

nm - not meaningful

For the three months ended June 30, 2023, income tax provision and the effective tax rate were primarily driven by activity within the foreign jurisdictions in which the company operates as valuation allowances were recorded against deferred tax assets in the U.S. and Canada. We released valuation allowances recorded against Canadian, U.S. Federal and certain state deferred tax assets in the period ending December 31, 2023.

For the three months ended June 30, 2024, income tax (benefit) and the effective tax rate were primarily driven by the impact of discrete excess tax benefits associated with Share-Based Compensation.

Our India subsidiary operates in a “Special Economic Zone (“SEZ”)”. One of the benefits associated with the SEZ is that the India subsidiary is not subject to regular India income taxes during its first five years of operations, which included fiscal 2018 through fiscal 2022. The India subsidiary is subject to 50% of regular India income taxes during its second five years of operations, which includes fiscal 2023 through fiscal 2027.

We have recorded and maintain valuation allowances offsetting the Company’s deferred tax assets in certain U.S. States and foreign jurisdictions. The ultimate realization of deferred tax assets depends on various factors including the generation of future taxable income in the periods in which the underlying temporary differences are deductible. We maintain valuation allowances for deferred tax assets until we have sufficient evidence to support the reversal of all or some portion of the allowances.

XML 22 R14.htm IDEA: XBRL DOCUMENT v3.24.2
Commitments and Contingencies
3 Months Ended
Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

7. Commitments and Contingencies

We are involved in legal actions that arise in the ordinary course of business. It is the opinion of management that the resolution of any current pending litigation will not have a material adverse effect on our financial position or results of operations.

XML 23 R15.htm IDEA: XBRL DOCUMENT v3.24.2
Earnings Per Share
3 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Earnings per Share

8. Earnings per Share

The following data shows the amounts used in computing earnings per share and the effect on earnings and the weighted average number of shares of dilutive potential common shares.

 

 

Three months ended
June 30,

 

(In thousands, except per share data)

2024

 

 

2023

 

Numerator:

 

 

 

 

 

Net income

$

14,106

 

 

$

1,548

 

Series A convertible preferred stock dividends

 

 

 

 

(459

)

Net income attributable to common shareholders

$

14,106

 

 

$

1,089

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

Weighted average shares outstanding - basic

 

27,134

 

 

 

24,936

 

Dilutive SSARs

 

710

 

 

 

1,008

 

Dilutive unvested restricted shares

 

270

 

 

 

231

 

Dilutive unvested restricted stock units

 

13

 

 

 

2

 

Weighted average shares outstanding - diluted

 

28,127

 

 

 

26,177

 

 

 

 

 

 

 

Income per share - basic:

$

0.52

 

 

$

0.04

 

Income per share - diluted:

$

0.50

 

 

$

0.04

 

 

 

 

 

 

 

Anti-dilutive SSARs, restricted shares,
   performance shares and preferred shares

 

7

 

 

 

1,735

 

Basic income per share is computed as net income attributable to common shareholders divided by the weighted average basic shares outstanding. The outstanding shares used to calculate the weighted average basic shares excludes 367,271 and 339,956 of restricted shares at June 30, 2024 and 2023, respectively, as these shares were issued but were not vested and therefore, not considered outstanding for purposes of computing basic income per share at the balance sheet dates.

Diluted income per share includes the impact of all potentially dilutive securities on earnings per share. We have stock-settled appreciation rights (SSARs), restricted shares, restricted stock units, and preferred shares that are potentially dilutive securities.

XML 24 R16.htm IDEA: XBRL DOCUMENT v3.24.2
Share-based Compensation
3 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Share-based Compensation

9. Share-based Compensation

We may grant incentive stock options, non-qualified stock options, SSARs, restricted shares, restricted stock units, and performance shares under our shareholder-approved 2020 Stock Incentive Plan (the 2020 Plan) for up to 2.25 million common shares, plus 868,864 common shares, the number of shares that were remaining for grant under the 2016 Stock

Incentive Plan (the 2016 Plan) as of the effective date of the 2020 Plan, plus the number of shares remaining for grant under the 2016 Plan that are forfeited, settled in cash, canceled or expired. The maximum aggregate number of restricted shares or restricted stock units that may be granted under the 2020 Plan is 3.1 million. We may also grant shares under our shareholder-approved Employee Stock Purchase Plan (the ESPP) for up to 500,000 common shares.

We may distribute authorized but unissued shares or treasury shares to satisfy share option and SSAR exercises or grants of restricted shares, restricted stock units, performance shares, or ESPP shares.

For SSARs, the exercise price must be set at least equal to the closing market price of our common shares on the date of grant. The maximum term of SSARs is seven years from the date of grant. The Compensation Committee of the Board of Directors establishes the period over which SSARs subject to a service condition vest and the vesting criteria for SSARs subject to a market condition.

Restricted shares and restricted stock units, whether time-vested or performance-based, may be issued at no cost or at a purchase price that may be below their fair market value, but are subject to forfeiture and restrictions on their sale or other transfer. Performance-based grants may be conditioned upon the attainment of specified performance objectives and other conditions, restrictions, and contingencies. Restricted shares have the right to receive dividends, if any, upon vesting, subject to the same forfeiture provisions that apply to the underlying grants.

We record compensation expense related to SSARs, restricted shares, restricted stock units, performance shares, and ESPP shares granted to certain employees and non-employee directors based on the fair value of the awards on the grant date. The fair value of restricted stock unit and restricted share grants subject only to a service condition is based on the closing price of our common shares on the grant date. For stock option and SSAR grants subject only to a service condition, we estimate the fair value on the grant date using the Black-Scholes-Merton option pricing model with inputs including the closing market price at grant date, exercise price and assumptions regarding the risk-free interest rate, expected volatility of our common shares based on historical volatility, and expected term as estimated using the simplified method. We use the simplified method for SSAR grants because we believe historical exercise data does not provide a reasonable basis upon which to estimate the expected term. For restricted stock unit, restricted share, and SSAR grants subject to a market condition, we estimate the fair value on the grant date through a lattice option pricing model that utilizes a Monte Carlo analysis with inputs including the closing market price at grant date, share price threshold, performance period term and assumptions regarding the risk-free interest rate and expected volatility of our common shares based on historical volatility. Inputs for SSAR grants subject to a market condition also include exercise price, remaining contractual term, and suboptimal exercise factor.

We record compensation expense for restricted stock units, restricted shares, and SSAR grants subject to a service condition using the graded vesting method. We record compensation expense for ESPP shares on a straight-line basis over the applicable offering period. We record compensation expense for SSAR grants subject only to a market condition over the derived service period, which is an output of the lattice option pricing model. Under the 2020 Plan, the fair value of performance shares is based on the closing price of our common shares on the settlement date of the performance award, for which we record compensation expense over the service period consistent with our annual bonus incentive plan as approved by the Compensation Committee of the Board of Directors.

The following table summarizes the share-based compensation expense for restricted and performance grants included in the condensed consolidated statements of operations:

 

Three months ended
June 30,

 

(In thousands)

2024

 

 

2023

 

Product development

 

2,636

 

 

 

1,625

 

Sales and marketing

 

331

 

 

 

166

 

General and administrative

 

1,462

 

 

 

1,376

 

Total share-based compensation expense

 

4,429

 

 

 

3,167

 

Stock-Settled Appreciation Rights

SSARs are rights granted to an employee to receive value equal to the difference between the price of our common shares on the date of exercise and the exercise price. The value is settled in common shares of Agilysys, Inc.

We use a Black-Scholes-Merton option pricing model to estimate the fair value of service condition SSARs and a lattice option pricing model to estimate the fair value of market condition SSARs. There were no SSARs granted during the three months ended June 30, 2024 and 2023.

The following table summarizes the activity during the three months ended June 30, 2024 for SSARs awarded under the 2020 and 2016 Plans:

(In thousands, except share and per share data)

 

Number of
Rights

 

 

Weighted-Average Exercise Price

 

 

Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

(per right)

 

 

(in years)

 

 

 

 

Outstanding at April 1, 2024

 

 

1,297,339

 

 

$

27.63

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(737,136

)

 

 

33.48

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2024

 

 

560,203

 

 

$

19.94

 

 

 

3.3

 

 

$

47,169

 

Exercisable at June 30, 2024

 

 

560,203

 

 

$

19.94

 

 

 

3.3

 

 

$

47,169

 

Vested and expected to vest at June 30, 2024

 

 

560,203

 

 

$

19.94

 

 

 

3.3

 

 

$

47,169

 

 

As of June 30, 2024, there was no unrecognized share-based compensation expense related to SSARs.

Restricted Shares

We granted shares to certain of our Directors, executives and key employees, the vesting of which is service-based. Certain restricted shares are also subject to a market condition. The following table summarizes the activity during the three months ended June 30, 2024 for restricted shares awarded under the 2020 Plan:

 

 

Number of Shares

 

 

Weighted-Average
Grant-Date
Fair Value

 

 

 

 

 

 

(per share)

 

Outstanding at April 1, 2024

 

 

436,177

 

 

$

65.52

 

Granted

 

 

13,149

 

 

 

103.30

 

Vested

 

 

(79,792

)

 

 

53.51

 

Forfeited

 

 

(2,263

)

 

 

70.58

 

Outstanding at June 30, 2024

 

 

367,271

 

 

$

68.05

 

 

The weighted-average grant date fair value of the restricted shares includes grants subject only to a service condition and certain grants subject to both a service condition and a market condition. As of June 30, 2024, total unrecognized share-based compensation expense related to unvested restricted shares was $12.9 million, which is expected to be recognized over a weighted-average vesting period of 2.0 years.

Restricted Stock Units

We granted restricted stock units to our Chief Executive Officer, the vesting of which is service-based. Certain restricted stock units are also subject to a market condition. The following table summarizes the activity during three months ended June 30, 2024 for restricted stock units awarded under the 2020 Plan:

 

 

 

Number of Shares

 

 

Weighted-Average Grant-Date Fair Value

 

 

 

 

 

 

(per share)

 

Outstanding at April 1, 2024

 

 

56,547

 

 

$

70.03

 

Granted

 

 

 

 

 

Vested

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Outstanding at June 30, 2024

 

 

56,547

 

 

$

70.03

 

As of June 30, 2024, total unrecognized share-based compensation expense related to non-vested restricted stock units was $2.0 million, which is expected to be recognized over the weighted-average vesting period of 1.8 years.

Performance Shares

Upon approval of the Compensation Committee of our Board of Directors, after achieving the performance conditions associated with our annual bonus plan, we granted 6,098 common shares to our Chief Executive Officer in May 2024 that vested immediately for a total value of $0.6 million.

Employee Stock Purchase Plan Shares

The ESPP permits participants to purchase common stock through regular payroll deductions, up to a specified percentage of their eligible compensation. The ESPP is compensatory because, among other provisions, it currently allows participants to purchase stock at up to a 15% discount from the lower of the closing price of a share of our common stock on the first or last trading day of the ESPP offering period. We measure share-based compensation expense for the ESPP based on the fair value of the ESPP grant at the beginning of the offering period. The fair value includes the value of the discount and the value associated with the call and put options that take advantage of the variability in the common stock price during the offering period. We estimate the value of the call and put options using the Black-Scholes-Merton option pricing model with inputs including the closing market price of our common stock on the first date of the offering period and assumptions regarding the risk-free interest rate, expected term, and expected volatility of our common shares over the offering period based on historical volatility.

 

 

Offering Period Ended

 

 

 

June 30, 2024

 

Grant date fair value

 

$

81.60

 

Risk-free interest rate over contractual term

 

 

5.36

%

Expected term (in years)

 

 

0.41

 

Expected volatility

 

 

47.41

%

The risk-free interest rate is based on the yield of a zero coupon U.S. Treasury bond whose maturity period approximates the expected term of the ESPP shares. The expected term is the offering period, which is typically six months.

We record amounts withheld from participants during each offering period in accrued salaries, wages and related benefits in the consolidated balance sheets until such shares are purchased. Amounts withheld from participants for the offering period ended June 30, 2024 totaled $0.5 million as of June 30, 2024.

As of June 30, 2024, there was no unrecognized share-based compensation expense related of the offering period ending June 30, 2024.

XML 25 R17.htm IDEA: XBRL DOCUMENT v3.24.2
Preferred Stock
9 Months Ended
Dec. 31, 2023
Equity [Abstract]  
Preferred Stock

10. Preferred Stock

Series A Convertible Preferred Stock

On May 22, 2020, we completed the sale of 1,735,457 shares of our preferred stock, without par value, designated as “Series A Convertible Preferred Stock” (the “Convertible Preferred Stock”) to MAK Capital Fund L.P. and MAK Capital Distressed Debt Fund I, LP (the “Holders”) each, in its capacity as a designee of MAK Capital One LLC (the “Purchaser”), pursuant to the terms of the Investment Agreement, dated as of May 11, 2020, between the Company and the Purchaser, for an aggregate purchase price of $35 million. We incurred issuance costs of $1.0 million. We added all issuance costs that were netted against the proceeds upon issuance of the Convertible Preferred Stock to its redemption value. As disclosed in our Annual Report for the fiscal year ended March 31, 2021, Michael Kaufman, the Chairman of the Company’s Board of Directors, is the Chief Executive Officer of MAK Capital One LLC.

Conversion

On November 24, 2023, at our option, we required conversion of all the outstanding shares of Convertible Preferred Stock to common stock. On November 27, 2023, we filed a Certificate of Elimination with the Secretary of State of the State of Delaware with respect to the Convertible Preferred Stock pursuant to which the Convertible Preferred Stock was eliminated and returned to the status of authorized and unissued preferred shares of the Company. Following the mandatory conversion of the outstanding shares of the Convertible Preferred Stock on November 24, 2023, there were no outstanding shares of the Convertible Preferred Stock. Accordingly, we removed the Series A convertible preferred stock, no par value from temporary equity on our consolidated balance sheet and recorded the associated increase of common shares at

$0.30 stated value and capital in excess of stated value further reflected in our consolidated statement of shareholders' equity.

Dividends

Prior to the conversion on November 24, 2023, the Holders were entitled to dividends on the Liquidation Preference at the rate of 5.25% per annum, payable semi-annually either (i) 50% in cash and 50% in kind as an increase in the then-current Liquidation Preference or (ii) 100% in cash, at the option of the Company. We paid dividends in the same period as declared by the Company’s Board of Directors.

Accounting Policy

Prior to the conversion on November 24, 2023, we classified convertible preferred stock as temporary equity in the consolidated balance sheets due to certain contingent redemption clauses that were at the election of the Holders. We increased the carrying value of the convertible preferred stock to its redemption value for all undeclared dividends using the interest method.
 

XML 26 R18.htm IDEA: XBRL DOCUMENT v3.24.2
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09 Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”) to update income tax

disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments in the ASU also remove disclosures related to certain unrecognized tax benefits and deferred taxes. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, or our fiscal 2026. The amendments may be applied prospectively or retrospectively with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.

In November 2023, the FASB issued ASU No. 2023-07 Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”) to expand reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 applies to entities with a single reportable segment. Annual disclosures are required for fiscal years beginning after December 15, 2023 or our fiscal 2025. Interim disclosures are required for periods within fiscal years beginning after December 15, 2024, or our fiscal 2026. Retrospective application is required for all prior periods presented with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.

XML 27 R19.htm IDEA: XBRL DOCUMENT v3.24.2
Additional Balance Sheet Information (Tables)
3 Months Ended
Jun. 30, 2024
Balance Sheet Related Disclosures [Abstract]  
Schedule of Additional Information Related to the Condensed Consolidated Balance Sheets

Additional information related to the condensed consolidated balance sheets is as follows:

 

(In thousands)

 

June 30, 2024

 

 

March 31, 2024

 

Accrued liabilities:

 

 

 

 

 

 

Salaries, wages, employee benefits, and payroll taxes

 

$

7,744

 

 

$

16,264

 

Income and indirect taxes payable

 

 

4,264

 

 

 

1,684

 

Other

 

 

1,119

 

 

 

1,574

 

Total

 

$

13,127

 

 

$

19,522

 

Other non-current liabilities:

 

 

 

 

 

 

Employee benefit obligations

 

 

4,571

 

 

 

4,315

 

Other

 

 

100

 

 

 

100

 

Total

 

$

4,671

 

 

$

4,415

 

XML 28 R20.htm IDEA: XBRL DOCUMENT v3.24.2
Supplemental Disclosures of Cash Flow Information (Tables)
3 Months Ended
Jun. 30, 2024
Supplemental Cash Flow Elements [Abstract]  
Schedule of supplemental cash flow information

Additional information related to the condensed consolidated statements of cash flows is as follows:

 

 

 

Three months ended
June 30,

 

(In thousands)

 

 

2024

 

 

 

2023

 

Cash receipts for interest, net

 

$

1,424

 

 

$

893

 

Cash payments for income tax, net

 

 

578

 

 

 

376

 

Cash payments for operating leases

 

 

912

 

 

 

1,425

 

Cash payments for finance leases

 

 

 

 

 

2

 

Accrued capital expenditures

 

 

181

 

 

 

320

 

XML 29 R21.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes (Tables)
3 Months Ended
Jun. 30, 2024
Income Tax Disclosure [Abstract]  
Effective tax rates from continuing operations

The following table compares our income tax provision and effective tax rates for the three months ended June 30, 2024 and 2023:

 

 

 

Three months ended
June 30,

 

(Dollars in thousands)

 

2024

 

 

2023

 

Income tax (benefit) provision

 

$

(6,734

)

 

$

352

 

Effective tax rate

 

nm

 

 

 

18.5

%

nm - not meaningful

XML 30 R22.htm IDEA: XBRL DOCUMENT v3.24.2
Earnings Per Share (Tables)
3 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of amounts used in computing earnings per share and the effect on earnings and the weighted average number of shares of dilutive potential common shares

The following data shows the amounts used in computing earnings per share and the effect on earnings and the weighted average number of shares of dilutive potential common shares.

 

 

Three months ended
June 30,

 

(In thousands, except per share data)

2024

 

 

2023

 

Numerator:

 

 

 

 

 

Net income

$

14,106

 

 

$

1,548

 

Series A convertible preferred stock dividends

 

 

 

 

(459

)

Net income attributable to common shareholders

$

14,106

 

 

$

1,089

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

Weighted average shares outstanding - basic

 

27,134

 

 

 

24,936

 

Dilutive SSARs

 

710

 

 

 

1,008

 

Dilutive unvested restricted shares

 

270

 

 

 

231

 

Dilutive unvested restricted stock units

 

13

 

 

 

2

 

Weighted average shares outstanding - diluted

 

28,127

 

 

 

26,177

 

 

 

 

 

 

 

Income per share - basic:

$

0.52

 

 

$

0.04

 

Income per share - diluted:

$

0.50

 

 

$

0.04

 

 

 

 

 

 

 

Anti-dilutive SSARs, restricted shares,
   performance shares and preferred shares

 

7

 

 

 

1,735

 

XML 31 R23.htm IDEA: XBRL DOCUMENT v3.24.2
Share-based Compensation (Tables)
3 Months Ended
Jun. 30, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of share-based compensation expense

The following table summarizes the share-based compensation expense for restricted and performance grants included in the condensed consolidated statements of operations:

 

Three months ended
June 30,

 

(In thousands)

2024

 

 

2023

 

Product development

 

2,636

 

 

 

1,625

 

Sales and marketing

 

331

 

 

 

166

 

General and administrative

 

1,462

 

 

 

1,376

 

Total share-based compensation expense

 

4,429

 

 

 

3,167

 

Activity related SSARs award

The following table summarizes the activity during the three months ended June 30, 2024 for SSARs awarded under the 2020 and 2016 Plans:

(In thousands, except share and per share data)

 

Number of
Rights

 

 

Weighted-Average Exercise Price

 

 

Remaining
Contractual
Term

 

 

Aggregate
Intrinsic
Value

 

 

 

 

 

 

(per right)

 

 

(in years)

 

 

 

 

Outstanding at April 1, 2024

 

 

1,297,339

 

 

$

27.63

 

 

 

 

 

 

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(737,136

)

 

 

33.48

 

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding at June 30, 2024

 

 

560,203

 

 

$

19.94

 

 

 

3.3

 

 

$

47,169

 

Exercisable at June 30, 2024

 

 

560,203

 

 

$

19.94

 

 

 

3.3

 

 

$

47,169

 

Vested and expected to vest at June 30, 2024

 

 

560,203

 

 

$

19.94

 

 

 

3.3

 

 

$

47,169

 

 

Activity related to restricted shares awarded by the Company The following table summarizes the activity during the three months ended June 30, 2024 for restricted shares awarded under the 2020 Plan:

 

 

Number of Shares

 

 

Weighted-Average
Grant-Date
Fair Value

 

 

 

 

 

 

(per share)

 

Outstanding at April 1, 2024

 

 

436,177

 

 

$

65.52

 

Granted

 

 

13,149

 

 

 

103.30

 

Vested

 

 

(79,792

)

 

 

53.51

 

Forfeited

 

 

(2,263

)

 

 

70.58

 

Outstanding at June 30, 2024

 

 

367,271

 

 

$

68.05

 

 

Employee Stock [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of principal assumptions utilized in valuing service condition SARs We estimate the value of the call and put options using the Black-Scholes-Merton option pricing model with inputs including the closing market price of our common stock on the first date of the offering period and assumptions regarding the risk-free interest rate, expected term, and expected volatility of our common shares over the offering period based on historical volatility.

 

 

Offering Period Ended

 

 

 

June 30, 2024

 

Grant date fair value

 

$

81.60

 

Risk-free interest rate over contractual term

 

 

5.36

%

Expected term (in years)

 

 

0.41

 

Expected volatility

 

 

47.41

%

Restricted Stock Units (RSUs) [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Activity related to restricted shares awarded by the Company The following table summarizes the activity during three months ended June 30, 2024 for restricted stock units awarded under the 2020 Plan:

 

 

 

Number of Shares

 

 

Weighted-Average Grant-Date Fair Value

 

 

 

 

 

 

(per share)

 

Outstanding at April 1, 2024

 

 

56,547

 

 

$

70.03

 

Granted

 

 

 

 

 

Vested

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Outstanding at June 30, 2024

 

 

56,547

 

 

$

70.03

 

XML 32 R24.htm IDEA: XBRL DOCUMENT v3.24.2
Revenue Recognition - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Disaggregation of Revenue [Line Items]    
Total net revenue $ 63,512 $ 56,059
Revenue recognized 26,800 22,100
Transfers to accounts receivable 1,900 1,600
Capitalized contract cost, net 4,800 4,000
Sales commissions and fees 900 900
Capitalized contract cost, amortization 400 400
Products [Member]    
Disaggregation of Revenue [Line Items]    
Total net revenue 9,874 12,781
Support, Maintenance, Subscription Services, and Professional Services [Member]    
Disaggregation of Revenue [Line Items]    
Total net revenue $ 53,600 $ 43,300
XML 33 R25.htm IDEA: XBRL DOCUMENT v3.24.2
Additional Balance Sheet Information - Schedule of Additional Information Related to the Condensed Consolidated Balance Sheets (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Mar. 31, 2024
Current liabilities:    
Salaries, wages, employee benefits, and payroll taxes $ 7,744 $ 16,264
Income and indirect taxes payable 4,264 1,684
Other 1,119 1,574
Total 13,127 19,522
Other non-current liabilities:    
Employee benefit obligations 4,571 4,315
Other 100 100
Total $ 4,671 $ 4,415
XML 34 R26.htm IDEA: XBRL DOCUMENT v3.24.2
Supplemental Disclosures of Cash Flow Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Supplemental Cash Flow Elements [Abstract]    
Cash receipts for interest, net $ 1,424 $ 893
Cash payments for income tax, net 578 376
Cash payments for operating leases 912 1,425
Cash payments for finance leases 0 2
Accrued capital expenditures $ 181 $ 320
XML 35 R27.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Income Tax Disclosure [Abstract]    
Income tax (benefit) provision $ (6,734) $ 352
Effective tax rate   18.50%
XML 36 R28.htm IDEA: XBRL DOCUMENT v3.24.2
Income Taxes (Details Textual)
3 Months Ended
Jun. 30, 2024
Operating Loss Carryforwards [Line Items]  
Regular corporate income tax rate in India 50.00%
XML 37 R29.htm IDEA: XBRL DOCUMENT v3.24.2
Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Numerator:    
Net income $ 14,106 $ 1,548
Series A convertible preferred stock dividends 0 (459)
Net income attributable to common shareholders $ 14,106 $ 1,089
Denominator:    
Weighted average shares outstanding - basic 27,134 24,936
Dilutive SSARs 710 1,008
Dilutive unvested restricted shares 270 231
Dilutive unvested restricted stock units 13 2
Weighted average shares outstanding - diluted 28,127 26,177
Income per share - basic: $ 0.52 $ 0.04
Income per share - diluted: $ 0.5 $ 0.04
Earnings Per Share, Diluted [Abstract]    
Anti-dilutive SSARs, restricted shares, performance shares and preferred shares 7 1,735
XML 38 R30.htm IDEA: XBRL DOCUMENT v3.24.2
Earnings Per Share (Details Textual) - shares
shares in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Earnings Per Share [Abstract]    
Incremental common shares attributable to restricted shares (in shares) 367,271 339,956
XML 39 R31.htm IDEA: XBRL DOCUMENT v3.24.2
Share-based Compensation (Details Textual)
$ in Thousands
3 Months Ended
Jun. 30, 2024
USD ($)
shares
Stock Based Compensation (Textual) [Abstract]  
Employee stock purchase plan discount on shares 15.00%
Employee Stock [Member]  
Stock Based Compensation (Textual) [Abstract]  
Unrecognized stock based compensation expense related to unvested restricted stock $ 0
Amounts withheld from participants $ 500
Performance Share [Member] | Chief Executive Officer [Member]  
Stock Based Compensation (Textual) [Abstract]  
Shares available for grant | shares 6,098
Share-based compensation, grant date fair value $ 600
Restricted Stock [Member]  
Stock Based Compensation (Textual) [Abstract]  
Weighted-average vesting period 2 years
Unrecognized stock based compensation expense related to unvested restricted stock $ 12,900
Restricted Stock Units (RSUs) [Member]  
Stock Based Compensation (Textual) [Abstract]  
Weighted-average vesting period 1 year 9 months 18 days
Unrecognized stock based compensation expense related to unvested restricted stock $ 2,000
Stock Settled Appreciation Rights (SSARs) [Member]  
Stock Based Compensation (Textual) [Abstract]  
Unrecognized stock based compensation expense related to unvested restricted stock $ 0
Two Thousand and Twenty Equity Incentive Plan [Member]  
Stock Based Compensation (Textual) [Abstract]  
Shares available for grant | shares 3,100,000
Two Thousand and Twenty Equity Incentive Plan [Member] | Common stock [Member] | Maximum [Member]  
Stock Based Compensation (Textual) [Abstract]  
Shares authorized under 2020 Equity incentive plan | shares 2,250,000
Common Shares Issued under Employee Stock Purchase Plan | shares 500,000
Two Thousand and Sixteen Stock Incentive Plan [Member] | Common stock [Member]  
Stock Based Compensation (Textual) [Abstract]  
Shares available for grant | shares 868,864
XML 40 R32.htm IDEA: XBRL DOCUMENT v3.24.2
Share-based Compensation (Details) - USD ($)
$ in Thousands
3 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Share-based Payment Arrangement, Noncash Expense $ 4,429 $ 3,167
Product development [Member]    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Summary of share-based compensation expense 2,636 1,625
Sales and marketing [Member]    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Summary of share-based compensation expense 331 166
General and administrative [Member]    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Summary of share-based compensation expense $ 1,462 $ 1,376
XML 41 R33.htm IDEA: XBRL DOCUMENT v3.24.2
Share-based Compensation (Details 2) - Stock Settled Appreciation Rights (SSARs) [Member]
$ / shares in Units, $ in Thousands
3 Months Ended
Jun. 30, 2024
USD ($)
$ / shares
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Number of Rights, Outstanding at Beginning of Period | shares 1,297,339
Number of Rights, Granted | shares 0
Number of Rights, Exercised | shares (737,136)
Number of Rights, Forfeited | shares 0
Number of Rights, Expired | shares 0
Number of Rights, Outstanding at End of Period | shares 560,203
Number of Rights, Exercisable at End of Period | shares 560,203
Number of Rights, Vested and expected to vest at June 30, 2024 | shares 560,203
Weighted Average Exercise Price, Outstanding at Beginning of Period | $ / shares $ 27.63
Weighted Average Exercise Price, Granted | $ / shares 0
Weighted Average Exercise Price, Exercised | $ / shares 33.48
Weighted Average Exercise Price, Forfeited | $ / shares 0
Weighted Average Exercise Price, Expired | $ / shares 0
Weighted Average Exercise Price, Outstanding at End of Period | $ / shares 19.94
Weighted Average Exercise Price, Exercisable at End of Period | $ / shares 19.94
Weighted Average Exercise Price, Vested and expected to vest at End of Period | $ / shares $ 19.94
Remaining Contractual Term, Outstanding at End of Period 3 years 3 months 18 days
Remaining Contractual Term, Exercisable at End of Period 3 years 3 months 18 days
Share Based Compensation Arrangement By Share Based Payment Award Vested And Expected To Vest Outstanding Remaining Contractual Term 3 years 3 months 18 days
Aggregate Intrinsic Value, Outstanding at End of Period | $ $ 47,169
Aggregate Intrinsic Value, Exercisable at End of Period | $ 47,169
Aggregate Intrinsic Value, Vested and expected to vest at End of Period | $ $ 47,169
XML 42 R34.htm IDEA: XBRL DOCUMENT v3.24.2
Share-based Compensation - Restricted Shares Rollforward (Details)
3 Months Ended
Jun. 30, 2024
$ / shares
shares
Restricted Stock [Member]  
Activity Related to Restricted Shares Awarded by the Company  
Number of Shares, Outstanding at beginning of period | shares 436,177
Number of Shares, Granted | shares 13,149
Number of Shares, Vested | shares (79,792)
Number of Shares, Forfeited | shares (2,263)
Number of Shares, Outstanding at end of period | shares 367,271
Weighted Average Grant-Date Fair Value, Outstanding at beginning of period | $ / shares $ 65.52
Weighted Average Grant Date Fair Value, Granted | $ / shares 103.3
Weighted Average Grant Date Fair Value, Vested | $ / shares 53.51
Weighted Average Grant Date Fair Value, Forfeited | $ / shares 70.58
Weighted Average Grant-Date Fair Value, Outstanding at end of period | $ / shares $ 68.05
Restricted Stock Units [Member]  
Activity Related to Restricted Shares Awarded by the Company  
Number of Shares, Outstanding at beginning of period | shares 56,547
Number of Shares, Granted | shares 0
Number of Shares, Vested | shares 0
Number of Shares, Forfeited | shares 0
Number of Shares, Outstanding at end of period | shares 56,547
Weighted Average Grant-Date Fair Value, Outstanding at beginning of period | $ / shares $ 70.03
Weighted Average Grant Date Fair Value, Granted | $ / shares 0
Weighted Average Grant Date Fair Value, Vested | $ / shares 0
Weighted Average Grant Date Fair Value, Forfeited | $ / shares 0
Weighted Average Grant-Date Fair Value, Outstanding at end of period | $ / shares $ 70.03
XML 43 R35.htm IDEA: XBRL DOCUMENT v3.24.2
Share-based Compensation - Schedule of Principal Assumptions Utilized in Valuing Service Condition SARs (Details) - Employee Stock [Member]
Jun. 30, 2024
$ / shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Weighted average grant date fair value (in dollars per share) $ 81.6
Risk-free interest rate over contractual term 5.36%
Expected term (in years) 4 months 28 days
Expected volatility 47.41%
XML 44 R36.htm IDEA: XBRL DOCUMENT v3.24.2
Preferred Stock - (Details Textual) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended
May 22, 2020
Jun. 30, 2024
Mar. 31, 2024
Class Of Stock [Line Items]      
Common stock, stated value   $ 0.3 $ 0.3
Preferred Stock Dividend Rate Percentage   5.25%  
Dividends declaration and payment terms   the Holders were entitled to dividends on the Liquidation Preference at the rate of 5.25% per annum, payable semi-annually either (i) 50% in cash and 50% in kind as an increase in the then-current Liquidation Preference or (ii) 100% in cash, at the option of the Company.  
Series A Convertible Preferred Stock [Member]      
Class Of Stock [Line Items]      
Preferred stock, par value   $ 0  
MAK Capital One, LLC [Member] | Convertible Preferred Stock [Member]      
Class Of Stock [Line Items]      
Preferred stock issued 1,735,457    
Preferred stock issued, value $ 35.0    
Payments of stock issuance costs $ 1.0    
EXCEL 45 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 46 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 47 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2 html 70 203 1 false 24 0 false 4 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100030 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100040 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 100050 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited) Sheet http://www.agilysys.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited Condensed Consolidated Statements of Comprehensive Income (Unaudited) Statements 5 false false R6.htm 100060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 100070 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited Condensed Consolidated Statements of Shareholders' Equity (Unaudited) Statements 7 false false R8.htm 100080 - Disclosure - Nature of Operations and Financial Statement Presentation Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureNatureOfOperationsAndFinancialStatementPresentation Nature of Operations and Financial Statement Presentation Notes 8 false false R9.htm 100090 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 100100 - Disclosure - Revenue Recognition Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognition Revenue Recognition Notes 10 false false R11.htm 100110 - Disclosure - Additional Balance Sheet Information Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureAdditionalBalanceSheetInformation Additional Balance Sheet Information Notes 11 false false R12.htm 100120 - Disclosure - Supplemental Disclosures of Cash Flow Information Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformation Supplemental Disclosures of Cash Flow Information Notes 12 false false R13.htm 100130 - Disclosure - Income Taxes Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxes Income Taxes Notes 13 false false R14.htm 100140 - Disclosure - Commitments and Contingencies Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 100150 - Disclosure - Earnings Per Share Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShare Earnings Per Share Notes 15 false false R16.htm 100160 - Disclosure - Share-based Compensation Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensation Share-based Compensation Notes 16 false false R17.htm 100170 - Disclosure - Preferred Stock Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStock Preferred Stock Notes 17 false false R18.htm 100190 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.agilysys.com/20240630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies 18 false false R19.htm 100200 - Disclosure - Additional Balance Sheet Information (Tables) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureAdditionalBalanceSheetInformationTables Additional Balance Sheet Information (Tables) Tables http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureAdditionalBalanceSheetInformation 19 false false R20.htm 100210 - Disclosure - Supplemental Disclosures of Cash Flow Information (Tables) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformationTables Supplemental Disclosures of Cash Flow Information (Tables) Tables http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformation 20 false false R21.htm 100220 - Disclosure - Income Taxes (Tables) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxes 21 false false R22.htm 100230 - Disclosure - Earnings Per Share (Tables) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareTables Earnings Per Share (Tables) Tables http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShare 22 false false R23.htm 100240 - Disclosure - Share-based Compensation (Tables) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables Share-based Compensation (Tables) Tables http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensation 23 false false R24.htm 100260 - Disclosure - Revenue Recognition - Narrative (Details) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails Revenue Recognition - Narrative (Details) Details 24 false false R25.htm 100270 - Disclosure - Additional Balance Sheet Information - Schedule of Additional Information Related to the Condensed Consolidated Balance Sheets (Details) Sheet http://www.agilysys.com/20240630/taxonomy/role/DisclosureAdditionalBalanceSheetInformationScheduleOfAdditionalInformationRelatedToTheCondensedConsolidatedBalanceSheetsDetails Additional Balance Sheet Information - Schedule of Additional Information Related to the Condensed Consolidated Balance Sheets (Details) Details 25 false false R26.htm 100280 - Disclosure - Supplemental Disclosures of Cash Flow Information (Details) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformationDetails Supplemental Disclosures of Cash Flow Information (Details) Details http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformationTables 26 false false R27.htm 100290 - Disclosure - Income Taxes (Details) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetails Income Taxes (Details) Details http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesTables 27 false false R28.htm 100300 - Disclosure - Income Taxes (Details Textual) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual Income Taxes (Details Textual) Details http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesTables 28 false false R29.htm 100320 - Disclosure - Earnings Per Share (Details) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails Earnings Per Share (Details) Details http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareTables 29 false false R30.htm 100330 - Disclosure - Earnings Per Share (Details Textual) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetailsTextual Earnings Per Share (Details Textual) Details http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareTables 30 false false R31.htm 100340 - Disclosure - Share-based Compensation (Details Textual) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual Share-based Compensation (Details Textual) Details http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables 31 false false R32.htm 100350 - Disclosure - Share-based Compensation (Details) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetails Share-based Compensation (Details) Details http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables 32 false false R33.htm 100360 - Disclosure - Share-based Compensation (Details 2) Sheet http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2 Share-based Compensation (Details 2) Details http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables 33 false false R34.htm 100370 - Disclosure - Share-based Compensation - Restricted Shares Rollforward (Details) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails Share-based Compensation - Restricted Shares Rollforward (Details) Details 34 false false R35.htm 100380 - Disclosure - Share-based Compensation - Schedule of Principal Assumptions Utilized in Valuing Service Condition SARs (Details) Sheet http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfPrincipalAssumptionsUtilizedInValuingServiceConditionSarsDetails Share-based Compensation - Schedule of Principal Assumptions Utilized in Valuing Service Condition SARs (Details) Details 35 false false R36.htm 100390 - Disclosure - Preferred Stock - (Details Textual) Sheet http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual Preferred Stock - (Details Textual) Details http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStock 36 false false All Reports Book All Reports agys-20240630.htm agys-20240630.xsd http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 false false JSON 51 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "agys-20240630.htm": { "nsprefix": "agys", "nsuri": "http://www.agilysys.com/20240630", "dts": { "inline": { "local": [ "agys-20240630.htm" ] }, "schema": { "local": [ "agys-20240630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/esma-arcrole-2018-11-21.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 177, "keyCustom": 26, "axisStandard": 10, "axisCustom": 0, "memberStandard": 18, "memberCustom": 6, "hidden": { "total": 7, "http://xbrl.sec.gov/dei/2024": 5, "http://fasb.org/us-gaap/2024": 2 }, "contextCount": 70, "entityCount": 1, "segmentCount": 24, "elementCount": 313, "unitCount": 4, "baseTaxonomies": { "http://fasb.org/us-gaap/2024": 351, "http://xbrl.sec.gov/dei/2024": 31 }, "report": { "R1": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "longName": "100010 - Statement - Condensed Consolidated Balance Sheets", "shortName": "Condensed Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "C_bd071c3e-8899-4ecb-96af-2c0793d690b6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bd071c3e-8899-4ecb-96af-2c0793d690b6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R3": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "longName": "100030 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "C_bd071c3e-8899-4ecb-96af-2c0793d690b6", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bd071c3e-8899-4ecb-96af-2c0793d690b6", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R4": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited", "longName": "100040 - Statement - Condensed Consolidated Statements of Operations (Unaudited)", "shortName": "Condensed Consolidated Statements of Operations (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "unique": true } }, "R5": { "role": "http://www.agilysys.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited", "longName": "100050 - Statement - Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "shortName": "Condensed Consolidated Statements of Comprehensive Income (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "longName": "100060 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:NetIncomeLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:DeferredIncomeTaxExpenseBenefit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "unique": true } }, "R7": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited", "longName": "100070 - Statement - Condensed Consolidated Statements of Shareholders' Equity (Unaudited)", "shortName": "Condensed Consolidated Statements of Shareholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "C_53092b2f-8885-4535-a8eb-bf92a32dc963", "name": "us-gaap:StockholdersEquity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_53092b2f-8885-4535-a8eb-bf92a32dc963", "name": "us-gaap:StockholdersEquity", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R8": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureNatureOfOperationsAndFinancialStatementPresentation", "longName": "100080 - Disclosure - Nature of Operations and Financial Statement Presentation", "shortName": "Nature of Operations and Financial Statement Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies", "longName": "100090 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognition", "longName": "100100 - Disclosure - Revenue Recognition", "shortName": "Revenue Recognition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureAdditionalBalanceSheetInformation", "longName": "100110 - Disclosure - Additional Balance Sheet Information", "shortName": "Additional Balance Sheet Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformation", "longName": "100120 - Disclosure - Supplemental Disclosures of Cash Flow Information", "shortName": "Supplemental Disclosures of Cash Flow Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxes", "longName": "100130 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies", "longName": "100140 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShare", "longName": "100150 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensation", "longName": "100160 - Disclosure - Share-based Compensation", "shortName": "Share-based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStock", "longName": "100170 - Disclosure - Preferred Stock", "shortName": "Preferred Stock", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "C_cc0f74ad-4fb9-41e2-86b5-56158ec516fa", "name": "us-gaap:PreferredStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_cc0f74ad-4fb9-41e2-86b5-56158ec516fa", "name": "us-gaap:PreferredStockTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "longName": "100190 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "18", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureAdditionalBalanceSheetInformationTables", "longName": "100200 - Disclosure - Additional Balance Sheet Information (Tables)", "shortName": "Additional Balance Sheet Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformationTables", "longName": "100210 - Disclosure - Supplemental Disclosures of Cash Flow Information (Tables)", "shortName": "Supplemental Disclosures of Cash Flow Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesTables", "longName": "100220 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "21", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareTables", "longName": "100230 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "22", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables", "longName": "100240 - Disclosure - Share-based Compensation (Tables)", "shortName": "Share-based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails", "longName": "100260 - Disclosure - Revenue Recognition - Narrative (Details)", "shortName": "Revenue Recognition - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "span", "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "unique": true } }, "R25": { "role": "http://www.agilysys.com/20240630/taxonomy/role/DisclosureAdditionalBalanceSheetInformationScheduleOfAdditionalInformationRelatedToTheCondensedConsolidatedBalanceSheetsDetails", "longName": "100270 - Disclosure - Additional Balance Sheet Information - Schedule of Additional Information Related to the Condensed Consolidated Balance Sheets (Details)", "shortName": "Additional Balance Sheet Information - Schedule of Additional Information Related to the Condensed Consolidated Balance Sheets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "C_bd071c3e-8899-4ecb-96af-2c0793d690b6", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "div", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bd071c3e-8899-4ecb-96af-2c0793d690b6", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "div", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformationDetails", "longName": "100280 - Disclosure - Supplemental Disclosures of Cash Flow Information (Details)", "shortName": "Supplemental Disclosures of Cash Flow Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "agys:InterestPaidReceipts", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "div", "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "agys:InterestPaidReceipts", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "div", "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetails", "longName": "100290 - Disclosure - Income Taxes (Details)", "shortName": "Income Taxes (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:IncomeTaxExpenseBenefit", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_99335172-2bbe-4c45-a52a-a5364cf102fe", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "div", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "unique": true } }, "R28": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual", "longName": "100300 - Disclosure - Income Taxes (Details Textual)", "shortName": "Income Taxes (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "agys:RegularCorporateIncomeTaxRateIndia", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "agys:RegularCorporateIncomeTaxRateIndia", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails", "longName": "100320 - Disclosure - Earnings Per Share (Details)", "shortName": "Earnings Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:NetIncomeLoss", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "agys:DilutiveSSARs", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "div", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "unique": true } }, "R30": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetailsTextual", "longName": "100330 - Disclosure - Earnings Per Share (Details Textual)", "shortName": "Earnings Per Share (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "agys:IncrementalCommonSharesAttributableToRestrictedShares", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "agys:IncrementalCommonSharesAttributableToRestrictedShares", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "us-gaap:EarningsPerShareTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "longName": "100340 - Disclosure - Share-based Compensation (Details Textual)", "shortName": "Share-based Compensation (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "agys:EmployeeStockPurchasePlanDiscountOnShares", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "agys:EmployeeStockPurchasePlanDiscountOnShares", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetails", "longName": "100350 - Disclosure - Share-based Compensation (Details)", "shortName": "Share-based Compensation (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:ShareBasedCompensation", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_2199fd49-f7db-4ff7-ab2b-f6c3263bb7eb", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "U_USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "unique": true } }, "R33": { "role": "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2", "longName": "100360 - Disclosure - Share-based Compensation (Details 2)", "shortName": "Share-based Compensation (Details 2)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "C_44cf9743-92c9-49db-8e74-ef9605ace907", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_44cf9743-92c9-49db-8e74-ef9605ace907", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails", "longName": "100370 - Disclosure - Share-based Compensation - Restricted Shares Rollforward (Details)", "shortName": "Share-based Compensation - Restricted Shares Rollforward (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "C_1524742e-dde1-488f-875a-cced609dd722", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_1524742e-dde1-488f-875a-cced609dd722", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "U_shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfPrincipalAssumptionsUtilizedInValuingServiceConditionSarsDetails", "longName": "100380 - Disclosure - Share-based Compensation - Schedule of Principal Assumptions Utilized in Valuing Service Condition SARs (Details)", "shortName": "Share-based Compensation - Schedule of Principal Assumptions Utilized in Valuing Service Condition SARs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "C_673127c5-e935-440e-ac71-5bd382dee9e2", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_673127c5-e935-440e-ac71-5bd382dee9e2", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "p", "td", "tr", "table", "ix:continuation", "div", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual", "longName": "100390 - Disclosure - Preferred Stock - (Details Textual)", "shortName": "Preferred Stock - (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "C_bd071c3e-8899-4ecb-96af-2c0793d690b6", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "U_UnitedStatesOfAmericaDollarsShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "p", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "first": true }, "uniqueAnchor": { "contextRef": "C_bfea95fc-361d-4c4b-b8c1-04c06a0ddbcb", "name": "us-gaap:PreferredStockDividendRatePercentage", "unitRef": "U_pure", "xsiNil": "false", "lang": null, "decimals": "4", "ancestors": [ "span", "us-gaap:DividendPaymentRestrictionsScheduleDescription", "span", "p", "us-gaap:PreferredStockTextBlock", "div", "body", "html" ], "reportCount": 1, "baseRef": "agys-20240630.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsPayableCurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Accounts Payable, Current, Total", "terseLabel": "Accounts payable", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r37", "r523" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net of allowance for expected credit losses of $944 and $974, respectively", "totalLabel": "Accounts Receivable, after Allowance for Credit Loss, Current, Total", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r572" ] }, "agys_AccretionOfConvertiblePreferredStockDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "AccretionOfConvertiblePreferredStockDividends", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Series A convertible preferred stock dividends", "terseLabel": "Series A convertible preferred stock dividends", "label": "Accretion Of Convertible Preferred Stock Dividends", "documentation": "Accretion of convertible preferred stock dividends." } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Accrued Liabilities, Current, Total", "terseLabel": "Accrued liabilities", "label": "Accrued Liabilities, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r39" ] }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureAdditionalBalanceSheetInformationScheduleOfAdditionalInformationRelatedToTheCondensedConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Accrued Liabilities", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities." } } }, "auth_ref": [ "r88" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r11", "r12", "r52", "r114", "r372", "r399", "r400" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss) [Member]", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r7", "r12", "r322", "r325", "r354", "r395", "r396", "r552", "r553", "r554", "r559", "r560", "r561", "r563" ] }, "agys_ActivityRelatedToRestrictedSharesAwardedByCompanyAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ActivityRelatedToRestrictedSharesAwardedByCompanyAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Activity Related to Restricted Shares Awarded by the Company", "label": "Activity Related To Restricted Shares Awarded By Company [Abstract]", "documentation": "Activity related to restricted shares awarded by the Company." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapital", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Additional Paid in Capital, Ending Balance", "periodStartLabel": "Additional Paid in Capital, Beginning Balance", "totalLabel": "Additional Paid in Capital, Total", "terseLabel": "Capital in excess of stated value", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r45", "r523", "r668" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Capital in excess of Stated value [Member]", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r411", "r559", "r560", "r561", "r563", "r622", "r669" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total", "terseLabel": "Share-based compensation", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r32", "r33", "r249" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:" } } }, "auth_ref": [] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of share-based compensation expense", "label": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r278", "r283" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AllowanceForDoubtfulAccountsReceivable", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "periodEndLabel": "Accounts Receivable, Allowance for Credit Loss, Ending Balance", "periodStartLabel": "Accounts Receivable, Allowance for Credit Loss, Beginning Balance", "terseLabel": "Allowance for expected credit losses", "label": "Accounts Receivable, Allowance for Credit Loss", "documentation": "Amount of allowance for credit loss on accounts receivable." } } }, "auth_ref": [ "r115", "r183", "r187", "r188", "r189", "r636" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Amortization of Intangible Assets, Total", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of internal-use software and intangibles", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r5", "r194", "r195", "r502" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Anti-dilutive SSARs, restricted shares, performance shares and preferred shares", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r161" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Assets", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r87", "r96", "r110", "r133", "r165", "r169", "r177", "r178", "r184", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r317", "r319", "r334", "r366", "r444", "r498", "r499", "r523", "r538", "r584", "r585", "r627" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrent", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r105", "r117", "r133", "r184", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r317", "r319", "r334", "r523", "r584", "r585", "r627" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current assets:", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "AwardTypeAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277" ] }, "us-gaap_BalanceSheetRelatedDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BalanceSheetRelatedDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Balance Sheet Related Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureBusinessCombination" ], "lang": { "en-us": { "role": { "terseLabel": "Business Combination", "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r83", "r314" ] }, "us-gaap_BusinessCombinationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "BusinessCombinationsAbstract", "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "auth_ref": [] }, "agys_CARESActMember": { "xbrltype": "domainItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "CARESActMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "CARES Act [Member]", "label": "C A R E S Act [Member]", "documentation": "CARES Act [Member]." } } }, "auth_ref": [] }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CapitalExpendituresIncurredButNotYetPaid", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued capital expenditures", "label": "Capital Expenditures Incurred but Not yet Paid", "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred." } } }, "auth_ref": [ "r17", "r18", "r19" ] }, "us-gaap_CapitalizedContractCostAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CapitalizedContractCostAmortization", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized contract cost, amortization", "label": "Capitalized Contract Cost, Amortization", "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer." } } }, "auth_ref": [ "r191" ] }, "us-gaap_CapitalizedContractCostNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CapitalizedContractCostNet", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Capitalized Contract Cost, Net, Total", "terseLabel": "Capitalized contract cost, net", "label": "Capitalized Contract Cost, Net", "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer." } } }, "auth_ref": [ "r190" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance", "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance", "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total", "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalents, at Carrying Value", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r15", "r107", "r494" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total", "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r15", "r66", "r131" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net decrease in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r0", "r66" ] }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CashFlowSupplementalDisclosuresTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Supplemental Disclosures of Cash Flow Information", "label": "Cash Flow, Supplemental Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." } } }, "auth_ref": [ "r63" ] }, "srt_ChiefExecutiveOfficerMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ChiefExecutiveOfficerMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Chief Executive Officer [Member]", "label": "Chief Executive Officer [Member]" } } }, "auth_ref": [ "r571" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "verboseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r102", "r111", "r112", "r113", "r133", "r154", "r155", "r158", "r160", "r167", "r168", "r184", "r206", "r208", "r209", "r210", "r213", "r214", "r216", "r217", "r219", "r220", "r222", "r334", "r405", "r406", "r407", "r408", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r432", "r453", "r471", "r484", "r485", "r486", "r487", "r488", "r545", "r556", "r564" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Class Of Stock [Line Items]", "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r111", "r112", "r113", "r167", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r405", "r406", "r407", "r408", "r503", "r545", "r556" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r42", "r89", "r369", "r431" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r71", "r200", "r201", "r489", "r578", "r580" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock [Member]", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r529", "r530", "r531", "r533", "r534", "r535", "r536", "r559", "r560", "r563", "r622", "r667", "r669" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, stated value", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r44" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r44", "r432" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "totalLabel": "Common Stock, Shares, Issued, Total", "terseLabel": "Common stock, shares issued", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r44" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "periodEndLabel": "Common Stock, Shares, Outstanding, Ending Balance", "periodStartLabel": "Common Stock, Shares, Outstanding, Beginning Balance", "terseLabel": "Common stock, shares outstanding", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r8", "r44", "r432", "r450", "r669", "r670" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockValue", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares, without par value, at $0.30 stated value; 80,000,000 shares authorized; 33,342,288 shares issued; and 27,872,345 and 27,376,862 shares outstanding at June 30, 2024 and March 31, 2024, respectively", "periodEndLabel": "Common Stock, Value, Issued, Ending Balance", "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance", "totalLabel": "Common Stock, Value, Issued, Total", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r44", "r371", "r523" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total comprehensive income", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r13", "r119", "r121", "r125", "r362", "r380", "r381" ] }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerAssetNetCurrent", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Contract with Customer, Asset, after Allowance for Credit Loss, Current, Total", "terseLabel": "Contract assets", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current." } } }, "auth_ref": [ "r224", "r226", "r237" ] }, "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerAssetReclassifiedToReceivable", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfers to accounts receivable", "label": "Contract with Customer, Asset, Reclassified to Receivable", "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional." } } }, "auth_ref": [ "r504" ] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiability", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Contract with Customer, Liability, Total", "terseLabel": "Contract liabilities", "label": "Contract with Customer, Liability", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r224", "r225", "r237" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue recognized", "label": "Contract with Customer, Liability, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r238" ] }, "us-gaap_ConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ConvertiblePreferredStockMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Convertible Preferred Stock [Member]", "label": "Convertible Preferred Stock [Member]", "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option." } } }, "auth_ref": [ "r216", "r217", "r219", "r533", "r534", "r535", "r536" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Cost of Goods and Services Sold, Total", "terseLabel": "Total cost of goods sold", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r56", "r57", "r360" ] }, "us-gaap_CostOfRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CostOfRevenueAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of goods sold:", "label": "Cost of Revenue [Abstract]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Income Tax Assets, Net, Total", "terseLabel": "Deferred income taxes, non-current", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r287", "r288" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Deferred income tax expense", "totalLabel": "Deferred Income Tax Expense (Benefit), Total", "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r5", "r99", "r558" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Deferred Income Tax Liabilities, Net, Total", "terseLabel": "Deferred income taxes, non-current", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r287", "r288", "r367" ] }, "agys_DenominatorAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "DenominatorAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Denominator:", "label": "Denominator [Abstract]", "documentation": "Denominator." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Depreciation, Total", "terseLabel": "Depreciation of fixed assets", "label": "Depreciation", "verboseLabel": "Depreciation of fixed assets", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r5", "r21" ] }, "agys_DilutiveSSARs": { "xbrltype": "sharesItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "DilutiveSSARs", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive SSARs", "label": "Dilutive S S A Rs", "documentation": "Dilutive SSARs." } } }, "auth_ref": [] }, "agys_DilutiveUnvestedRestrictedStockUnits": { "xbrltype": "sharesItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "DilutiveUnvestedRestrictedStockUnits", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive unvested restricted stock units", "label": "Dilutive Unvested Restricted Stock Units", "documentation": "Dilutive unvested restricted stock units." } } }, "auth_ref": [] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r236", "r505", "r506", "r507", "r508", "r509", "r510", "r511" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation Of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r236", "r505", "r506", "r507", "r508", "r509", "r510", "r511" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensation" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based Compensation", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r247", "r251", "r279", "r280", "r282", "r514" ] }, "us-gaap_DividendPaymentRestrictionsScheduleDescription": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "DividendPaymentRestrictionsScheduleDescription", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends declaration and payment terms", "label": "Dividend Payment Restrictions Schedule, Description", "documentation": "Description of dividends paid, restrictions on dividend payments, statutory capital and surplus amounts, requirements and future requirements." } } }, "auth_ref": [ "r35" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Period End Date", "verboseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r542" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r543" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "verboseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Net income per share - basic:", "terseLabel": "Income per share - basic:", "totalLabel": "Earnings Per Share, Basic, Total", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r126", "r140", "r141", "r142", "r143", "r144", "r145", "r151", "r154", "r158", "r159", "r160", "r164", "r312", "r316", "r328", "r329", "r363", "r382", "r496" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Net income per share - diluted:", "terseLabel": "Income per share - diluted:", "totalLabel": "Earnings Per Share, Diluted, Total", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r126", "r140", "r141", "r142", "r143", "r144", "r145", "r154", "r158", "r159", "r160", "r164", "r312", "r316", "r328", "r329", "r363", "r382", "r496" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share, Diluted [Abstract]", "label": "Earnings Per Share, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r150", "r161", "r162", "r163" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r337" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Effective Income Tax Rate Reconciliation, Percent, Total", "terseLabel": "Effective tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r290", "r516" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureAdditionalBalanceSheetInformationScheduleOfAdditionalInformationRelatedToTheCondensedConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Salaries, wages, employee benefits, and payroll taxes", "totalLabel": "Employee-related Liabilities, Current, Total", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r39" ] }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted-average vesting period", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r281" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecognized stock based compensation expense related to unvested restricted stock", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r616" ] }, "us-gaap_EmployeeStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EmployeeStockMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfPrincipalAssumptionsUtilizedInValuingServiceConditionSarsDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Employee Stock [Member]", "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock." } } }, "auth_ref": [] }, "agys_EmployeeStockPurchasePlanDiscountOnShares": { "xbrltype": "percentItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "EmployeeStockPurchasePlanDiscountOnShares", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Employee stock purchase plan discount on shares", "label": "Employee Stock Purchase Plan Discount On Shares", "documentation": "Employee Stock Purchase Plan Discount On Shares" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r540" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r540" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r540" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r544" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r540" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r540" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Business", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r540" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r540" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "EquityComponentDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r8", "r103", "r122", "r123", "r124", "r135", "r136", "r137", "r139", "r144", "r146", "r148", "r166", "r185", "r186", "r196", "r223", "r302", "r303", "r309", "r310", "r311", "r313", "r315", "r316", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r339", "r340", "r341", "r342", "r343", "r344", "r346", "r347", "r354", "r379", "r395", "r396", "r397", "r411", "r471" ] }, "us-gaap_FinanceLeasePrincipalPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "FinanceLeasePrincipalPayments", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash payments for finance leases", "label": "Finance Lease, Principal Payments", "documentation": "Amount of cash outflow for principal payment on finance lease." } } }, "auth_ref": [ "r350", "r352" ] }, "us-gaap_GainLossRelatedToLitigationSettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GainLossRelatedToLitigationSettlement", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Legal settlements", "terseLabel": "Legal settlements", "label": "Gain (Loss) from Litigation Settlement", "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process." } } }, "auth_ref": [ "r498", "r581" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "General and Administrative Expense, Total", "terseLabel": "General and administrative", "label": "General and Administrative Expense", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r60", "r455" ] }, "us-gaap_GeneralAndAdministrativeExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GeneralAndAdministrativeExpenseMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "General and administrative [Member]", "label": "General and Administrative Expense [Member]", "documentation": "Primary financial statement caption encompassing general and administrative expense." } } }, "auth_ref": [ "r60" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "Goodwill", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Goodwill, Ending Balance", "periodStartLabel": "Goodwill, Beginning Balance", "totalLabel": "Goodwill, Total", "terseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r108", "r192", "r361", "r499", "r501", "r517", "r523", "r574", "r575" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "GrossProfit", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r53", "r58", "r95", "r133", "r184", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r334", "r497", "r498", "r566", "r567", "r568", "r569", "r570", "r584" ] }, "agys_GrossProfitRatio": { "xbrltype": "percentItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "GrossProfitRatio", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Gross profit margin", "label": "Gross Profit Ratio", "documentation": "Gross profit ratio." } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperations", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent, Total", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "terseLabel": "Net income", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent." } } }, "auth_ref": [ "r34", "r55", "r68", "r140", "r141", "r142", "r143", "r144", "r156", "r160", "r316" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before taxes", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r54", "r91", "r95", "r364", "r377", "r497", "r498", "r566", "r567", "r568", "r569", "r570" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location", "label": "Statement of Income Location, Balance [Axis]", "documentation": "Information by location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r197", "r198", "r199", "r331", "r332", "r333", "r392", "r394", "r456", "r492", "r518", "r638" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income Statement Location", "label": "Statement of Income Location, Balance [Domain]", "documentation": "Location in statement of income where disaggregated amount has been reported." } } }, "auth_ref": [ "r198", "r199", "r331", "r332", "r333", "r392", "r394", "r456", "r492", "r518", "r638" ] }, "us-gaap_IncomeTaxAuthorityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxAuthorityAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "label": "Income Tax Jurisdiction [Axis]", "documentation": "Information by income tax jurisdiction." } } }, "auth_ref": [ "r130", "r290", "r291", "r296", "r300", "r516", "r618" ] }, "us-gaap_IncomeTaxAuthorityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxAuthorityDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "label": "Income Tax Jurisdiction [Domain]", "documentation": "Income tax jurisdiction." } } }, "auth_ref": [ "r130", "r290", "r291", "r296", "r300", "r516", "r618" ] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income tax." } } }, "auth_ref": [ "r134", "r286", "r290", "r293", "r294", "r295", "r297", "r298", "r304", "r306", "r307", "r308", "r410", "r516" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Income tax (benefit) provision", "verboseLabel": "Income tax (benefit) expense", "totalLabel": "Income Tax Expense (Benefit), Total", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r98", "r100", "r147", "r148", "r165", "r174", "r178", "r289", "r290", "r305", "r383", "r516" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Income Taxes Paid, Net, Total", "label": "Income Taxes Paid, Net", "terseLabel": "Cash payments for income tax, net", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r16", "r130", "r299", "r300" ] }, "agys_IncreaseDecreaseInOperatingAssetsAndLiabilties": { "xbrltype": "monetaryItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "IncreaseDecreaseInOperatingAssetsAndLiabilties", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Changes in operating assets and liabilities", "label": "Increase Decrease In Operating Assets And Liabilties", "documentation": "Changes in operating assets and liabilties." } } }, "auth_ref": [] }, "agys_IncrementalCommonSharesAttributableToRestrictedShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "IncrementalCommonSharesAttributableToRestrictedShares", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Incremental common shares attributable to restricted shares (in shares)", "label": "Incremental Common Shares Attributable To Restricted Shares", "documentation": "Incremental Common Shares Attributable to Restricted Shares" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Intangible Assets, Net (Excluding Goodwill), Total", "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r193", "r576", "r577" ] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InterestExpense", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Interest Expense, Total", "terseLabel": "Interest expense", "label": "Interest Expense, Operating and Nonoperating", "documentation": "Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense." } } }, "auth_ref": [ "r165", "r169", "r173", "r175", "r178", "r345", "r498", "r499" ] }, "agys_InterestPaidReceipts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "InterestPaidReceipts", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash receipts for interest, net", "label": "Interest Paid Receipts", "documentation": "Interest Paid Receipts" } } }, "auth_ref": [] }, "us-gaap_InternalRevenueServiceIRSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InternalRevenueServiceIRSMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Internal Revenue Service (IRS) [Member]", "label": "Internal Revenue Service (IRS) [Member]", "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity." } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InventoryNet", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Inventory, Net, Total", "terseLabel": "Inventories", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r116", "r495", "r523" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "InvestmentIncomeInterest", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "negatedLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r165", "r172", "r178", "r498", "r555" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and shareholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r49", "r90", "r374", "r523", "r557", "r573", "r624" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r40", "r106", "r133", "r184", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r318", "r319", "r320", "r334", "r523", "r584", "r627", "r628" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureAdditionalBalanceSheetInformationScheduleOfAdditionalInformationRelatedToTheCondensedConsolidatedBalanceSheetsDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current liabilities:", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureAdditionalBalanceSheetInformationScheduleOfAdditionalInformationRelatedToTheCondensedConsolidatedBalanceSheetsDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other non-current liabilities:", "label": "Liabilities, Noncurrent [Abstract]" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_MajorityShareholderMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "MajorityShareholderMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "MAK Capital One, LLC [Member]", "label": "Majority Shareholder [Member]", "documentation": "Owner that controls more than 50 percent of the voting interest in the entity through direct or indirect ownership." } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MaximumMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum [Member]", "label": "Maximum [Member]" } } }, "auth_ref": [ "r202", "r203", "r204", "r205", "r245", "r284", "r330", "r359", "r391", "r393", "r401", "r423", "r424", "r475", "r477", "r480", "r481", "r482", "r490", "r491", "r500", "r503", "r513", "r519", "r520", "r521", "r522", "r525", "r586", "r629", "r630", "r631", "r632", "r633", "r634" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "MinimumMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum [Member]", "label": "Minimum [Member]" } } }, "auth_ref": [ "r202", "r203", "r204", "r205", "r245", "r284", "r330", "r359", "r391", "r393", "r401", "r423", "r424", "r475", "r477", "r480", "r481", "r482", "r490", "r491", "r500", "r503", "r513", "r519", "r520", "r521", "r525", "r586", "r629", "r630", "r631", "r632", "r633", "r634" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash used in financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r129" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Financing activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r129" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Investing activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivities", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r66", "r67", "r68" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Operating activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net income", "label": "Net Income (Loss)", "totalLabel": "Net income", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r59", "r68", "r92", "r104", "r118", "r120", "r124", "r133", "r138", "r140", "r141", "r142", "r143", "r144", "r147", "r148", "r156", "r184", "r206", "r207", "r208", "r209", "r210", "r211", "r212", "r213", "r214", "r312", "r316", "r329", "r334", "r378", "r452", "r469", "r470", "r537", "r584" ] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net income attributable to common shareholders", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r127", "r140", "r141", "r142", "r143", "r151", "r152", "r157", "r160", "r316" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Recently Issued Accounting Pronouncements", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense):", "label": "Nonoperating Income (Expense) [Abstract]" } } }, "auth_ref": [] }, "agys_NumberOfSharesWithheldForTaxesUponExerciseOfStockOptionsSsarsOrVestingOfRestrictedShares": { "xbrltype": "sharesItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "NumberOfSharesWithheldForTaxesUponExerciseOfStockOptionsSsarsOrVestingOfRestrictedShares", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Number Of Shares Withheld For Taxes Upon Exercise Of Stock Options Ssars Or Vesting Of Restricted Shares", "documentation": "Number of Shares Withheld For Taxes Upon Exercise of Stock Options, SSARs or Vesting of Restricted Shares", "negatedLabel": "Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares (in shares)" } } }, "auth_ref": [] }, "agys_NumeratorAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "NumeratorAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Numerator:", "label": "Numerator [Abstract]", "documentation": "Numerator." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingExpensesAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Operating expenses:", "label": "Operating Expenses [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingIncomeLoss", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "label": "Operating Income (Loss)", "totalLabel": "Operating income", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r95", "r497", "r566", "r567", "r568", "r569", "r570" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities, current", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r349" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities, non-current", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r349" ] }, "us-gaap_OperatingLeasePayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeasePayments", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash payments for operating leases", "label": "Operating Lease, Payments", "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use." } } }, "auth_ref": [ "r351", "r352" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r348" ] }, "us-gaap_OperatingLossCarryforwardsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLossCarryforwardsLineItems", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Loss Carryforwards [Line Items]", "label": "Operating Loss Carryforwards [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r301" ] }, "us-gaap_OperatingLossCarryforwardsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OperatingLossCarryforwardsTable", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Loss Carryforwards [Table]", "label": "Operating Loss Carryforwards [Table]", "documentation": "Disclosure of information about operating loss carryforward. Includes, but is not limited to, tax authority, amount and expiration date of operating loss carryforward, and likelihood of utilization." } } }, "auth_ref": [ "r301" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureNatureOfOperationsAndFinancialStatementPresentation" ], "lang": { "en-us": { "role": { "terseLabel": "Nature of Operations and Financial Statement Presentation", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r36", "r85", "r402", "r403" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureAdditionalBalanceSheetInformationScheduleOfAdditionalInformationRelatedToTheCondensedConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Current", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r39" ] }, "us-gaap_OtherAccruedLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAccruedLiabilitiesNoncurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureAdditionalBalanceSheetInformationScheduleOfAdditionalInformationRelatedToTheCondensedConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Accrued Liabilities, Noncurrent", "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r41" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Other Assets, Noncurrent, Total", "terseLabel": "Other non-current assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r109" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent, Total", "terseLabel": "Unrealized translation adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r3", "r7", "r86" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Unrealized foreign currency translation adjustments", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax", "documentation": "Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r2", "r50", "r51", "r52", "r335", "r336", "r338" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss):", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherExpenses", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other charges, net", "label": "Other Expenses", "documentation": "Amount of expense classified as other." } } }, "auth_ref": [ "r60", "r61" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureAdditionalBalanceSheetInformationScheduleOfAdditionalInformationRelatedToTheCondensedConsolidatedBalanceSheetsDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "terseLabel": "Other non-current liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r41" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense), net", "negatedLabel": "Other income (expense), net", "totalLabel": "Other Nonoperating Income (Expense), Total", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r62" ] }, "us-gaap_PaymentsForProceedsFromLifeInsurancePolicies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsForProceedsFromLifeInsurancePolicies", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Payments for (Proceeds from) Life Insurance Policies, Total", "negatedLabel": "Additional investments in corporate-owned life insurance policies", "label": "Payments for (Proceeds from) Life Insurance Policies", "documentation": "The net cash outflow or inflow for net proceeds and payments derived from carrying life insurance policies for which the entity is the beneficiary." } } }, "auth_ref": [] }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of preferred stock dividends", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity." } } }, "auth_ref": [ "r64" ] }, "us-gaap_PaymentsOfStockIssuanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsOfStockIssuanceCosts", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Payments of stock issuance costs", "label": "Payments of Stock Issuance Costs", "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security." } } }, "auth_ref": [ "r14" ] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "negatedLabel": "Repurchase of common shares to satisfy employee tax withholding", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r128" ] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Payments to Acquire Productive Assets, Total", "negatedLabel": "Capital expenditures", "label": "Payments to Acquire Productive Assets", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r97", "r619", "r620", "r621" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureAdditionalBalanceSheetInformationScheduleOfAdditionalInformationRelatedToTheCondensedConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Liability, Defined Benefit Plan, Noncurrent, Total", "terseLabel": "Employee benefit obligations", "label": "Liability, Defined Benefit Plan, Noncurrent", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent." } } }, "auth_ref": [ "r41", "r240", "r241", "r242", "r512" ] }, "agys_PercentageOfDeferralOfEmployerPaidPortionOfSocialSecurityTaxesDueInYearTwo": { "xbrltype": "percentItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "PercentageOfDeferralOfEmployerPaidPortionOfSocialSecurityTaxesDueInYearTwo", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of deferral of the employer-paid portion of social security taxes due in December 31, 2022", "label": "Percentage Of Deferral Of Employer Paid Portion Of Social Security Taxes Due In Year Two", "documentation": "Percentage of deferral of the employer-paid portion of social security taxes due in year two." } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PerformanceSharesMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Share [Member]", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name", "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PlanNameDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Plan Name", "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r590", "r591", "r592", "r593", "r594", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615" ] }, "us-gaap_PreferredStockDividendRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockDividendRatePercentage", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock Dividend Rate Percentage", "label": "Preferred Stock, Dividend Rate, Percentage", "documentation": "The percentage rate used to calculate dividend payments on preferred stock." } } }, "auth_ref": [ "r217", "r476", "r478", "r479", "r483" ] }, "us-gaap_PreferredStockNoParValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockNoParValue", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value", "label": "Preferred Stock, No Par Value", "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r43", "r587" ] }, "us-gaap_PreferredStockTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStock" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred Stock", "label": "Preferred Stock [Text Block]", "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock." } } }, "auth_ref": [ "r73" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PreferredStockValue", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Series A convertible preferred stock, par value", "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance", "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance", "totalLabel": "Preferred Stock, Value, Issued, Total", "terseLabel": "Series A convertible preferred stock, no par value", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r43", "r370", "r523" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r551" ] }, "agys_ProductDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ProductDevelopmentMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product development [Member]", "label": "Product Development [Member]", "documentation": "Product development." } } }, "auth_ref": [] }, "us-gaap_ProductMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ProductMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Products [Member]", "label": "Product [Member]", "documentation": "Article or substance produced by nature, labor or machinery." } } }, "auth_ref": [ "r505" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service", "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r179", "r360", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r493", "r505", "r524", "r525", "r526", "r527", "r528", "r582", "r583", "r589", "r637", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service", "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r179", "r360", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r493", "r505", "r524", "r525", "r526", "r527", "r528", "r582", "r583", "r589", "r637", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656", "r657", "r658", "r659", "r660", "r661", "r662", "r663", "r664", "r665", "r666" ] }, "agys_ProfessionalServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ProfessionalServicesMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Professional services [Member]", "label": "Professional Services [Member]", "documentation": "Professional Services [Member]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance", "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance", "totalLabel": "Property, Plant and Equipment, Net, Total", "terseLabel": "Property and equipment, net", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r6", "r353", "r365", "r376", "r523" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r202", "r203", "r204", "r205", "r243", "r245", "r274", "r275", "r276", "r284", "r330", "r357", "r358", "r359", "r391", "r393", "r401", "r423", "r424", "r475", "r477", "r480", "r481", "r482", "r490", "r491", "r500", "r503", "r513", "r519", "r520", "r521", "r522", "r525", "r531", "r579", "r586", "r623", "r630", "r631", "r632", "r633", "r634" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "RangeMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r202", "r203", "r204", "r205", "r243", "r245", "r274", "r275", "r276", "r284", "r330", "r357", "r358", "r359", "r391", "r393", "r401", "r423", "r424", "r475", "r477", "r480", "r481", "r482", "r490", "r491", "r500", "r503", "r513", "r519", "r520", "r521", "r522", "r525", "r531", "r579", "r586", "r623", "r630", "r631", "r632", "r633", "r634" ] }, "agys_RegularCorporateIncomeTaxRateIndia": { "xbrltype": "percentItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "RegularCorporateIncomeTaxRateIndia", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Regular corporate income tax rate in India", "label": "Regular Corporate Income Tax Rate India", "documentation": "Regular corporate income tax rate in India." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related and Nonrelated Parties [Domain]", "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r182", "r244", "r355", "r356", "r368", "r375", "r426", "r427", "r428", "r429", "r430", "r449", "r451", "r474" ] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Related Party", "label": "Related and Nonrelated Parties [Axis]", "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest." } } }, "auth_ref": [ "r182", "r244", "r355", "r356", "r368", "r375", "r426", "r427", "r428", "r429", "r430", "r449", "r451", "r474", "r626" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Repayments of Long-term Debt, Total", "negatedLabel": "Principal payments under long-term obligations", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r65", "r408" ] }, "agys_RepurchasesOfSharesToSatisfyEmployeeTaxWithholding": { "xbrltype": "monetaryItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "RepurchasesOfSharesToSatisfyEmployeeTaxWithholding", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "label": "Repurchases Of Shares To Satisfy Employee Tax Withholding", "documentation": "Repurchases of shares to satisfy employee tax withholding.", "terseLabel": "Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares", "negatedLabel": "Shares withheld for taxes upon exercise of SSARs or vesting of restricted shares" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Research and Development Expense, Total", "terseLabel": "Product development", "label": "Research and Development Expense", "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity." } } }, "auth_ref": [ "r285", "r492", "r498", "r635" ] }, "us-gaap_RestrictedStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock [Member]", "label": "Restricted Stock [Member]", "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met." } } }, "auth_ref": [ "r20" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units [Member]", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance", "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance", "totalLabel": "Retained Earnings (Accumulated Deficit), Total", "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r46", "r76", "r373", "r398", "r400", "r409", "r433", "r523" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RetainedEarningsMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings [Member]", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r103", "r135", "r136", "r137", "r139", "r144", "r146", "r148", "r185", "r186", "r196", "r302", "r303", "r309", "r310", "r311", "r313", "r315", "r316", "r321", "r323", "r324", "r326", "r327", "r346", "r347", "r395", "r397", "r411", "r669" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Revenue from Contract with Customer, Excluding Assessed Tax, Total", "terseLabel": "Total net revenue", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r93", "r94", "r165", "r170", "r171", "r176", "r178", "r179", "r180", "r181", "r235", "r236", "r360" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognition" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r101", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r239" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "RevenuesAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Net revenue:", "label": "Revenues [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfPrincipalAssumptionsUtilizedInValuingServiceConditionSarsDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_SalesCommissionsAndFees": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SalesCommissionsAndFees", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales commissions and fees", "label": "Sales Commissions and Fees", "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller)." } } }, "auth_ref": [ "r60" ] }, "srt_ScenarioForecastMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScenarioForecastMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Forcast [Member]", "label": "Forecast [Member]" } } }, "auth_ref": [ "r246", "r562" ] }, "srt_ScenarioUnspecifiedDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "ScenarioUnspecifiedDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "auth_ref": [ "r149", "r246", "r546", "r562" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureAdditionalBalanceSheetInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Additional Information Related to the Condensed Consolidated Balance Sheets", "label": "Schedule of Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSupplementalDisclosuresOfCashFlowInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of supplemental cash flow information", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of amounts used in computing earnings per share and the effect on earnings and the weighted average number of shares of dilutive potential common shares", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r565" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Effective tax rates from continuing operations", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r292", "r516", "r617" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]", "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements." } } }, "auth_ref": [ "r31" ] }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Summary of share-based compensation expense", "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]", "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement." } } }, "auth_ref": [ "r31" ] }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureBusinessCombinationTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree." } } }, "auth_ref": [ "r84" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2", "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfPrincipalAssumptionsUtilizedInValuingServiceConditionSarsDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r248", "r250", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277" ] }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Activity related to restricted shares awarded by the Company", "label": "Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]", "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year." } } }, "auth_ref": [ "r77" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Activity related SSARs award", "label": "Share-Based Payment Arrangement, Option and Stock Appreciation Rights, Activity [Table Text Block]", "documentation": "Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year." } } }, "auth_ref": [ "r77" ] }, "agys_ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ScheduleOfShareBasedPaymentAwardStockAppreciationRightsValuationAssumptionsTableTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "documentation": "Schedule of Share-based Payment Award, Stock Appreciation Rights, Valuation Assumptions [Table Text Block]", "label": "Schedule Of Share Based Payment Award Stock Appreciation Rights Valuation Assumptions Table [Text Block]", "terseLabel": "Schedule of principal assumptions utilized in valuing service condition SARs" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule Of Stock By Class [Table]", "label": "Stock, Class of Stock [Table]", "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks." } } }, "auth_ref": [ "r22", "r23", "r24", "r25", "r26", "r27", "r72", "r74", "r75", "r76", "r111", "r112", "r113", "r167", "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r405", "r406", "r407", "r408", "r503", "r545", "r556" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r539" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r541" ] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingAndMarketingExpense", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Selling and Marketing Expense, Total", "terseLabel": "Sales and marketing", "label": "Selling and Marketing Expense", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "us-gaap_SellingAndMarketingExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingAndMarketingExpenseMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and marketing [Member]", "label": "Selling and Marketing Expense [Member]", "documentation": "Primary financial statement caption encompassing selling and marketing expense." } } }, "auth_ref": [ "r60" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total operating expense", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r60" ] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Series A Preferred Stock [Member]", "terseLabel": "Series A Convertible Preferred Stock [Member]", "label": "Series A Preferred Stock [Member]", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r549", "r550", "r588" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total", "verboseLabel": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ShareBasedCompensationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]" } } }, "auth_ref": [] }, "agys_ShareBasedCompensationAmountsWithheldFromParticipants": { "xbrltype": "monetaryItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationAmountsWithheldFromParticipants", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts withheld from participants", "label": "Share Based Compensation Amounts Withheld from Participants", "documentation": "Share based compensation amounts withheld from participants." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Shares, Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r268" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Grant Date Fair Value, Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r268" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Shares, Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r266" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Grant Date Fair Value, Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r266" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Shares, Outstanding at beginning of period", "periodEndLabel": "Number of Shares, Outstanding at end of period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r263", "r264" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfPrincipalAssumptionsUtilizedInValuingServiceConditionSarsDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average grant date fair value (in dollars per share)", "periodStartLabel": "Weighted Average Grant-Date Fair Value, Outstanding at beginning of period", "periodEndLabel": "Weighted Average Grant-Date Fair Value, Outstanding at end of period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r263", "r264" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining Contractual Term, Outstanding at End of Period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms", "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r82" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Shares, Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r267" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Share-based compensation, grant date fair value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value", "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash." } } }, "auth_ref": [ "r270" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Grant Date Fair Value, Vested", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r267" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfPrincipalAssumptionsUtilizedInValuingServiceConditionSarsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected volatility", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r274" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfPrincipalAssumptionsUtilizedInValuingServiceConditionSarsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Risk-free interest rate over contractual term", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r276" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2", "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfPrincipalAssumptionsUtilizedInValuingServiceConditionSarsDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r248", "r250", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277" ] }, "agys_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable": { "xbrltype": "sharesItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisable", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Rights, Exercisable at End of Period", "label": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable", "documentation": "Share based compensation arrangement by share based payment award non option equity instruments exercisable." } } }, "auth_ref": [] }, "agys_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Exercisable at End of Period", "label": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Aggregate Intrinsic Value", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Aggregate Intrinsic Value." } } }, "auth_ref": [] }, "agys_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price, Exercisable at End of Period", "label": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Rights, Exercised", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "documentation": "Number of non-option equity instruments exercised by participants." } } }, "auth_ref": [ "r10" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Rights, Expired", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Expirations", "documentation": "Number of shares under non-option equity instrument agreements for which rights to exercise lapsed." } } }, "auth_ref": [ "r81" ] }, "agys_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price, Expired", "label": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations In Period Weighted Average Exercise Price", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations In Period Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of Rights, Forfeited", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures", "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event." } } }, "auth_ref": [ "r80" ] }, "agys_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price, Forfeited", "label": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures In Period Weighted Average Exercise Price", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures In Period Weighted Average Exercise Price" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Rights, Granted", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted", "documentation": "Net number of non-option equity instruments granted to participants." } } }, "auth_ref": [ "r9" ] }, "agys_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Outstanding at End of Period", "label": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value", "documentation": "Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of Rights, Outstanding at Beginning of Period", "periodEndLabel": "Number of Rights, Outstanding at End of Period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments." } } }, "auth_ref": [ "r78", "r79" ] }, "agys_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted Average Exercise Price, Outstanding at Beginning of Period", "periodEndLabel": "Weighted Average Exercise Price, Outstanding at End of Period", "label": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price", "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Shares authorized under 2020 Equity incentive plan", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r515" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Shares available for grant", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r30" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Intrinsic Value, Vested and expected to vest at End of Period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r271" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Number of Rights, Vested and expected to vest at June 30, 2024", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number", "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r271" ] }, "agys_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageExerciseNumber": { "xbrltype": "perShareItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageExerciseNumber", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price, Vested and expected to vest at End of Period", "documentation": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestWeightedAverageExerciseNumber", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Weighted Average Exercise Number" } } }, "auth_ref": [] }, "agys_ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExpectedToVestOutstandingRemainingContractualTerm": { "xbrltype": "durationItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardVestedAndExpectedToVestOutstandingRemainingContractualTerm", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Remaining Contractual Term, Exercisable at End of Period", "label": "Share Based Compensation Arrangement By Share Based Payment Award Vested And Expected To Vest Outstanding Remaining Contractual Term", "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Vested and Expected to Vest, Outstanding, Remaining Contractual Term" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationRestrictedSharesRollforwardDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "All Award Types", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277" ] }, "agys_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price, Exercised", "label": "Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price", "documentation": "Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price" } } }, "auth_ref": [] }, "agys_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted Average Exercise Price, Granted", "label": "Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price", "documentation": "Share Based Compensation Arrangements By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price" } } }, "auth_ref": [] }, "agys_ShareIssuedUponExerciseOfSsars": { "xbrltype": "sharesItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "ShareIssuedUponExerciseOfSsars", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued upon exercise of SSARs ( in shares)", "label": "Share Issued Upon Exercise of SSARs", "documentation": "Share issued upon exercise of SSARs" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfPrincipalAssumptionsUtilizedInValuingServiceConditionSarsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Expected term (in years)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r273" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2" ], "lang": { "en-us": { "role": { "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award Vested And Expected To Vest Outstanding Remaining Contractual Term", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term", "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r271" ] }, "agys_SharesIssuedUponExerciseOfSsars": { "xbrltype": "monetaryItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "SharesIssuedUponExerciseOfSsars", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued upon exercise of SSARs", "label": "Shares Issued Upon Exercise of SSARs", "documentation": "Shares issued upon exercise of SSARs", "negatedLabel": "Shares issued upon exercise of SSARs" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SharesOutstanding", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Recently Issued Accounting Pronouncements", "terseLabel": "Summary of Significant Accounting Policies", "label": "Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r69", "r132" ] }, "us-gaap_StateAndLocalJurisdictionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StateAndLocalJurisdictionMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "State and Local Jurisdiction [Member]", "label": "State and Local Jurisdiction [Member]", "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax." } } }, "auth_ref": [ "r290" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r102", "r111", "r112", "r113", "r133", "r154", "r155", "r158", "r160", "r167", "r168", "r184", "r206", "r208", "r209", "r210", "r213", "r214", "r216", "r217", "r219", "r220", "r222", "r334", "r405", "r406", "r407", "r408", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r432", "r453", "r471", "r484", "r485", "r486", "r487", "r488", "r545", "r556", "r564" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r8", "r44", "r47", "r48", "r103", "r122", "r123", "r124", "r135", "r136", "r137", "r139", "r144", "r146", "r148", "r166", "r185", "r186", "r196", "r223", "r302", "r303", "r309", "r310", "r311", "r313", "r315", "r316", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r339", "r340", "r341", "r342", "r343", "r344", "r346", "r347", "r354", "r379", "r395", "r396", "r397", "r411", "r471" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r135", "r136", "r137", "r166", "r347", "r360", "r404", "r422", "r425", "r426", "r427", "r428", "r429", "r430", "r432", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r445", "r446", "r447", "r448", "r449", "r451", "r454", "r455", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r471", "r532" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "srt_StatementScenarioAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "StatementScenarioAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "auth_ref": [ "r149", "r246", "r546", "r547", "r562" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r135", "r136", "r137", "r166", "r182", "r347", "r360", "r404", "r422", "r425", "r426", "r427", "r428", "r429", "r430", "r432", "r435", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r445", "r446", "r447", "r448", "r449", "r451", "r454", "r455", "r457", "r458", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r471", "r532" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationDetails2", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock Settled Appreciation Rights (SSARs) [Member]", "terseLabel": "Stock Settled Appreciation Rights (SSARs) [Member]", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "agys_StockBasedCompensationTextualAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "StockBasedCompensationTextualAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Based Compensation (Textual) [Abstract]", "label": "Stock Based Compensation Textual [Abstract]", "documentation": "Stock based compensation." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "verboseLabel": "Conversion of Series A preferred stock (in shares)", "terseLabel": "Preferred stock issued", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities." } } }, "auth_ref": [ "r8", "r24", "r44", "r47", "r76", "r215" ] }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Common Shares Issued under Employee Stock Purchase Plan", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan." } } }, "auth_ref": [ "r8", "r43", "r44", "r76" ] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total", "terseLabel": "Restricted shares issued, net (in shares)", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "negatedLabel": "Restricted shares issued, net (in shares)", "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited." } } }, "auth_ref": [ "r8", "r43", "r44", "r76" ] }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosurePreferredStockDetailsTextual" ], "lang": { "en-us": { "role": { "verboseLabel": "Conversion of preferred stock", "terseLabel": "Preferred stock issued, value", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities." } } }, "auth_ref": [ "r8", "r44", "r47", "r48", "r76" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures, Total", "terseLabel": "Restricted shares issued, net", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited." } } }, "auth_ref": [ "r8", "r76" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquity", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Total shareholders' equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r44", "r47", "r48", "r70", "r434", "r450", "r472", "r473", "r523", "r538", "r557", "r573", "r624", "r669" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders' equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "agys_SubscriptionAndMaintenanceMember": { "xbrltype": "domainItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "SubscriptionAndMaintenanceMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "documentation": "Subscription and maintenance.", "label": "Subscription And Maintenance Member", "terseLabel": "Subscription and maintenance [Member]" } } }, "auth_ref": [] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureSharebasedCompensationScheduleOfPrincipalAssumptionsUtilizedInValuingServiceConditionSarsDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual", "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationTables" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureAdditionalBalanceSheetInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Balance Sheet Information", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity." } } }, "auth_ref": [ "r548" ] }, "us-gaap_SupplementalCashFlowElementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SupplementalCashFlowElementsAbstract", "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]" } } }, "auth_ref": [] }, "agys_SupportMaintenanceSubscriptionServicesAndProfessionalServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "SupportMaintenanceSubscriptionServicesAndProfessionalServicesMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureRevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Support, Maintenance, Subscription Services, and Professional Services [Member]", "label": "Support Maintenance Subscription Services And Professional Services [Member]", "documentation": "Support, Maintenance, Subscription Services, And Professional Services [Member]" } } }, "auth_ref": [] }, "us-gaap_TaxesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TaxesPayableCurrent", "crdr": "credit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/DisclosureAdditionalBalanceSheetInformationScheduleOfAdditionalInformationRelatedToTheCondensedConsolidatedBalanceSheetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Income and indirect taxes payable", "totalLabel": "Taxes Payable, Current, Total", "label": "Taxes Payable, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r38", "r39" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual", "label": "Title and Position [Axis]" } } }, "auth_ref": [ "r571", "r625" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2024", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual", "label": "Title and Position [Domain]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfShareholdersEquityUnaudited" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury stock [Member]", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r28" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury shares", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r28" ] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "TreasuryStockValue", "crdr": "debit", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury shares, 5,469,903 and 5,965,426 at June 30, 2024 and March 31, 2024, respectively", "periodEndLabel": "Treasury Stock, Value, Ending Balance", "periodStartLabel": "Treasury Stock, Value, Beginning Balance", "totalLabel": "Treasury Stock, Value, Total", "label": "Treasury Stock, Value", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r28", "r29", "r44", "r47" ] }, "agys_TwoThousandAndSixteenStockIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "TwoThousandAndSixteenStockIncentivePlanMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Two Thousand and Sixteen Stock Incentive Plan [Member]", "verboseLabel": "Two Thousand and Sixteen Stock Incentive Plan [Member]", "label": "Two Thousand And Sixteen Stock Incentive Plan [Member]", "documentation": "Two Thousand and Sixteen Stock Incentive Plan" } } }, "auth_ref": [] }, "agys_TwoThousandAndTwentyEquityIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "TwoThousandAndTwentyEquityIncentivePlanMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureShareBasedCompensationDetailsTextual" ], "lang": { "en-us": { "role": { "verboseLabel": "Two Thousand and Twenty Equity Incentive Plan [Member]", "label": "Two Thousand and Twenty Equity Incentive Plan [Member]", "documentation": "Two thousand and twenty equity incentive plan member." } } }, "auth_ref": [] }, "us-gaap_UnusualRiskOrUncertaintyByNatureAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnusualRiskOrUncertaintyByNatureAxis", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual Risk or Uncertainty, Nature", "label": "Unusual Risk or Uncertainty, Nature [Axis]", "documentation": "Information by nature of risk and uncertainty, for example, but not limited to, threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost." } } }, "auth_ref": [] }, "us-gaap_UnusualRiskOrUncertaintyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "UnusualRiskOrUncertaintyNatureDomain", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "Unusual Risk or Uncertainty, Nature", "label": "Unusual Risk or Uncertainty, Nature [Domain]", "documentation": "Describes the nature of the unusual risk or uncertainty, such as the threat of expropriation of its assets by a foreign government, rapid technological obsolescence in the industry, risk of natural disaster from earthquake or weather events, and availability of or continuation of a labor force at a reasonable cost." } } }, "auth_ref": [] }, "agys_UsStateStatutesOfLimitationsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.agilysys.com/20240630", "localname": "UsStateStatutesOfLimitationsMember", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureIncomeTaxesDetailsTextual" ], "lang": { "en-us": { "role": { "terseLabel": "US State Statutes of Limitations [Member]", "label": "US State Statutes of Limitations [Member]", "documentation": "US state statutes of limitations member" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Weighted Average Number Diluted Shares Outstanding Adjustment, Total", "terseLabel": "Dilutive unvested restricted shares", "label": "Weighted Average Number of Shares Outstanding, Diluted, Adjustment", "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation." } } }, "auth_ref": [ "r565" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Weighted average shares outstanding - diluted", "terseLabel": "Weighted average shares outstanding - diluted", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r153", "r160" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://www.agilysys.com/20240630/taxonomy/role/Role_DisclosureEarningsPerShareDetails", "http://www.agilysys.com/20240630/taxonomy/role/Role_StatementCondensedConsolidatedStatementsOfOperationsUnaudited" ], "lang": { "en-us": { "role": { "totalLabel": "Weighted Average Number of Shares Outstanding, Basic, Total", "terseLabel": "Weighted average shares outstanding - basic", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r151", "r160" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-18" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "505", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477908/944-505-50-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/230/tableOfContent" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/235/tableOfContent" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/440/tableOfContent" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "480", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/505/tableOfContent" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/805/tableOfContent" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "a", "Publisher": "SEC" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/260/tableOfContent" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-24" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479483/340-40-50-3" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "340", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479483/340-40-50-3" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "405", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-2" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480535/715-20-45-3" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/718/tableOfContent" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1D", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/740/tableOfContent" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12B", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "23", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "323", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-9" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-3" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-12" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483013/835-20-50-1" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "12A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.W.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "985", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H" }, "r494": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52" }, "r497": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31" }, "r498": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48" }, "r499": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "49", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49" }, "r500": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A" }, "r501": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24" }, "r502": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40" }, "r503": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r504": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10" }, "r505": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r506": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r507": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r508": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r509": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r510": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r511": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91" }, "r512": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17" }, "r513": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8" }, "r514": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r515": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r516": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "231", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231" }, "r517": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "100", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100" }, "r518": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "102", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102" }, "r519": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "103", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103" }, "r520": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r521": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r522": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "107", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107" }, "r523": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10" }, "r524": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2" }, "r525": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F" }, "r526": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C" }, "r527": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9E", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E" }, "r528": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18" }, "r529": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6" }, "r531": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2" }, "r535": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3" }, "r536": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6" }, "r537": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10" }, "r538": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12" }, "r539": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r540": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r541": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r543": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r545": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3" }, "r546": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10" }, "r547": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3" }, "r548": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/210/tableOfContent" }, "r549": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r550": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r551": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1" }, "r552": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4" }, "r553": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5" }, "r554": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6" }, "r555": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r556": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r557": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r558": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r559": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23" }, "r560": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24" }, "r561": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5" }, "r562": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4" }, "r563": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6" }, "r564": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55" }, "r565": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1" }, "r566": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "270", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1" }, "r567": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22" }, "r568": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30" }, "r569": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(ee)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r570": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32" }, "r571": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13" }, "r572": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2" }, "r573": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3" }, "r574": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r575": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1" }, "r576": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r577": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2" }, "r578": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "405", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/405-30/tableOfContent" }, "r579": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10" }, "r580": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/450/tableOfContent" }, "r581": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1" }, "r582": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9" }, "r583": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1" }, "r584": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r585": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A" }, "r586": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B" }, "r587": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13" }, "r588": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2" }, "r589": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5" }, "r590": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r591": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r592": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r593": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r594": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r595": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r596": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r597": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r599": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r600": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r601": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r602": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r603": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r604": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r605": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r606": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r607": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r608": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r609": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r610": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r611": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r612": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r613": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r614": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r615": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r616": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r617": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12" }, "r618": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "805", "SubTopic": "50", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4G", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B" }, "r665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2" }, "r667": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4" }, "r668": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1" }, "r669": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" }, "r670": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3" } } } ZIP 52 0000950170-24-086879-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-086879-xbrl.zip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end XML 53 agys-20240630_htm.xml IDEA: XBRL DOCUMENT 0000078749 agys:ProfessionalServicesMember 2024-04-01 2024-06-30 0000078749 us-gaap:StockAppreciationRightsSARSMember 2024-04-01 2024-06-30 0000078749 srt:MaximumMember agys:TwoThousandAndTwentyEquityIncentivePlanMember us-gaap:CommonStockMember 2024-06-30 0000078749 us-gaap:RetainedEarningsMember 2024-03-31 0000078749 2023-04-01 2023-06-30 0000078749 srt:ChiefExecutiveOfficerMember us-gaap:PerformanceSharesMember 2024-04-01 2024-06-30 0000078749 us-gaap:RestrictedStockUnitsRSUMember 2024-04-01 2024-06-30 0000078749 srt:MaximumMember agys:TwoThousandAndTwentyEquityIncentivePlanMember us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000078749 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000078749 us-gaap:SellingAndMarketingExpenseMember 2023-04-01 2023-06-30 0000078749 2023-06-30 0000078749 us-gaap:RestrictedStockMember 2024-04-01 2024-06-30 0000078749 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0000078749 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000078749 2024-06-30 0000078749 us-gaap:SellingAndMarketingExpenseMember 2024-04-01 2024-06-30 0000078749 2024-04-01 2024-06-30 0000078749 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000078749 us-gaap:CommonStockMember 2023-03-31 0000078749 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000078749 2023-04-01 2023-12-31 0000078749 us-gaap:EmployeeStockMember 2024-04-01 2024-06-30 0000078749 us-gaap:ProductMember 2024-04-01 2024-06-30 0000078749 us-gaap:RestrictedStockUnitsRSUMember 2024-06-30 0000078749 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000078749 us-gaap:SeriesAPreferredStockMember 2024-06-30 0000078749 us-gaap:GeneralAndAdministrativeExpenseMember 2023-04-01 2023-06-30 0000078749 us-gaap:GeneralAndAdministrativeExpenseMember 2024-04-01 2024-06-30 0000078749 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0000078749 agys:TwoThousandAndTwentyEquityIncentivePlanMember 2024-06-30 0000078749 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000078749 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000078749 us-gaap:CommonStockMember 2023-06-30 0000078749 srt:ChiefExecutiveOfficerMember us-gaap:PerformanceSharesMember 2024-06-30 0000078749 agys:ProductDevelopmentMember 2023-04-01 2023-06-30 0000078749 us-gaap:RetainedEarningsMember 2023-06-30 0000078749 us-gaap:CommonStockMember 2024-06-30 0000078749 us-gaap:TreasuryStockCommonMember 2024-03-31 0000078749 us-gaap:RetainedEarningsMember 2023-03-31 0000078749 us-gaap:TreasuryStockCommonMember 2023-03-31 0000078749 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000078749 us-gaap:RestrictedStockMember 2024-06-30 0000078749 us-gaap:RestrictedStockMember 2024-03-31 0000078749 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000078749 us-gaap:CommonStockMember 2024-03-31 0000078749 agys:SupportMaintenanceSubscriptionServicesAndProfessionalServicesMember 2024-04-01 2024-06-30 0000078749 agys:ProductDevelopmentMember 2024-04-01 2024-06-30 0000078749 us-gaap:RetainedEarningsMember 2024-06-30 0000078749 us-gaap:StockAppreciationRightsSARSMember 2024-06-30 0000078749 us-gaap:MajorityShareholderMember us-gaap:ConvertiblePreferredStockMember 2020-05-22 2020-05-22 0000078749 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0000078749 2024-03-31 0000078749 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0000078749 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0000078749 us-gaap:StockAppreciationRightsSARSMember 2024-03-31 0000078749 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000078749 2023-03-31 0000078749 agys:TwoThousandAndSixteenStockIncentivePlanMember us-gaap:CommonStockMember 2024-06-30 0000078749 agys:SubscriptionAndMaintenanceMember 2023-04-01 2023-06-30 0000078749 agys:ProfessionalServicesMember 2023-04-01 2023-06-30 0000078749 us-gaap:TreasuryStockCommonMember 2023-06-30 0000078749 2024-07-19 0000078749 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000078749 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0000078749 us-gaap:EmployeeStockMember 2024-06-30 0000078749 us-gaap:EmployeeStockMember 2024-06-30 2024-06-30 0000078749 agys:SubscriptionAndMaintenanceMember 2024-04-01 2024-06-30 0000078749 us-gaap:ProductMember 2023-04-01 2023-06-30 0000078749 agys:SupportMaintenanceSubscriptionServicesAndProfessionalServicesMember 2023-04-01 2023-06-30 0000078749 us-gaap:TreasuryStockCommonMember 2024-06-30 pure iso4217:USD shares shares iso4217:USD false 0000078749 Q1 --03-31 2024 10-Q true 2024-06-30 2024 false 000-5734 AGILYSYS, INC. DE 34-0907152 3655 Brookside Parkway Suite 300 Alpharetta GA 30022 770 810-7800 Common Stock, without par value AGYS NASDAQ Yes Yes Large Accelerated Filer false false false 27881838 144111000 144891000 944000 974000 27308000 29441000 3523000 2287000 5300000 4587000 6523000 7731000 186765000 188937000 17663000 17930000 17843000 18384000 32659000 32791000 16706000 16952000 76237000 67373000 7825000 8063000 355698000 350430000 10085000 9422000 49200000 56148000 13127000 19522000 4992000 4279000 77404000 89371000 549000 554000 18903000 19613000 4671000 4415000 0.3 0.3 80000000 80000000 33342288 33342288 27872345 27376862 10003000 10003000 5469903 5965426 1642000 1791000 98277000 94680000 151861000 137755000 -4328000 -4170000 254171000 236477000 355698000 350430000 9874000 12781000 38043000 32125000 15595000 11153000 63512000 56059000 5226000 6565000 8108000 7637000 10310000 8800000 23644000 23002000 39868000 33057000 0.628 0.59 14720000 13321000 7014000 7301000 10483000 9365000 838000 923000 251000 430000 550000 759000 -265000 -0 34121000 32099000 5747000 958000 1782000 1101000 -157000 -159000 7372000 1900000 -6734000 352000 14106000 1548000 0 -459000 14106000 1089000 27134000 24936000 0.52 0.04 28127000 26177000 0.5 0.04 14106000 1548000 -158000 523000 13948000 2071000 14106000 1548000 838000 923000 251000 430000 -8861000 -129000 4429000 3167000 9665000 5917000 1098000 22000 869000 3065000 0 2000 -869000 -3067000 0 918000 925000 1783000 0 1000 -925000 -2702000 -84000 -2000 -780000 -5749000 144891000 112842000 144111000 107093000 33342 10003000 -5965 -1791000 94680000 137755000 -4170000 236477000 4850000 4850000 11 3000 -3000 498 -150000 150000 14 4000 1100000 1104000 14106000 14106000 -158000 -158000 33342 10003000 -5470 -1642000 98277000 151861000 -4328000 254171000 31607 9482000 -6280 -1884000 52978000 52764000 -4030000 109310000 3377000 3377000 12 3000 -3000 50 -15000 15000 37 11000 2602000 2613000 1548000 1548000 -459000 -459000 523000 523000 31607 9482000 -6255 -1877000 53735000 53853000 -3507000 111686000 <p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">1. Nature of Operations and Financial Statement Presentation</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Nature of Operations</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Agilysys has been a leader in hospitality software for more than 45 years, delivering innovative cloud-native SaaS and on-premise solutions for hotels, resorts and cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare. The Company’s software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. Agilysys also is known for its world-class customer-centric service. Many of the top hospitality companies around the world use Agilysys solutions to improve guest loyalty, drive revenue growth, and increase operational efficiencies. Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India, with headquarters in Alpharetta, GA.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The Company has just one reportable segment serving the global hospitality industry.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Basis of Presentation</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The accompanying unaudited Condensed Consolidated Financial Statements include our accounts consolidated with our wholly-owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Our fiscal year ends on March 31st. References to a particular year refer to the fiscal year ending in March of that year. For example, fiscal 2025 refers to the fiscal year ending March 31, 2025.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Our unaudited interim financial statements are prepared in accordance with U.S. generally accepted accounting principles (GAAP) for interim financial information, the instructions to the Quarterly Report on Form 10-Q (Quarterly Report) under the Securities Exchange Act of 1934, as amended (the Exchange Act), and Rule 10-01 of Regulation S-X under the Exchange Act. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations relating to interim financial statements.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The Condensed Consolidated Balance Sheet as of June 30, 2024, as well as the Condensed Consolidated Statements of Operations, Condensed Consolidated Statements of Comprehensive Income, Condensed Consolidated Statements of Cash Flows, and Condensed Consolidated Statements of Shareholders’ Equity for the three months ended June 30, 2024 and 2023, are unaudited. However, these financial statements have been prepared on the same basis as those in the audited annual financial statements. In the opinion of management, all adjustments of a recurring nature necessary to fairly state the results of operations, financial position, and cash flows have been made.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">These unaudited interim financial statements should be read together with the consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended March 31, 2024, filed with the Securities and Exchange Commission (SEC) on May 22, 2024.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that may affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported periods. Actual results could differ from those estimates.</span></p> <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2. Summary of Significant Accounting Policies</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">A detailed description of our significant accounting policies can be found in the audited financial statements for the fiscal year ended March 31, 2024, included in our Annual Report on Form 10-K. There have been no material changes to our significant accounting policies from those disclosed therein.</span></p><div style="font-size:10pt;font-family:'Proxima Nova',sans-serif;"><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Recently Issued Accounting Pronouncements</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(“ASU 2023-09”) to update income tax</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments in the ASU also remove disclosures related to certain unrecognized tax benefits and deferred taxes. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, or our fiscal 2026. The amendments may be applied prospectively or retrospectively with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">In November 2023, the FASB issued ASU No. 2023-07 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> (“ASU 2023-07”) to expand reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 applies to entities with a single reportable segment. Annual disclosures are required for fiscal years beginning after December 15, 2023 or our fiscal 2025. Interim disclosures are required for periods within fiscal years beginning after December 15, 2024, or our fiscal 2026. Retrospective application is required for all prior periods presented with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.</span></p></div> <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Recently Issued Accounting Pronouncements</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2023-09 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Income Taxes (Topic 740): Improvements to Income Tax Disclosures </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(“ASU 2023-09”) to update income tax</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">disclosure requirements primarily by requiring specific categories and greater disaggregation within the rate reconciliation and disaggregation of income taxes paid by jurisdiction. The amendments in the ASU also remove disclosures related to certain unrecognized tax benefits and deferred taxes. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, or our fiscal 2026. The amendments may be applied prospectively or retrospectively with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">In November 2023, the FASB issued ASU No. 2023-07 </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> (“ASU 2023-07”) to expand reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The amendments in the ASU require that a public entity disclose, on an annual and interim basis, significant segment expenses that are regularly provided to an entity's chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and any additional measures of a segment's profit or loss used by the CODM when deciding how to allocate resources. ASU 2023-07 applies to entities with a single reportable segment. Annual disclosures are required for fiscal years beginning after December 15, 2023 or our fiscal 2025. Interim disclosures are required for periods within fiscal years beginning after December 15, 2024, or our fiscal 2026. Retrospective application is required for all prior periods presented with early adoption is permitted. We are currently assessing the impact of the requirements on our consolidated financial statements and disclosures.</span></p> <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">3. Revenue Recognition</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Our customary business practice is to enter into legally enforceable written contracts with our customers. The majority of our contracts are governed by a master service agreement between us and the customer, which sets forth the general terms and conditions of any individual contract between the parties, which is then supplemented by a customer order to specify the different goods and services, the associated prices, and any additional terms for an individual contract. Performance obligations specific to each individual contract are defined within the terms of each order. Each performance obligation is identified based on the goods and services that will be transferred to our customer that are both capable of being distinct and are distinct within the context of the contract. The transaction price is determined based on the consideration to which we will be entitled and expect to receive in exchange for transferring goods or services to the customer. Typically, our contracts do not provide our customer with any right of return or refund; we do not constrain the contract price as it is probable that there will not be a significant revenue reversal due to a return or refund.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Typically, our customer contracts contain one or more of the following goods or services which constitute performance obligations.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Our proprietary software licenses typically provide for a perpetual right to use our software. Generally, our contracts do not provide significant services of integration and customization and installation services are not required to be purchased directly from us. The software is delivered before related services are provided and is functional without professional services, updates and technical support. We have concluded that the software license is distinct as the customer can benefit from the software on its own. Software revenue is typically recognized when the software is delivered or made available for download to the customer.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We recognize revenue for hardware sales when the product is shipped to the customer and when obligations that affect the customer’s final acceptance of the arrangement have been fulfilled. Hardware is purchased from suppliers and provided to the end-user customers via drop-ship or from inventory. We are responsible for negotiating price both with the supplier and the customer, payment to the supplier, establishing payment terms and product returns with the customer, and we bear the credit risk if the customer does not pay for the goods. As the principal contact with the customer, we recognize revenue and cost of goods sold when we ship or are notified by the supplier that the product has been shipped. In certain limited instances, as shipping terms dictate, revenue is recognized upon receipt at the point of destination or upon installation at the customer site.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Our subscription service revenue is comprised of fees for contracts that provide customers a right to access our software for a subscribed period. We do not provide the customer the contractual right to license the software at any time outside of the subscription period under these contracts. Our subscription service revenue is primarily based on rates per location, including rates per points of sale and per room. We recognize certain subscription service revenue on a per-transaction basis. The customer can only benefit from the software and software maintenance when provided the right to access the software. Accordingly, each of the rights to access the software, the maintenance services, any hosting services, and any transaction-based services is not considered a distinct performance obligation in the context of the contract and should be combined into a single performance obligation to be recognized over the contract period. The Company recognizes subscription revenue over a one-month period based on the typical monthly invoicing and renewal cycle in accordance with our customer agreement terms.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We derive maintenance service revenue from providing unspecified updates, upgrades, bug fixes, and technical support services for our proprietary software. These services represent a stand-ready obligation that is concurrently delivered and</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">has the same pattern of transfer to the customer; we account for these maintenance services as a single performance obligation. Maintenance revenue includes the same services provided by third-parties for remarketed software. We recognize substantially all maintenance revenue over the contract period of the maintenance agreement. We also recognize certain maintenance service revenue based on the volume of payment transactions processed by third parties through access to our software.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Professional services revenues primarily consist of fees for consulting, implementation, installation, integration, development and training and are generally recognized over time as the customer simultaneously receives and consumes the benefits of the professional services as the services are being performed. Certain professional development services are recognized upon delivery of the developed solutions to the customer. At the end of each reporting period, we recognize the most likely amount of variable consideration on any contract holdbacks we expect to bill for development services delivered. Professional services can be provided by internal or external providers, do not significantly affect the customer’s ability to access or use other provided goods or services, and provide a measure of benefit beyond that of other promised goods or services in the contract. As a result, professional services are considered distinct in the context of the contract and represent a separate performance obligation. Professional services that are billed on a time and materials basis are recognized over time as the services are performed. For contracts billed on a fixed price basis, revenue is recognized over time using an input method based on labor hours expended to date relative to the total labor hours expected to be required to satisfy the related performance obligation.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We use the market approach to derive standalone selling price (“SSP”) by maximizing observable data points (in the form of recently executed customer contracts) to determine the price customers are willing to pay for the goods and services transferred. If the contract contains a single performance obligation, the entire transaction price is allocated to that performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative SSP basis.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Shipping and handling fees billed to customers are recognized as revenue and the related costs are recognized in cost of goods sold. Revenue is recorded net of any applicable taxes collected and remitted to governmental agencies.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Disaggregation of Revenue</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We derive and report our revenue from the sale of products (proprietary software licenses, third party hardware and operating systems), subscription and maintenance, and professional services. Products revenue recognized at a point in time totaled </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">9.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">12.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> for the three months ended June 30, 2024 and 2023, respectively. Subscription, maintenance, and substantially all professional services revenue recognized over time totaled </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">53.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">43.3</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> for the three months ended June 30, 2024 and 2023, respectively.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Contract Balances</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Contract assets are rights to consideration in exchange for goods or services that we have transferred to a customer when that right is conditional on something other than the passage of time. The majority of our contract assets represent unbilled amounts related to products and professional services. We expect billing and collection of our contract assets to occur within the next twelve months. We receive payments from customers based upon contractual billing schedules and accounts receivable are recorded when the right to consideration becomes unconditional. Contract liabilities represent consideration received or consideration which is unconditionally due from customers prior to transferring goods or services to the customer under the terms of the contract.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Revenue recognized from amounts included in contract liabilities at the beginning of the period was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">26.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">22.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> for the three months ended June 30, 2024 and 2023, respectively. Because the right to the transaction became unconditional, we transferred to accounts receivable from contract assets at the beginning of the period, </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> for the three months ended June 30, 2024 and 2023, respectively.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Our arrangements are for a period of one year or less. As a result, unsatisfied performance obligations as of June 30, 2024 are expected to be satisfied and the allocated transaction price recognized in revenue within a period of 12 months or less.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Assets Recognized from Costs to Obtain a Contract</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Sales commission expenses that would not have occurred absent the customer contracts are considered incremental costs to obtain a contract. We expense the incremental costs to obtain a contract as incurred when the expected benefit and amortization period is one year or less. For subscription contracts that are renewed monthly based on an agreement term, we capitalize commission expenses and amortize as we satisfy the underlying performance obligations, generally based on the contract terms and anticipated renewals. Other sales commission expenses have a period of benefit of one year or less and are therefore expensed as incurred in line with the practical expedient elected.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We had </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.8</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> and $</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">4.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million of capitalized sales incentive costs as of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">June 30, 2024 and 2023, respectively. These balances are included in other non-current assets on our condensed consolidated balance sheets. During the three months ended June 30, 2024 and 2023, we expensed </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">, respectively, of sales commissions, which included amortization of capitalized amounts of </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> and </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.4</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">, respectively. These expenses are included in operating expenses – sales and marketing in our condensed consolidated statement of operations. All other costs to obtain a contract are not considered incremental and therefore are expensed as incurred.</span></p> 9900000 12800000 53600000 43300000 26800000 22100000 1900000 1600000 4800000 4000000 900000 900000 400000 400000 <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">4. Additional Balance Sheet Information</span></p><div style="font-size:12pt;font-family:'Proxima Nova',sans-serif;"><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Additional information related to the condensed consolidated balance sheets is as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:64.78%;"></td> <td style="width:1.68%;"></td> <td style="width:1%;"></td> <td style="width:15.38%;"></td> <td style="width:1%;"></td> <td style="width:1.68%;"></td> <td style="width:1%;"></td> <td style="width:12.48%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">June 30, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Accrued liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Salaries, wages, employee benefits, and payroll taxes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">7,744</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">16,264</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Income and indirect taxes payable</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">4,264</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,684</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">1,119</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,574</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">13,127</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">19,522</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Other non-current liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Employee benefit obligations</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">4,571</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">4,315</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">100</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">4,671</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">4,415</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table></div> <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Additional information related to the condensed consolidated balance sheets is as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:64.78%;"></td> <td style="width:1.68%;"></td> <td style="width:1%;"></td> <td style="width:15.38%;"></td> <td style="width:1%;"></td> <td style="width:1.68%;"></td> <td style="width:1%;"></td> <td style="width:12.48%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(In thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">June 30, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">March 31, 2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Accrued liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Salaries, wages, employee benefits, and payroll taxes</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">7,744</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">16,264</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Income and indirect taxes payable</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">4,264</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,684</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">1,119</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,574</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">13,127</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">19,522</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Other non-current liabilities:</span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Employee benefit obligations</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">4,571</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">4,315</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Other</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">100</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">100</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Total</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">4,671</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">4,415</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table> 7744000 16264000 4264000 1684000 1119000 1574000 13127000 19522000 4571000 4315000 100000 100000 4671000 4415000 <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">5. Supplemental Disclosures of Cash Flow Information</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><div style="font-size:12pt;font-family:'Proxima Nova',sans-serif;"><p style="font-size:10pt;margin-top:2pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Additional information related to the condensed consolidated statements of cash flows is as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.78%;"></td> <td style="width:1.62%;"></td> <td style="width:1%;"></td> <td style="width:13.14%;"></td> <td style="width:1%;"></td> <td style="width:1.62%;"></td> <td style="width:1%;"></td> <td style="width:12.84%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Three months ended<br/>June 30,</span></p></td> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(In thousands)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2024</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2023</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Cash receipts for interest, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">1,424</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">893</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Cash payments for income tax, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">578</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">376</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Cash payments for operating leases</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">912</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,425</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Cash payments for finance leases</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Accrued capital expenditures</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">181</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">320</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table></div> <p style="font-size:10pt;margin-top:2pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Additional information related to the condensed consolidated statements of cash flows is as follows:</span></p><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.78%;"></td> <td style="width:1.62%;"></td> <td style="width:1%;"></td> <td style="width:13.14%;"></td> <td style="width:1%;"></td> <td style="width:1.62%;"></td> <td style="width:1%;"></td> <td style="width:12.84%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Three months ended<br/>June 30,</span></p></td> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(In thousands)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2024</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2023</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Cash receipts for interest, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">1,424</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">893</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Cash payments for income tax, net</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">578</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">376</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Cash payments for operating leases</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">912</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,425</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Cash payments for finance leases</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Accrued capital expenditures</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">181</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">320</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table> 1424000 893000 578000 376000 912000 1425000 0 2000 181000 320000 <p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">6. Income Taxes</span></p><div style="font-size:10pt;font-family:'Proxima Nova',sans-serif;"><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following table compares our income tax provision and effective tax rates for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">three months ended June 30, 2024 and 2023:</span></p><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.72%;"></td> <td style="width:1.72%;"></td> <td style="width:1%;"></td> <td style="width:12.92%;"></td> <td style="width:1%;"></td> <td style="width:1.72%;"></td> <td style="width:1%;"></td> <td style="width:12.92%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Three months ended<br/>June 30,</span></p></td> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Income tax (benefit) provision</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(</span><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">6,734</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">352</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Effective tax rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">nm</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">18.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">%</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:6pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">nm - not meaningful</span></p></div><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">For the three months ended June 30, 2023, income tax provision and the effective tax rate were primarily driven by activity within the foreign jurisdictions in which the company operates as valuation allowances were recorded against deferred tax assets in the U.S. and Canada. We released valuation allowances recorded against Canadian, U.S. Federal and certain state deferred tax assets in the period ending December 31, 2023.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">For the three months ended June 30, 2024, income tax (benefit) and the effective tax rate were primarily driven by the impact of discrete excess tax benefits associated with Share-Based Compensation.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Our India subsidiary operates in a “Special Economic Zone (“SEZ”)”. One of the benefits associated with the SEZ is that the India subsidiary is not subject to regular India income taxes during its first five years of operations, which included fiscal 2018 through fiscal 2022. The India subsidiary is subject to </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">50</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">% of regular India income taxes during its second five years of operations, which includes fiscal 2023 through fiscal 2027.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We have recorded and maintain valuation allowances offsetting the Company’s deferred tax assets in certain U.S. States and foreign jurisdictions. The ultimate realization of deferred tax assets depends on various factors including the generation of future taxable income in the periods in which the underlying temporary differences are deductible. We maintain valuation allowances for deferred tax assets until we have sufficient evidence to support the reversal of all or some portion of the allowances.</span></p> <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following table compares our income tax provision and effective tax rates for the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">three months ended June 30, 2024 and 2023:</span></p><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:66.72%;"></td> <td style="width:1.72%;"></td> <td style="width:1%;"></td> <td style="width:12.92%;"></td> <td style="width:1%;"></td> <td style="width:1.72%;"></td> <td style="width:1%;"></td> <td style="width:12.92%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Three months ended<br/>June 30,</span></p></td> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(Dollars in thousands)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Income tax (benefit) provision</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(</span><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">6,734</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">352</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Effective tax rate</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">nm</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">18.5</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">%</span></p></td> </tr> </table><p style="font-size:10pt;margin-top:6pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">nm - not meaningful</span></p> -6734000 352000 0.185 0.50 <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">7. Commitments and Contingencies</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We are involved in legal actions that arise in the ordinary course of business. It is the opinion of management that the resolution of any current pending litigation will not have a material adverse effect on our financial position or results of operations.</span></p> <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">8. Earnings per Share</span></p><div style="font-size:12pt;font-family:'Proxima Nova',sans-serif;"><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following data shows the amounts used in computing earnings per share and the effect on earnings and the weighted average number of shares of dilutive potential common shares.</span></p><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.68%;"></td> <td style="width:1%;"></td> <td style="width:13.120000000000001%;"></td> <td style="width:1%;"></td> <td style="width:2.08%;"></td> <td style="width:1%;"></td> <td style="width:13.120000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Three months ended<br/>June 30,</span></p></td> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(In thousands, except per share data)</span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Numerator:</span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Net income</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">14,106</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,548</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Series A convertible preferred stock dividends</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(</span><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">459</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Net income attributable to common shareholders</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">14,106</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,089</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="background-color:#ededed;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:10pt;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Denominator:</span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Weighted average shares outstanding - basic</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">27,134</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">24,936</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Dilutive SSARs</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">710</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,008</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Dilutive unvested restricted shares</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">270</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">231</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Dilutive unvested restricted stock units</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">13</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Weighted average shares outstanding - diluted</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">28,127</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">26,177</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:10pt;vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Income per share - basic:</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">0.52</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.04</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Income per share - diluted:</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">0.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.04</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="background-color:#ededed;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Anti-dilutive SSARs, restricted shares,<br/>   performance shares and preferred shares</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,735</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Basic income per share is computed as net income attributable to common shareholders divided by the weighted average basic shares outstanding. The outstanding shares used to calculate the weighted average basic shares excludes </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;white-space:pre-wrap;min-width:fit-content;color:#000000;">367,271</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> and </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">339,956</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> of restricted shares at </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">June 30, 2024 and 2023, respectively, as these shares were issued but were not vested and therefore, not considered outstanding for purposes of computing basic income per share at the balance sheet dates.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Diluted income per share includes the impact of all potentially dilutive securities on earnings per share. We have stock-settled appreciation rights (SSARs), restricted shares, restricted stock units, and preferred shares that are potentially dilutive securities.</span></p> <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following data shows the amounts used in computing earnings per share and the effect on earnings and the weighted average number of shares of dilutive potential common shares.</span></p><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:67.68%;"></td> <td style="width:1%;"></td> <td style="width:13.120000000000001%;"></td> <td style="width:1%;"></td> <td style="width:2.08%;"></td> <td style="width:1%;"></td> <td style="width:13.120000000000001%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Three months ended<br/>June 30,</span></p></td> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(In thousands, except per share data)</span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Numerator:</span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Net income</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">14,106</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,548</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Series A convertible preferred stock dividends</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(</span><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">459</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">)</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Net income attributable to common shareholders</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">14,106</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,089</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="background-color:#ededed;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:10pt;vertical-align:top;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Denominator:</span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Weighted average shares outstanding - basic</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">27,134</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">24,936</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Dilutive SSARs</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">710</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,008</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Dilutive unvested restricted shares</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">270</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">231</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:15pt;white-space:pre-wrap;vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="margin-left:15pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Dilutive unvested restricted stock units</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">13</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">2</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Weighted average shares outstanding - diluted</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">28,127</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">26,177</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="text-indent:10pt;vertical-align:top;border-bottom:0.5pt solid #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Income per share - basic:</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">0.52</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.04</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Income per share - diluted:</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">0.50</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.04</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="background-color:#ededed;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Anti-dilutive SSARs, restricted shares,<br/>   performance shares and preferred shares</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">7</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,735</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table> 14106000 1548000 0 -459000 14106000 1089000 27134000 24936000 710000 1008000 270000 231000 13000 2000 28127000 26177000 0.52 0.04 0.5 0.04 7000 1735000 367271000 339956000 <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">9. Share-based Compensation</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We may grant incentive stock options, non-qualified stock options, SSARs, restricted shares, restricted stock units, and performance shares under our shareholder-approved 2020 Stock Incentive Plan (the 2020 Plan) for up to </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million common shares, plus </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">868,864</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> common </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">shares, the number of shares that were remaining for grant under the 2016 Stock</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Incentive </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Plan (the 2016 Plan) as of the effective date of the 2020 Plan, plus the number of shares remaining for grant under the 2016 Plan that are forfeited, settled in cash, canceled or expired. The maximum aggregate number of restricted shares or restricted stock units that may be granted under the 2020 Plan is </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">3.1</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million. We may also grant shares under our shareholder-approved Employee Stock Purchase Plan (the ESPP) for up to </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">500,000</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> common shares.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We may distribute authorized but unissued shares or treasury shares to satisfy share option and SSAR exercises or grants of restricted shares, restricted stock units, performance shares, or ESPP shares.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">For SSARs, the exercise price must be set at least equal to the closing market price of our common shares on the date of grant. The maximum term of SSARs is seven years from the date of grant. The Compensation Committee of the Board of Directors establishes the period over which SSARs subject to a service condition vest and the vesting criteria for SSARs subject to a market condition.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Restricted shares and restricted stock units, whether time-vested or performance-based, may be issued at no cost or at a purchase price that may be below their fair market value, but are subject to forfeiture and restrictions on their sale or other transfer. Performance-based grants may be conditioned upon the attainment of specified performance objectives and other conditions, restrictions, and contingencies. Restricted shares have the right to receive dividends, if any, upon vesting, subject to the same forfeiture provisions that apply to the underlying grants.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We record compensation expense related to SSARs, restricted shares, restricted stock units, performance shares, and ESPP shares granted to certain employees and non-employee directors based on the fair value of the awards on the grant date. The fair value of restricted stock unit and restricted share grants subject only to a service condition is based on the closing price of our common shares on the grant date. For stock option and SSAR grants subject only to a service condition, we estimate the fair value on the grant date using the Black-Scholes-Merton option pricing model with inputs including the closing market price at grant date, exercise price and assumptions regarding the risk-free interest rate, expected volatility of our common shares based on historical volatility, and expected term as estimated using the simplified method. We use the simplified method for SSAR grants because we believe historical exercise data does not provide a reasonable basis upon which to estimate the expected term. For restricted stock unit, restricted share, and SSAR grants subject to a market condition, we estimate the fair value on the grant date through a lattice option pricing model that utilizes a Monte Carlo analysis with inputs including the closing market price at grant date, share price threshold, performance period term and assumptions regarding the risk-free interest rate and expected volatility of our common shares based on historical volatility. Inputs for SSAR grants subject to a market condition also include exercise price, remaining contractual term, and suboptimal exercise factor.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We record compensation expense for restricted stock units, restricted shares, and SSAR grants subject to a service condition using the graded vesting method. We record compensation expense for ESPP shares on a straight-line basis over the applicable offering period. We record compensation expense for SSAR grants subject only to a market condition over the derived service period, which is an output of the lattice option pricing model. Under the 2020 Plan, the fair value of performance shares is based on the closing price of our common shares on the settlement date of the performance award, for which we record compensation expense over the service period consistent with our annual bonus incentive plan as approved by the Compensation Committee of the Board of Directors.</span></p><div style="font-size:10pt;font-family:'Proxima Nova',sans-serif;"><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following table summarizes the share-based compensation expense for restricted and performance grants included in the condensed consolidated statements of operations:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:64.147%;"></td> <td style="width:1%;"></td> <td style="width:15.197%;"></td> <td style="width:1%;"></td> <td style="width:1.46%;"></td> <td style="width:1%;"></td> <td style="width:15.197%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Three months ended<br/>June 30,</span></p></td> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(In thousands)</span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Product development</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2,636</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,625</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Sales and marketing</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">331</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">166</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">General and administrative</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">1,462</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,376</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Total share-based compensation expense</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">4,429</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">3,167</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Stock-Settled Appreciation Rights</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">SSARs are rights granted to an employee to receive value equal to the difference between the price of our common shares on the date of exercise and the exercise price. The value is settled in common shares of Agilysys, Inc.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We use a Black-Scholes-Merton option pricing model to estimate the fair value of service condition SSARs and a lattice option pricing model to estimate the fair value of market condition SSARs. There were no SSARs granted during the three months ended June 30, 2024 and 2023.</span></p><div style="font-size:10pt;font-family:'Proxima Nova',sans-serif;"><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following table summarizes the activity during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">three months ended June 30, 2024 for SSARs awarded under the 2020 and 2016 Plans:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:48.49%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:9.178%;"></td> <td style="width:1%;"></td> <td style="width:1.26%;"></td> <td style="width:1%;"></td> <td style="width:10.857999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.238%;"></td> <td style="width:1%;"></td> <td style="width:1.26%;"></td> <td style="width:1%;"></td> <td style="width:7.719%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Number of<br/>Rights</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Weighted-Average Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Remaining<br/>Contractual<br/>Term</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(per right)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(in years)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at April 1, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,297,339</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">27.63</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Exercised</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(</span><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">737,136</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">33.48</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Expired</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at June 30, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">560,203</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">19.94</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">3.3</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">47,169</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Exercisable at June 30, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">560,203</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">19.94</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">3.3</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">47,169</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Vested and expected to vest at June 30, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">560,203</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">19.94</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">3.3</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">47,169</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></div><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">As of June 30, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">, there was </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> unrecognized share-based compensation expense related to SSARs.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Restricted Shares</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We granted shares to certain of our Directors, executives and key employees, the vesting of which is service-based. Certain restricted shares are also subject to a market condition. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following table summarizes the activity during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">three months ended June 30, 2024 for restricted shares awarded under the 2020 Plan:</span></span></p><div style="font-size:10pt;font-family:'Proxima Nova',sans-serif;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:64.88%;"></td> <td style="width:1.36%;"></td> <td style="width:1%;"></td> <td style="width:12.82%;"></td> <td style="width:1%;"></td> <td style="width:1.68%;"></td> <td style="width:1%;"></td> <td style="width:15.26%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Number of Shares</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Weighted-Average<br/>Grant-Date<br/>Fair Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(per share)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at April 1, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">436,177</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">65.52</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">13,149</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">103.30</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Vested</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(</span><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">79,792</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">53.51</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(</span><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,263</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">70.58</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at June 30, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">367,271</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">68.05</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></div><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The weighted-average grant date fair value of the restricted shares includes grants subject only to a service condition and certain grants subject to both a service condition and a market condition. As of June 30, 2024, total unrecognized share-based compensation expense related to</span><span style="color:#000000;white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">unvested restricted shares was </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">12.9</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">, which is expected to be recognized over a weighted-average vesting period of </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2.0</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> years.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Restricted Stock Units</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We granted restricted stock units to our Chief Executive Officer, the vesting of which is service-based. Certain restricted stock units are also subject to a market condition. </span><span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following table summarizes the activity during </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">three months ended June 30, 2024 for restricted stock units awarded under the 2020 Plan:</span></span></p><div style="font-size:10pt;font-family:'Proxima Nova',sans-serif;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:64.88%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:12.98%;"></td> <td style="width:1%;"></td> <td style="width:1.68%;"></td> <td style="width:1%;"></td> <td style="width:15.24%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Number of Shares</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Weighted-Average Grant-Date Fair Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(per share)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at April 1, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">56,547</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">70.03</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Vested</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at June 30, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">56,547</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">70.03</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">As of June 30, 2024, total unrecognized share-based compensation expense related to non-vested restricted stock units was $</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">2.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million, which is expected to be recognized over the weighted-average vesting period of </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">1.8</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> years.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Performance Shares</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Upon approval of the Compensation Committee of our Board of Directors, after achieving the performance conditions associated with our annual bonus plan, we granted </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">6,098</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> common shares to our Chief Executive Officer in May 2024 that vested immediately for a total value of $</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.6</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Employee Stock Purchase Plan Shares</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The ESPP permits participants to purchase common stock through regular payroll deductions, up to a specified percentage of their eligible compensation. The ESPP is compensatory because, among other provisions, it currently allows participants to purchase stock at up to a </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">15</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">% discount from the lower of the closing price of a share of our common stock on the first or last trading day of the ESPP offering period. We measure share-based compensation expense for the ESPP based on the fair value of the ESPP grant at the beginning of the offering period. The fair value includes the value of the discount and the value associated with the call and put options that take advantage of the variability in the common stock price during the offering period. </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We estimate the value of the call and put options using the Black-Scholes-Merton option pricing model with inputs including the closing market price of our common stock on the first date of the offering period and assumptions regarding the risk-free interest rate, expected term, and expected volatility of our common shares over the offering period based on historical volatility.</span></span></p><div style="font-size:10pt;font-family:'Proxima Nova',sans-serif;"> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.04%;"></td> <td style="width:2.08%;"></td> <td style="width:1%;"></td> <td style="width:15.88%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Offering Period Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">June 30, 2024</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Grant date fair value</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">81.60</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Risk-free interest rate over contractual term</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">5.36</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Expected term (in years)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">0.41</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Expected volatility</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">47.41</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">%</span></p></td> </tr> </table></div><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The risk-free interest rate is based on the yield of a zero coupon U.S. Treasury bond whose maturity period approximates the expected term of the ESPP shares. The expected term is the offering period, which is typically six months.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We record amounts withheld from participants during each offering period in accrued salaries, wages and related benefits in the consolidated balance sheets until such shares are purchased. Amounts withheld from participants for the offering period ended June 30, 2024 totaled $</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.5</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million as of June 30, 2024.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:12pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">As of June 30, 2024, there was </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> unrecognized share-based compensation expense related of the offering period ending June 30, 2024.</span></p> 2250000 868864 3100000 500000 <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following table summarizes the share-based compensation expense for restricted and performance grants included in the condensed consolidated statements of operations:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:64.147%;"></td> <td style="width:1%;"></td> <td style="width:15.197%;"></td> <td style="width:1%;"></td> <td style="width:1.46%;"></td> <td style="width:1%;"></td> <td style="width:15.197%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="6" style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Three months ended<br/>June 30,</span></p></td> <td style="vertical-align:top;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(In thousands)</span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2024</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">2023</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Product development</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">2,636</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,625</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Sales and marketing</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">331</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">166</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">General and administrative</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">1,462</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,376</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Total share-based compensation expense</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">4,429</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">3,167</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table> 2636000 1625000 331000 166000 1462000 1376000 4429000 3167000 <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following table summarizes the activity during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">three months ended June 30, 2024 for SSARs awarded under the 2020 and 2016 Plans:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:48.49%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:9.178%;"></td> <td style="width:1%;"></td> <td style="width:1.26%;"></td> <td style="width:1%;"></td> <td style="width:10.857999999999999%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:1%;"></td> <td style="width:11.238%;"></td> <td style="width:1%;"></td> <td style="width:1.26%;"></td> <td style="width:1%;"></td> <td style="width:7.719%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:8pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(In thousands, except share and per share data)</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Number of<br/>Rights</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Weighted-Average Exercise Price</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Remaining<br/>Contractual<br/>Term</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Aggregate<br/>Intrinsic<br/>Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(per right)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(in years)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at April 1, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,297,339</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">27.63</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Exercised</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(</span><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">737,136</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">33.48</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Expired</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at June 30, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">560,203</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">19.94</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">3.3</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">47,169</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Exercisable at June 30, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">560,203</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">19.94</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">3.3</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">47,169</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Vested and expected to vest at June 30, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">560,203</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">19.94</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">3.3</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">47,169</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> 1297339 27.63 0 0 737136 33.48 0 0 0 0 560203 19.94 P3Y3M18D 47169000 560203 19.94 P3Y3M18D 47169000 560203 19.94 P3Y3M18D 47169000 0 <span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following table summarizes the activity during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">three months ended June 30, 2024 for restricted shares awarded under the 2020 Plan:</span> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:64.88%;"></td> <td style="width:1.36%;"></td> <td style="width:1%;"></td> <td style="width:12.82%;"></td> <td style="width:1%;"></td> <td style="width:1.68%;"></td> <td style="width:1%;"></td> <td style="width:15.26%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Number of Shares</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Weighted-Average<br/>Grant-Date<br/>Fair Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(per share)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at April 1, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">436,177</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">65.52</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">13,149</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">103.30</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Vested</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(</span><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">79,792</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">53.51</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(</span><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">2,263</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">70.58</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at June 30, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">367,271</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">68.05</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> 436177 65.52 13149 103.3 79792 53.51 2263 70.58 367271 68.05 12900000 P2Y <span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">The following table summarizes the activity during </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">three months ended June 30, 2024 for restricted stock units awarded under the 2020 Plan:</span><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:64.88%;"></td> <td style="width:1.22%;"></td> <td style="width:1%;"></td> <td style="width:12.98%;"></td> <td style="width:1%;"></td> <td style="width:1.68%;"></td> <td style="width:1%;"></td> <td style="width:15.24%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Number of Shares</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Weighted-Average Grant-Date Fair Value</span></p></td> <td style="vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">(per share)</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at April 1, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">56,547</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">70.03</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Granted</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Vested</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="text-indent:10pt;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="margin-left:10pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Forfeited</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">—</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:0.5pt solid #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Outstanding at June 30, 2024</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">56,547</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">70.03</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;border-bottom:2.25pt double #009cde;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> </table> 56547 70.03 0 0 0 0 0 0 56547 70.03 2000000 P1Y9M18D 6098 600000 0.15 <span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">We estimate the value of the call and put options using the Black-Scholes-Merton option pricing model with inputs including the closing market price of our common stock on the first date of the offering period and assumptions regarding the risk-free interest rate, expected term, and expected volatility of our common shares over the offering period based on historical volatility.</span> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"> <tr style="visibility:collapse;"> <td style="width:80.04%;"></td> <td style="width:2.08%;"></td> <td style="width:1%;"></td> <td style="width:15.88%;"></td> <td style="width:1%;"></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Offering Period Ended</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;white-space:pre-wrap;word-break:break-word;"> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td colspan="2" style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">June 30, 2024</span></p></td> <td style="vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Grant date fair value</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">81.60</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Risk-free interest rate over contractual term</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">5.36</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">%</span></p></td> </tr> <tr style="height:10pt;background-color:#ffffff;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Expected term (in years)</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">0.41</span></span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:10pt;background-color:#ededed;word-break:break-word;"> <td style="white-space:pre-wrap;vertical-align:middle;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Expected volatility</span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p></td> <td style="white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:right;"><span style="font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">47.41</span></p></td> <td style="white-space:nowrap;vertical-align:bottom;"><p style="font-size:10pt;margin-top:0;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;font-weight:bold;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">%</span></p></td> </tr> </table> 81.6 0.0536 P0Y4M28D 0.4741 500000 0 <p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">10. Preferred Stock</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Series A Convertible Preferred Stock</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">On May 22, 2020, we completed the sale of </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1,735,457</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> shares of our preferred stock, without par value, designated as “Series A Convertible Preferred Stock” (the “Convertible Preferred Stock”) to MAK Capital Fund L.P. and MAK Capital Distressed Debt Fund I, LP (the “Holders”) each, in its capacity as a designee of MAK Capital One LLC (the “Purchaser”), pursuant to the terms of the Investment Agreement, dated as of May 11, 2020, between the Company and the Purchaser, for an aggregate purchase price of $</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">35</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million. We incurred issuance costs of $</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">1.0</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> million. We added all issuance costs that were netted against the proceeds upon issuance of the Convertible Preferred Stock to its redemption value. As disclosed in our Annual Report for the fiscal year ended March 31, 2021, Michael Kaufman, the Chairman of the Company’s Board of Directors, is the Chief Executive Officer of MAK Capital One LLC.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Conversion</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">On November 24, 2023, at our option, we required conversion of all the outstanding shares of Convertible Preferred Stock to common stock. On November 27, 2023, we filed a Certificate of Elimination with the Secretary of State of the State of Delaware with respect to the Convertible Preferred Stock pursuant to which the Convertible Preferred Stock was eliminated and returned to the status of authorized and unissued preferred shares of the Company. Following the mandatory conversion of the outstanding shares of the Convertible Preferred Stock on November 24, 2023, there were no outstanding shares of the Convertible Preferred Stock. Accordingly, we removed the Series A convertible preferred stock, </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> par </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">value from temporary equity on our consolidated balance sheet and recorded the associated increase of common shares at</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">$</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">0.30</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> stated value and capital in excess of stated value further reflected in our consolidated statement of shareholders' equity.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Dividends</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Prior to the conversion on November 24, 2023,</span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> the Holders were entitled to dividends on the Liquidation Preference at the rate of </span><span style="font-size:10pt;font-family:'Proxima Nova',sans-serif;color:#000000;white-space:pre-wrap;min-width:fit-content;">5.25</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">% per annum, payable semi-annually either (i) 50% in cash and 50% in kind as an increase in the then-current Liquidation Preference or (ii) 100% in cash, at the option of the Company.</span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> We paid dividends in the same period as declared by the Company’s Board of Directors.</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;font-style:italic;min-width:fit-content;">Accounting Policy</span></p><p style="font-size:10pt;margin-top:12pt;font-family:Proxima Nova;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;">Prior to the conversion on November 24, 2023, we classified convertible preferred stock as temporary equity in the consolidated balance sheets due to certain contingent redemption clauses that were at the election of the Holders. We increased the carrying value of the convertible preferred stock to its redemption value for all undeclared dividends using the interest method.<br/></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:'Proxima Nova',sans-serif;min-width:fit-content;"> </span></p> 1735457000 35000000 1000000 0 0.3 the Holders were entitled to dividends on the Liquidation Preference at the rate of 5.25% per annum, payable semi-annually either (i) 50% in cash and 50% in kind as an increase in the then-current Liquidation Preference or (ii) 100% in cash, at the option of the Company. 0.0525